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Osteoarthritis (OA) is characterised by the degeneration of the cartilage matrix
leading to cartilage destruction and loss. The underlying bone is therefore no longer
protected from the forces associated with joint movement. Chondrocytes are the only
cell type found in normal cartilage. These are considered to be terminally
differentiated cells that play a role in the synthesis and maintenance of the cartilage
matrix. The repeated and abrupt force changes that chondrocytes are subjected to
provide stimuli that can modify the cells metabolic function. In addition to
mechanical stimuli, chondrocyte function can also be regulated by a variety of
cytokines and growth factors. Several proinflammatory cytokines have been shown to
mediate their effects through the induction of nitric oxide (NO) production. The aim
of this study was to investigate the interactions between cyclic mechanical
stimulation, nitric oxide production and the regulation of human chondrocyte
proteoglycan levels.
Transformed chondrocyte cell lines and primary OA human articular
chondrocytes (HAC) were grown in monolayer culture. Cells were exposed to
cyclical mechanical stimulation (MS) using an apparatus that produces strain on the
base of the culture dish, causing the deformation of attached cells. Chondrocytes
were also incubated with a cytokine cocktail containing IL-1 (3, TNFa, IL-6 and IFNy
(CYT). Nitric oxide synthase (NOS) mRNA, protein and nitrite levels were
measured, as well as aggrecan mRNA levels.
Unexpectedly, the transformed chondrocyte cell lines C20A4 and C28I2 did
not express detectable levels ofNOS protein or nitrite activity, while increased
inducible NOS (iNOS) mRNA following CYT stimulation suggested that the cells
were able to sense this stimulus.
Primary OA HAC showed increased production of iNOS mRNA, protein and
nitrite following CYT or IL-ip stimulation. The simultaneous application ofCYT
and MS also showed elevated iNOS mRNA, protein and nitrite levels, although these
were significantly lower than following CYT alone. An IL-4 neutralising antibody
and a (31 integrin function blocking antibody did not reverse the decreased CYT
induced iNOS associated with MS. This suggests that MS decreases CYT induced
iNOS through an IL-4 and a pi integrin independent mechanism.
A novel iNOS inhibitor (AR-C102222) was shown to have little effect on
iNOS mRNA and protein levels following CYT stimulation ofprimary OA HAC.
However, a dose dependent decrease in nitrite production was seen.
Aggrecan mRNA levels in primary OA HAC were decreased following
stimulation with CYT. The possible role ofNO in this decreased aggrecan mRNA
level was investigated. MS and a novel iNOS inhibitor both decreased the production
ofNO, but did not alter the CYT mediated decreased aggrecan mRNA. The NO
donor SNAP did not alter aggecan mRNA levels. These results suggest that NO is not
involved in regulating aggrecan mRNA levels, although several factors may influence
the aggrecan mRNA levels which makes it difficult to confirm this conclusion. The
final study using cells from an iNOS knockout mouse suggested that both NO
dependent and independent mechanisms exist by which CYT can decrease aggrecan
mRNA levels.
These studies demonstrate that MS may have an anti-inflammatory role
through decreasing CYT induced iNOS. Further work is required, however, to
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Chapter 1 - Introduction
1.1 - Articular Cartilage
1.1.1 - Structure of Articular Cartilage
Articular cartilage is a highly specialised and uniquely designed bio-material that
forms the smooth, gliding surface covering the heads of long bones in articular joints.
This avascular, aneural and alymphatic tissue provides protection for the underlying
bone against shearing and compressive forces. Articular cartilage is composed of
water (65-80%), collagen (10-30%), proteoglycans (5-10%) and chondrocytes, the
cells responsible for cartilage synthesis and homeostasis (0.4-2%) (Kuettner et al
1991; Poole 1997). The cartilage is normally divided into 4 zones parallel to the
surface (Figure 1.2) (Collins and McElligott 1960):
(I) Superficial zone (5-10%); adjacent to joint cavity, where collagen fibrils
are arranged tangentially to the surface. The cells are discoidal with their
long axis parallel to the surface.
(II) Intermediate (transitional) zone (40-45%); the coiled collagen fibrils are
randomly oriented in an interlacing meshwork, with the cells spheroidal
and evenly spaced.
(III) Deep zone (40-45%); the cells are large, rounded and aligned in vertical
columns. The collagen fibres are arranged radially to the surface.
(IV) Calcified zone (5-10%); adjacent to the subchondral bone. There are few
cells and the matrix is mineralised with crystals of calcium salts. The
border between the deep and calcified zone is visible in histological
sections and is called the tide mark.
The matrix of the intermediate and deep zones can be further divided into the
pericellular, territorial and interterritorial, each with different structural organisation
(Poole et al 1982) (Figure 1.1). The pericellular matrix and the chondrocyte form a
structure known as the chondron, composed of a fine collagen type II mesh containing
the cell. Collagen VI is found only in the pericellular matrix and is thought to link
collagen II to the chondrocyte. The different zones of cartilage have altered ECM
composition, with increased collagens in superficial areas and increased PGs in deep
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areas exposing the cells within each zone to different strains (Langelier et al 2000).
The cartilage extracellular matrix (ECM) is composed of fibrillar and non-fibrillar
components.
The fibrillar matrix is a network consisting primarily of triple helical type II collagen
molecules (Aigner et al 2002b). This is the major structural component of cartilage,
forming a highly cross-linked fibrillar network that is found throughout the ECM,
providing the strength of the tissue by resisting shear and tensile forces (Kempson et
al 1973). The tangential arrangement of these fibres in the superficial layer resists
shear stresses during joint movement whereas the radial organisation in deeper layers
functions primarily to resist the internal swelling pressure of the matrix (Meachim et
al 1974). Collagen types VI, IX, XI, XII and XIV are minor components of the
cartilage ECM, however they appear to have important structural and functional
properties (Goldring 2000).
The non-fibrillar matrix consists mainly of aggrecan monomers highly sulphated
through the covalent attachment of glycosaminoglycan (GAG) sidechains of
chondroitin sulphate and keratan sulphate (Doege et al 1991). Aggrecan accounts for
approximately 80% of proteoglycans (PG) in articular cartilage (Carney and Muir
1988), forming large macromolecular aggregates via link protein stabilisation of its
non-covalent interaction with polymeric hyaluronic acid through the G1 globular
domain of the aggrecan core protein (Poole et al 1980). Full-length aggrecan attached
to hyaluronan binds the cell surface receptor CD44 (Embry and Knudson 2003). The
GAG molecules consist of long chain, unbranched, repeating dimeric polysaccharides
containing both carboxyl and sulphate groups to provide a highly negatively charged
aggregate. Polymorphism in the chondroitin sulphate domain makes aggrecan a
heterogeneous population (Hardingham and Bayliss 1990). The fixed negative charge
of the PGs dictate the extracellular ionic composition of cartilage, causing high
osmolality that results in fluid being imbibed by cartilage. This swelling is resisted by
the collagen fibres, so even at rest there is a hydrostatic pressure of 0.2MPa in human
articular cartilage. Under compressive force cartilage is compliant, rapidly recovering
its elasticity as water is drawn back into the matrix by the hydrophilic aggrecan
aggregates (Carney and Muir 1988). The PGs also act as permeability barriers
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preventing molecules such as immunoglobulins from entering the tissue (Urban
1994).
The collagen network therefore provides tensile strength that hinders the expansion of
the viscoelastic aggrecan, providing compressive stiffness and the ability to resist
deformation and dissipate load (Maroudas 1976; Poole 1997).
There are several other matrix proteins that are not unique to cartilage, but have
important roles in cartilage stucture and function. The small leucine-rich
proteoglycans biglycan, decorin, fibromodulin and lumican interact with the collagen
network, contributing to the fixed charge density and binding growth factors such as
transforming growth factor P (TGF-P) (Heinegard and Oldberg 1989). Non-
collagenous proteins are also found, with fibronectin promoting attachment to
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Figure 1.2 - Hematoxylin-eosin stained section of human articular cartilage
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1.1.2 - Chondrocytes
Chondrocytes are the only cell type found in normal cartilage. These are considered
to be terminally differentiated cells that play a role in the synthesis and maintenance
of the cartilage matrix (Goldring 2000). A dynamic balance exists between PG
synthesis and degradation allowing chondrocytes to maintain a uniform concentration
of PGs within the cartilage matrix (Morales and Hascall 1989).
The matrix metalloproteases (MMPs) are a family of enzymes that degrade cartilage
ECM including collagens (Billinghurst et al 1997) and PGs (Lark et al 1997). These
MMPs are synthesised as latent proenzymes activated through proteolytic cleavage by
molecules such as plasmin and cathepsin B (Mehraban et al 1994). These enzymes
are kept under control by the production of molecules termed tissue inhibitors of
MMPs (TIMPs) (Attur et al 2000). The production ofMMPs is upregulated by
proinflammatory cytokines such as interleukin-1P (IL-ip) (Little et al 2002). The
inhibition of IL-ip activity through addition of IL-1 receptor antagonist (IL-lra)
(Bresnihan et al 1998) or transfection with the non-functional IL-1 receptor II (IL-
1RII) (Attur et al 2000; Attur et al 2002) leads to a decrease in MMP production.
ADAM-TS (a disintegrin and metalloproteinase with thrombospondin type) 1, 4 and 5
are enzymes involved in aggrecan cleavage (Tortorella et al 1999).
The variation in PG concentration within cartilage and across the joint indicates that
sensitive mechanisms exist to regulate PG turnover which are dependent on the
chondrocytes' physicochemical environment (Langelier et al 2000).
The repeated and abrupt force changes that chondrocytes are subjected to provide
mechanical stimuli that can modify the cells metabolic function. Attachment of the
ECM to the cell surface provides a mechanism through which mechanical signals
could be sensed by the cells. The dynamic aggrecan proteoglycan structure assembled
on hyaluronic acid (HA) binds to its receptor, CD44, on the cell membrane (Knudson
1993). Several integrin molecules have been identified on the cell surface that bind
specific components of the ECM (Knudson and Loeser 2002; Salter et al 1992). An
example of the response to strain is the frequency dependent increase in PG synthesis
that occurs following compression (Urban 1994).
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In addition to mechanical stimuli, chondrocyte function can also be regulated by a
variety of cytokines and growth factors. These include the proinflammatory cytokines
such as IL-ip and tumour necrosis factor a (TNFa) which act through the generation
of other inflammatory mediators resulting in decreased synthesis and increased
breakdown of PGs (Goldring 2000). Growth factors including TGF|3 and insulin-like
growth factor-1 (IGF-1) stimulate chondrocyte differentiation and the synthesis of
cartilage matrix components, such as PGs and collagen type II (Aigner et al 2002b).
Chondrocytes are also influenced by other factors in their extracellular environment.
The concentration of fixed negative charges on the proteoglycans influences H+ ion
concentrations and so extracellular pH. Chondrocytes obtain their energy primarily
via anaerobic glycolysis, with lactic acid diffusing out to the synovial fluid causing
pH gradients. The avascular nature of cartilage results in gradients of other molecules
including oxygen varying from 6% in superficial to 1% in deep layers (Urban 1994).
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1.2 - Osteoarthritis
Radiographic evidence of osteoarthritis (OA) is seen in at least one joint in more than
70% of persons from 55-74 years old and contributes greatly to the cost of health care
for ageing populations (Gabriel et al 1997, Lawrence et al 1998). The incidence in
women is higher than in men, especially for hand and knee OA, and particularly after
50 years of age (Butler et al 1988). Extrinsic factors such as physical activity and
injury influence OA. Intrinsic factors that determine load distribution include
alignment, muscle strength and varus-valgus laxity, and can all contribute to OA
(Sharma 2001). The risk of developing knee OA is increased due to increased weight
(Anderson and Felson 1988) and genetic studies have identified multiple gene
variations associated with an increased risk in OA. This suggests there is potentially a
genetic component involved in OA progression (Reginato and Olsen 2002).
The macroscopic alteration in the cartilage surface in OA includes fibrillation, erosion
and cracking. The most widely used system for grading OA from gross pathology is
that proposed by Collins and McElligott (1960). The microscopic structure of
cartilage is commonly graded using the system described by Mankin et al (1971). The
combined use of both macroscopic and microscopic techniques will allow more
competent assessments ofjoint changes in OA (Ostergaard et al 1997a).
The disease involves the slowly progressive loss of articular cartilage. Cartilage
swelling is an early event in OA, probably occurring due to collagen damage that
allows PGs to swell further (Maroudas and Venn 1977). Increased swelling dilutes
GAGs and cartilage has a reduced load bearing capacity and decreased hydraulic
permeability (Armstrong and Mow 1982). Degeneration is first observed at the
articular surface in the form of fibrillation. Superficial fibrillation is associated with
increased denaturation and loss of type II collagen as collagen fibrils are degraded
leading to a loss of tensile properties of the cartilage (Hollander et al 1995). The
damage of the matrix is associated with the release of PGs including decorin, biglycan
and aggrecan (Kempson et al 1973)). The early damage and loss ofmatrix molecules
is accompanied by increased aggrecan, decorin and biglycan and type II collagen in
the mid and deep zones, thought to be due to the increased load on these cells
following the damage to the superficial layer (Nelson et al 1998).
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The OA lesion is often localised to the weight bearing cartilage or to sites of trauma,
suggesting mechanical factors may be the critical signal for OA initiation and
progression (Goldring 1999; Urban 1994). Although OA is frequently regarded as a
non-inflammatory arthritis considerable data implicate a role for proinflammatory
cytokines derived from both the synovium and chondrocytes in cartilage destruction
during OA. OA cartilage has been reported to express inducible Nitric oxide synthase
(iNOS) following stimulation with IL-ip and TNFa, which results in the release of
Nitric oxide (NO) which, as will be discussed later, may contribute to cartilage
pathology (Amin et al 1997).
The size of aggrecan molecules and their pattern of sulphation alter with ageing
(Roughley 2001), while collagen crosslinking increases with age, making cartilage
stiffer and more brittle (Eyre et al 1998). These changes will alter loading conditions
for the cells, so are likely to induce early pathologic changes in OA (Aigner et al
2002b).
Collagen damage is seen around the chondrocytes extending into the interterritorial
sites, implicating the chondrocyte as the mediator of this matrix damage (Hollander et
al 1995). The chondrocytes alter during OA with; (1) proliferation and cell death (2)
changes in synthetic activity (3) matrix degradation (4) phenotypic modulation (5)
osteophyte formation (Sandell and Aigner 2001).
Proliferation
A very low proliferative activity is observed in OA chondrocytes that is absent from
normal cells (Poole 1997; Bush and Hall 2003). This proliferation is probably
responsible for chondrocyte clustering seen in OA and may be due to better access to
proliferative factors from the synovial fluid following fissuring/damage of the
collagen network.
Apoptosis
Apoptosis is enhanced in OA, particularly close to the articular surface (Hashimoto et
al 1998). However it is only seen in very small percentage of cells (<1%) with a
small increase in empty lacunae (Aigner and Dudhia 1997), suggesting it will not
contribute significantly to OA pathology (Sandell and Aigner 2001).
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ECM binding is required for survival, with loss of binding leading to apoptosis
(Anoikis). Loss ofmatrix components and their cell surface receptors, including
collagen type II, integrins, hyaluronan and CD44, may therefore cause death (Aigner
et al 2002b; Kuhn et al 2004). Mechanical injury can also induce cell death, with the
magnitude and rate of application of force determining the outcome (Aigner et al
2002b; Kuhn et al 2004).
Mineral deposits are seen in zones of apoptosis, suggesting the cells may enter a
differentiation state similar to that seen in the hypertrophic zone of cartilage.
Apoptosis in chondrocytes can be blocked by caspase inhibitors. Although in vitro
studies suggest that caspase inhibition does not always rescue cells from cell death,
some experimental models demonstrate that caspase inhibition can lead to improved
disease outcome (Kuhn et al (2004)).
Synthetic activity
Work has shown that a net loss ofECM components occurs at all stages in OA despite
an early increase in synthesis. However these studies looked at the tissue as a whole.
Individual cellular analysis revealed a loss of fixed charges occurs in the upper zones
ofOA cartilage, where the cells decreased matrix synthesis, while in the deeper zone
where the ECM is still intact, cells remain activated (Aigner and Dudhia 1997). This
increased synthesis of matrix may be an early attempt at repair, with collagen type II
and aggrecan detected, a response which is lost in late OA (Poole et al 1991).
The collagen fibre network in cartilage consists of large crosslinked rigid structures
that are difficult to repair or replace. The production of new collagen molecules fails
to remodel and repair the tissue and overall tensile strength is reduced. Aggrecan has
a faster turnover than collagen and so can be more easily replaced by newly
synthesised molecules. PG changes occur initially at the cartilage surface, with
chemical alterations and increased swelling (Thompson and Oegema 1979). Reduced
ionic content and osmolality due to dilution ofGAGs increases the cell volume by as
much as 90% and will influence the balance between matrix synthesis and
degradation (Bush and Hall 2003). In advanced OA the PG levels are significantly
reduced as visualised by safranin O and alcian blue staining (Mankin et al 1971).
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Matrix degradation
The major proinflammatory cytokines associated with cartilage loss are IL-1(3 and
TNFa (Lotz et al 1995), with increased expression of both by OA chondrocytes
(Towle et al 1997; Webb et al 1997). Increased expression of the type IIL-1 receptor
(IL-1RI) in OA chondrocytes was associated with increased MMP production
(Martel-Pelletier et al 1992). The p55 TNF receptor has been localised to
chondrocytes at sites of focal loss of cartilage PGs (Webb et al 1997).
MMPs are found localised in regions of cartilage damage (Hembry et al 1995) and are
elevated in the synovial fluid and cartilage from OA patients (Okada et al 1992).
MMPs 1,2,3,7,8,13 and 14 are produced by chondrocytes (Sandell and Aigner 2001).
Increased MMP3 (Stromelysin) is seen in early OA, with increased MMP 13 and
MMP2 in late stage OA. (Aigner et al 2002a; Aigner and McKenna 2002). There is a
10 fold increase in fibronectin in OA cartilage (Brown and Jones 1990). Proteolytic
degradation of fibronectin produces fragments that are able to initiate degradation of
aggrecan through autocrine/paracrine IL-ip synthesis that causes MMP induction
(Arner and Tortorella 1995; Homandberg et al 1992; Roughley 2001), previously
demonstrated in fibroblasts (Werb et al 1989). ADAM-TS4 and ADAM TS5 are
present in OA cartilage and are responsible for aggrecan degradation. This generates
novel termini (neoepitopes) that can be detected in the synovial fluid and cartilage of
OA patients using specific antibodies, with the N-terminus of the molecule buried in
the binding site cavity of the specific antibody (Hughes et al 1995; Mort et al 2003).
Aggrecan neoepitopes are detected in vitro and in the synovial fluid ofOA patients as
a marker of tissue destruction, with an ADAM-TS inhibitor preventing aggrecan
damage of cartilage in vitro (Malfait et al 2002).
Increased synthesis ofmatrix-degrading enzymes, including collagenase and
aggrecanase, and decreased TIMP is seen in OA (Attur et al 2000; Lohmander et al
1999; Sandell and Aigner 2001). This decreased inhibition ofMMPs will allow
increased action in degrading the cartilage matrix.
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Phenotypic modulation
Collagen types III, IIA and X are expressed in different zones ofOA cartilage,
suggesting alteration of the chondrocyte phenotype. No expression of collagen type I
was detected in any zone of normal or OA cartilage. Collagen type IIA expression, a
marker of dedifferentiation, is seen mainly in the upper-mid zone ofOA cartilage
(Aigner and McKenna 2002). Type X collagen synthesis (normally associated with
calcification of the matrix through endochondral ossification) is found in the deep
layer of cartilage in OA (von der Mark et al 1992). Hypertrophy is associated with
apoptosis and partial calcification of the matrix. Any products of cell death will
remain in the cartilage and contribute to pathologic cartilage degradation (Sandell and
Aigner 2001).
The expression of cell adhesion molecules is altered in OA chondrocytes. An
example of this is the upregulation of CD44 in deep zones ofOA cartilage
(Ostergaard et al 1997b). The increased expression of pi integrin in OA cartilage has
been shown in vitro and in vivo (Loeser et al 1995). The expression of a2, a4 and P2
integrins have been described in OA but not normal cartilage (Ostergaard et al 1998).
These studies suggest that the normal chondrocyte-ECM interactions are interrupted
in OA, which may play a role in the onset or progression of disease. Increased
synthesis of fibronectin (Burton-Wurster et al 1986), type VI collagen (Swoboda et al
1998) and tensin (Salter 1993) have all been described during OA and will influence
the way in which the cell senses mechanical signals. Alterations in collagen type VI,
thought to link the chondrocyte to collagen type II in the pericellular matrix, have
been described in OA (Aigner and McKenna 2002). This may impede proper cell-
matrix interactions so will alter the way in which the cell senses strains and thus
modulate the synthetic activity of the cells. Pericellular matrix is important in
regulating the biomechanical environment of the chondrocyte, so alterations in OA
may affect the magnitude and distribution of mechanical signals perceived by the
chondrocytes (Alexopoulos et al 2003).
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1.3 - Proinflammatory Cytokine signalling (Figure 1.3)
Cytokines and growth factors are important regulators of chondrocyte function. Gene
deletion studies have revealed that few individual cytokines are absolutely essential
for life or even for individual cellular functions, suggesting that one cytokine can
compensate for the loss of another (Okazaki and Leonard 2002). Redundancy of
cytokines may be explained partly by the observation that one or more receptor
subunit may be utilised by different cytokines and also by regions of sequence
homology in the cytoplasmic domains of some receptors which may underline
common signalling pathways (Murakami et al 1991). Growth factors such as TGFP,
IGF-1 and the bone morphogenic proteins (BMP) are important in cartilage anabolism
(Aigner et al 2002b). Anti-inflammatory cytokines such as IL-4 are expressed in OA
as well as normal cartilage and can counteract the activities of proinflammatory
cytokines, playing a chondroprotective role (Joosten et al 1997).
The proinflammatory cytokines IL-ip and TNFa are the principal mediators of
cartilage catabolism through decreasing matrix synthesis and increasing its
degradation (Goldring 2000). The production of iNOS and synthesis ofNO has been
suggested as the mechanism through which these cytokines mediate many of their
effects. Interferon gamma (IFNy) and Interleukin 6 (IL-6) are involved in the
regulation of production of proinflammatory molecules including iNOS following IL-
ip and TNFa stimulation of cells (de Vera et al 1996; Van de Loo et al 1997a). It is
important, therefore, to understand the signalling pathways of these cytokines, the
activation of iNOS and the effects mediated by NO.
1.3.1 - IL-ip
IL-ip is detected in OA where it influences the balance between matrix synthesis and
degradation, leading to disease progression. IL-ip is activated by an IL-1 converting
enzyme (ICE) (Slack et al 1993).
IL-1 receptor antagonist (IL-lra) is a molecule that binds the IL-1 receptor but does
not initiate intracellular signalling (Hannum et al 1990), so decreasing the number of
receptors available for IL-1 binding. Type I (IL-1RI) and type II (IL-1RII) receptors
exist. IL-1RII has a short cytoplasmic tail and appears to act as a control, binding IL-
1 but not initiating any signal cascades and so preventing its activity. The large
intracellular domain associated with IL-1RI, however, is involved in IL-1 mediated
13
signalling and biological responses (Bird et al 1992). The binding of IL-1 to the IL-
1RI causes recruitment of the IL-1 receptor accessory protein (IL-lRacP) (Greenfeder
et al 1995). The Toll/IL-1 receptor domain (TIR) on the cytoplasmic tail of both the
IL-1RI and IL-lRacP acts as a binding site for MyD88 following a conformational
alteration caused by IL-1 binding. MyD88 recruits the serine/threonine kinases,
intracellular receptor for activated kinase (IRAK) 1, which associates with IL-lRacP,
and IRAK2 that associates with IL-1RI (Slack et al 2000). This causes the IRAK
phosphorylation that is required for activation of the transcription factor Nuclear
Factor kB (NFkB). Flyperphosphorylation of IRAKs occurs during signalling, which
leads to their degradation. Tollip (toll interacting protein) interacts with IRAKs which
may allow its association with the IL-1R. TNF-receptor associated factor (TRAF) 6
activation and ubiquitination occurs following IRAK recruitment, interacting with the
mitogen activated protein kinase (MAPK) TAK-1. TAK-1 is phosphorylated and
ubiquitinated, causing activation rather than the classical degradation seen after
ubiquitination. TAK1 can then activate the kinase responsible for phosphorylation of
the NFkB inhibitor IkB, IKK-2, leading to release ofNFkB for nuclear translocation
and cellular signalling (IL-ip signalling reviewed in O'Neill 2002). TAK-1 can also
activate p38 MAPK and c-Jun NH2 terminal kinase (JNK), causing phosphorylation
of transcription factors such as ATF-2 and the stabilisation ofmRNA containing AU
repeats such as TNFa and cyclooxygenase II (COXII) (Hua et al 2002). p38 MAPK
inhibition decreased IL-ip induced collagen degradation in a cartilage culture model
(Ridley et al 1997), and showed protection against cartilage destruction in the rat AIA
model (Badger et al 2000).
1.3.2-TNFa
TNFa is produced by chondrocytes in OA (Melchiorri et al 1998) and exists as a
homotrimer in solution (Banner et al 1993). TNFa knockout mice develop more
severe arthritis than wild-type mice as early chondrocyte apoptosis due to TNFa is
prevented, allowing more time for the chondrocytes to produce the degradative
enzymes responsible for cartilage breakdown (Butler et al 1997). The TNFa gene
promoter contains a number of regulatory elements with increased TNFa production
seen when IFNy and IL-ip are added simultaneously implicating signal transducer
and activator of transcription (STAT) involvement in addition to NFkB and AP-1
(Hua et al 2002). The 3'UTR of TNFa mRNA contains an octanucleotide AU repeat
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sequence that is associated with mRNA degradation and interferes with translation
(Hua et al 2002).
p55 and p75 are two TNFa receptors present in cartilage, although not both on the
same cells. TNFa can self-regulate through the induction of cleavage of its own
receptors which are capable of neutralising TNFa. This response, however, is
disrupted in OA (Westacott et al 2000). The p55 receptor cytoplasmic domain
contains potential phosphorylation sites for the cAMP dependent protein kinase,
protein kinase C (PKC) and tyrosine kinases that are not seen on p75. A serine rich
domain on p75, however, constitutively undergoes phosphorylation. The crystal
structure reveals that three receptor molecules bind symmetrically to one TNFa trimer
(Banner et al 1993). Both receptors bind TNFa with equally high affinity and
transduce signals independent of each other. After TNFa binds its receptor it is
quickly internalised and degraded, with TNFa receptor expression regulated by a
number of factors including IL-1, IL-4, IL-6, TNFa, and PKC. Both receptors can
activate NFkB, although most of the biological effects of TNFa are mediated via the
p55 receptor (Nicola NA).
TNFa reduces the activity of the collagen type II and link protein promoters via
MEK1/2 and NFkB, rather than through p38 or JNK in rat articular chondrocytes
(Seguin and Bernier 2003). However, in another study NFkB and AP-1 were
activated by TNFa via p38 and JNK in human astrocytes, suggesting cytokine
signalling is a complex process (Hua et al 2002). The binding of upstream regulators
ofMAPKs (MEKKs) to regulatory proteins can alter specificity, seen in TNFa
signalling where Gck links MEKK1 to JNK activation, whilst Tax association allows
preferential NFkB stimulation (Shi and Kehrl 1997; Yin et al 1998; Yuasa et al 1998).
1.3.3-IL-6
IL-1 (3, TNFa and IFNy can increase IL-6 in fibroblasts (Akira et al 1993).
Transcriptional control elements include NFkB, nuclear factor IL-6 (NF-IL-6) and an
AP-1 site. Fluid induced shear using a cone viscometer for 1-48 hours induced IL-6
production in normal and OA human chondrocytes. This had little effect on PG
synthesis and degradation. It does, however, modulate the effects of growth factors
and pro-inflammatory mediators (Mohtai et al 1996). IL-6 heterogeneity is seen
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through N and O linked glycosylation and phosphorylation, which could explain any
differences in its observed activities (Nicola NA). sIL-6Ra was found to potentiate
the inhibitory effect of IL-6 on PG synthesis, but this effect is moderate compared to
IL-lp (Guerne et al 1999; Silacci et al 1998). IL-6 knockout mice showed decreased
inflammatory cell infiltration but elevated PG loss during the acute phase of zymosan
induced arthritis (Van de Loo et al 1997b).
The IL-6 receptor complex is made up of two non-binding signal transducing gpl30
molecules and a single low affinity IL-6 alpha chain receptor (Murakami et al 1993),
yielding a high affinity receptor capable of signal transduction (Hibi et al 1990).
Signalling occurs as homodimerised gpl30 associates with a tyrosine kinase, causing
gpl30 phosphorylation (Murakami et al 1993). The tyrosine kinase is likely to be
JAK1, JAK2 or Tyk2 as all bind to gpl30 and are activated after gpl30 stimulation
with IL-6 (Stahl et al 1994). STAT3 activation by tyrosine kinases attached to gpl30
allows its translocation to the nucleus, which due to its large size requires a nuclear
import receptor. MEKK1 and SEK can enhance the transcriptional activity of STAT3
by further phosphorylation (Schuringa et al 2000). IL-6 is also involved in activation
ofERK1/2, p38 and INK as well as PDkinase causing protein kinase B (PKB)
activation of proapoptotic factors. Several control mechanisms exist, including the
recruitment of SHP2 phosphatase to activated gpl30 that can inhibit JAK and STAT
activation. Protein inhibitors of activated STATs (PIAS) are also important regulators
of the JAK/STAT pathway, with PIAS3 inhibiting STAT3 activation due to IL-6 and
PIAS1 preventing IFNy induced STAT1 signalling. SOCS (suppressors of cytokine
signalling) produced by IL-6 via the JAK/STAT pathway inhibit STAT mediated
signal transduction and so act as classical feedback inhibitors (IL-6 signalling
reviewed in (Nicola NA).
STAT binding sites are often in close proximity to binding sites for other transcription
factors, such as NF-IL-6 (Kordula and Travis 1996), NFkB (Brown et al 1995) and
AP-1 (Zhang et al 1999). This suggests a mechanism by which synergy can occur
when more than one cytokine is present.
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1.3.4 - IFNy
Increased IFNy is seen in RA and OA (Westacott et al 1990). There is synergistic
activity of IFNy with other cytokines such as IL-ip, upregulating pro-inflammatory
factors such as NO, IL-6 and prostaglandin E2 (PGE2), and decreasing PGs. IFNy also
shows some anti-inflammatory effects where it synergistically increases IL-lra
production, so controlling IL-1 signalling, as well as decreasing IL-8 and stromelysin
(Henrotin et al 2000). It may be that different concentrations of IFNy have different
effects, or it could be that different subpopulations of chondrocytes within the joint
differ in their responsiveness to cytokines.
The IFNy molecule is active in a dimeric conformation (Farrar and Schreiber 1993)
and the receptor contains both an alpha and a beta subunit. IFNy binds two alpha
receptors and causes alpha subunit dimerisation (Fountoulakis et al 1992), bringing
the two receptors together. The alpha subunit cytoplasmic domain contains a
sequence that associates with a kinase that is likely to be JAK1 or JAK2 as these are
required for IFNy induced cellular responses (Watling et al 1993). The beta subunit
has a similar JAK site (Murakami et al 1991), binding either JAK1 or JAK2. The
close proximity of the receptors following IFNy binding brings the JAKs together,
causing their phosphorylation and activation as well as alpha chain tyrosine
phosphorylation that creates a p91 binding site close to the activated tyrosine kinase.
p91 is a gamma-activated factor which migrates from the cytoplasm to the nucleus
where it binds to the gamma-activated sequence (GAS) of IFNy responsive promoters
(Shuai et al 1992). p91 binds and is activated by phosphorylation, dissociating from
the IFNy receptor and associating with other activated p91 or activated transcription
factors causing nuclear translocation and gene transcription (Shuai et al 1992). The
identification of STAT1 docking sites on the IFNy receptor causing STAT1
phosphorylation, dimerisation and subsequent activation through further
phosphorylation has also been implicated in IFNy signalling. Activated STAT-1 then
binds DNA and affects gene transcription (Nicola NA).
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Figure 1.3 - Proinflammatory cytokine signalling. IL-1(3, TNFa, IL-6 and IFNy all attach to
different receptors and initiate different intracellular signalling cascades. Each of these cytokines
activate transcription factors that can influence iNOS gene transcription (complete arrows entering
nucleus). Several other molecules are also activated that may influence iNOS gene transcription
(dashed arrows entering nucleus).
1.3.5 - Nitric Oxide Synthase (NOS)
NOS catalyses the oxidation of arginine (arg) to NO and citrulline. There are three
genetically distinct NOS isoforms, neuronal NOS (nNOS or type I), endothelial NOS
(eNOS or type III) and inducible NOS (iNOS or type II). These were initially
identified in neurons, endothelial cells and macrophages respectively (Bredt and
Snyder 1990; Pollock et al 1991; Xie et al 1992). The NOS contain both an N-
terminal oxygenase and a C-terminal reductase domain. The oxygenase domain binds
haem, tetrahydrobiopterin (BH4) and arg, whilst Flavin adenine dinucleotide (FAD),
Flavin mononucleotide (FMN), Nicotinamide adenine dinucleotide phosphate
(NADPH) and Calmodulin (CaM) are associated with the reductase domain (Ghosh
and Stuehr 1995; Richards and Marietta 1994). The enzyme is activated upon
homodimerization that requires the presence of the haem group, as well as BH4 and
arg for stabilisation (Klatt et al 1995). Zinc tetrathiolate has been located at the dimer
interface, tetrahedrally binding to two cysteines from each subunit and is also
involved in dimer stability (Chen et al 1995; Fischmann et al 1999).
The active NOS enzymes gain electrons from NADPH and transport them through
FAD and FMN to the haem group (Adak et al 1999) of the other NOS enzyme in the
dimer (Siddhanta et al 1996) (Figure 1.4). Arg is closely associated with, but not
bound to, the haem group and can be oxidised to citrulline and NO (Crane et al 1998).
Each of the NOS isoforms has a different activity, with turnover numbers for NO
synthesis of approximately 200min"', lOOmin"1 and 20min"' for iNOS, nNOS and
eNOS respectively (Roman et al 2002). The binding ofCaM increases the rate of
electron transfer from NADPH through the flavins to the haem centre through a
conformational change (Abu-Soud et al 1994; Craig et al 2002). An autoinhibitory
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loop prevents CaM binding in low calcium (Ca ) concentrations in both eNOS and
nNOS (Figure 1.5), so regulating the activity of the enzymes (Salerno et al 1997).
C-terminal tails of 20-42 amino acids long have been identified on the NOS isoforms
and are suggested to both protect the flavins from external oxidation and inhibit the
electron flow between them (Roman et al 2000a; Roman et al 2000b; Roman et al
2002) (see Figure 1.5). The inhibitory function of the tail may be important in iNOS
in preventing excessive electron delivery to the haem, which would result in inactivity
of the enzyme (Adak and Stuehr 2001).
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Arginine + Oi Citrulline + NO
Figure 1.4 - Electron flow and reaction catalysed by NOS
Within the NOS homodimer the electrons flow from NADPH FAD FMN in the reductase
domain of one monomer to the BH4 and Haem in the oxygenase domain of the other monomer. The
BH4 and Haem within the active site catalyse the reaction of oxygen with arginine, generating
citrulline and NO as products.The presence of Ca2+/CaM is required for electron flow through the
reductase domain.
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DOMAIN DOMAIN
Figure 1.5 - Domain structure of human nNOS, eNOS and iNOS
Oxygenase, reductase and PDZ domains are denoted by solid boxes with the amino acid residue
number at the start/end of each domain. The cysteine residue which ligates the heme, location of
Zinc (Zn) ligating cysteines and the Calmodulin (CaM) site is indicated in each isoform. The
autoinhibitory loop within the FMN regions of nNOS and eNOS are shown as are the dimer
interface in the oxygenase domain. Myristoylation (Myr) and palmitoylation (Palm) sites on
eNOS are shown. Adapted from Alderton et al (2001).
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eNOS
NO was originally described as an endothelial derived relaxing factor. In the
endothelium NO is produced in picomolar amounts in response to receptor stimulation
by molecules such as acetylcholine and bradykinin, and to sheer stress (Farrell and
Blake 1996). The production ofNO has a biphasic response (Mullershausen et al
2001). NO initially influences basal vascular tone by diffusion to adjacent vascular
smooth muscle cells and activation of the haem containing enzyme soluble guanylyl
cyclase. This leads to increased cGMP levels resulting in activation of different
cGMP-dependent effector proteins such as protein kinases (Hofmann et al 2000),
phosphodiesterases (Juilfs et al 1999) and ion channels (Biel et al 1999). The
relaxation of vascular smooth muscle leading to vasodilation occurs at this stage.
However, the second stage is activation of phosphodiesterase 5 by NO, which leads to
a rapid decrease in cGMP causing NO induced desensitisation of the cGMP response
(Mullershausen et al 2001).
Phosphorylation of the reductase domain of eNOS has been shown at four sites, Thr
495, Ser 617, Ser 635 and Ser 1177 (Chen et al 1999; Michell et al 2001), each
influencing enzyme activity. PKC phosphorylates eNOS at Thr 495, negatively
regulating eNOS activity (Matsubara et al 2003), while PKB phosphorylates eNOS at
Ser 1177 stimulating its activity (Ming et al 2002).
nNOS
NO synthesis is seen throughout the brain (Farrell and Blake 1996). Coupled to the
NMDA receptor, nNOS is activated by the influx of calcium associated with
glutamate activation. This can lead to neurotoxicity but may also be neuroprotective
depending upon the redox state ofNO. NO could potentially act as a retrograde
synaptic messenger, where modulation of synaptic transmission may cause long term
potentiation type responses that are implicated in learning and memory. nNOS can
also mediate vasodilation; so coupling neural activity to local increases in blood flow.
There is also a role for NO in pain mechanisms and it may be both pro- or anti¬
nociceptive at different sites (Farrell and Blake 1996).
Phosphorylation of the inhibitory loop of nNOS has also been described but, unlike in
eNOS, this decreases both electron transfer and NO production (Hayashi et al 1999).
The kinases implicated in nNOS phosphorylation are different to those seen for
eNOS. Calcium/calmodulin dependent protein kinase II (CaM Kinase II)
21
phosphorylates nNOS at Ser 847, which decreases nNOS activity (Rameau et al
2004). PKA and PKG have also been implicated in nNOS phosphorylation and
subsequent downregulation of activity (Dinerman et al 1994).
Eliasson et al (1997) reported more than ten differentially spliced nNOS transcripts,
producing several different proteins.
iNOS
Expression of the iNOS gene is an important part of the immune response to infection,
with macrophage phagocytosis leading to iNOS induction in humans (Watkins et al
1997) and LPS shown to induce iNOS in rodent macrophages (Nathan and Xie 1994).
Indeed, in knockout (KO) mice studies infection cannot be appropriately cleared,
leading to chronic infection and death (Mashimo and Goyal 1999). The much
reduced inflammatory response is well demonstrated following injection of iNOS KO
mice with lipopolysaccharide (LPS), where it prevents the death seen in the wild type
(WT) mice (Wei et al 1995). Overexpression of iNOS is seen in human diseases such
as OA and rheumatoid arthritis (RA), where expression is induced by exposure to
inflammatory cytokines such as IL-lp, TNFa and IFNy (Kahle et al 1992; Melchiorri
et al 1998; Westacott et al 1990).
Due to the role of iNOS in host immunity and the pathophysiology associated with its




The human iNOS (hiNOS) promoter is a sixteen kilobase region at the 5' untranslated
region (UTR) of the hiNOS gene that contains several sequences coding for both
positive and negative regulatory elements (Figure 1.6).
Cytokine responsive elements upstream of -3.8kb are required for iNOS
transcriptional activation. Five NFkB binding sites from -4.7kb to -7.2kb were
identified, with the site at -5.8kb required for promoter activity and the others
cooperatively increasing iNOS gene transcription (de Vera et al 1996; Taylor et al
1998). A negative regulatory element (NRE) identified by Feng et al (2002) at -6.7kb
binds constitutively expressed NFkB repressing factor (NRF). This interaction is
implicated in control of promoter activity regulating basal iNOS expression.
The investigation of IFNy effects on hiNOS gene transcription focussed on the JAK
mediated STAT 1 binding to the hiNOS promoter. IFNy (Dalton et al 1993), IFNy
receptor (Kamijo et al 1993) and STAT-1 (Meraz et al 1996) KO mice are defective in
iNOS induction by cytokines. The previously identified -5.2kb NFkB site was shown
to bind STAT-1, with the -5.8kb site shown to facilitate both STAT-1 and NFkB
binding (Ganster et al 2001).
Marks-Konczalik et al (1998) identified two further NFkB sites and two AP-1 sites in
the first 8.3kb of the promoter that are required for transcription. The AP-1
transcription factor subunits are Jun D and Fra 2 while both Rel A/Rel A and
RelA/p50 subunit dimers make up NFkB. The role of AP-1 in iNOS expression is
controversial, it is likely that different dimers of AP-1 factors will bind to activator or
repressor sites. Indeed, an AP-1 like site was identified by Pance et al (2002) that
caused repression of hiNOS transcription.
This transcription factor network is further complicated by other transcriptional
control proteins including NF-IL-6, which are known to interact with NFkB and have
sites on the hiNOS promoter (LeClair et al 1992; Marks-Konczalik et al 1998). It is
therefore likely that complex mechanisms involving many transcription factor
combinations may actually regulate the iNOS gene.
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This is supported by the interactions between transcription factors involved in iNOS
induction. IFNy-induced IFN regulatory factor (IRF-1) and TNFa induced NFkB
interact while binding the hiNOS promoter in stimulated macrophages (Saura et al
1999). It has been suggested that this interaction physically bends the hiNOS
promoter DNA and thus may explain the mechanism by which IFNy increases iNOS
transcription. Histone deacetylase (HDAC) 2 interacts with the NFkB subunit p65,
with increased HDAC 2 causing increased cytokine-induced iNOS. This indicates
that hyperacylation may act by limiting the functional efficacy ofNFkB, so regulating
iNOS (Yu et al 2002a).
STAT-3 also binds the p65 subunit ofNFkB, acting as a dominant negative inhibitor
ofNFkB activity, causing the indirect suppression of cytokine-induced iNOS (Yu et
al 2002b).
-16kb -8.2kb -6.7kb -6. lkb -5.8kb -5.5kb -5.3kb -5.2kb -5. lkb -632b to-351b -30b
Figure 1.6 - Human iNOS gene promoter sequence
Mutational and deletional studies of the human iNOS 5'UTR
have identified several sites specific for transcription factor
binding (NFkB, STAT-1 and AP-1) involved in cytokine
mediated iNOS induction. This region also contains negative
regulatory regions (AP-1-like site and Negative regulatory
element recognised by NFkB repressing factor) that inhibit iNOS
induction. The section from -8.2kb to —16kb is known to affect
iNOS transcription but the specific elements within this region
have yet to be characterised.
iNOS Post-Transcriptional Regulation
Four AUUUA and one AUUUUA motifs have been identified in the 3'UTR of
hiNOS, which are known to destabilise mRNA (Rodriguez-Pascual et al 2000). A
protein, HuR, binds to the AU rich elements of the iNOS 3'UTR. Inhibition ofHuR
can reduce cytokine-induced iNOS mRNA whereas overexpression potentiates
cytokine-induced iNOS expression (Rodriguez-Pascual et al 2000). Calcium has also
been shown to inhibit IL-ip induced NO by reducing iNOS mRNA stability (Geng
and Lotz 1995).
Alternative splicing of the hiNOS gene occurs, with deletions of exon 8 and exon 9
described. Eissa et al (1998) showed that these deletions do not affect the production
X Negative— RegulatoryElement
O- STAT-l A = AP"' LikeV Repressive R gion
A -API RC±= SlartofCcne'—* I—I Transcription
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of iNOS protein, but do inhibit its activity by preventing dimerisation. iNOS splice
variants with deletions in haem and FMN domain have also been detected (Eissa et al
1996).
Albakri and Stuehr (1996) showed that NO can interact with cellular haem, preventing
its incorporation into the iNOS enzyme. NO can also inactivate the enzyme through
the formation of a stable ferrous nitrosyl complex with the haem in the enzyme
(Cooper 1999). An NO donor (SNAP) inhibited dimerisation of iNOS monomers
without affecting haem release (Chen et al 2002). This inhibition of iNOS activity by
NO itself indicates a classic negative regulatory mechanism by which NO production
can control its own levels.
iNOS phosphorylation has been reported, however the role this has has not been
further investigated with the suggestion that it may play a role in the control of
subcellular localisation (Pan et al 1996).
iNOS Protein-Protein Interactions
There are several proteins that directly interact with iNOS influencing its expression
(Zhang et al 2003). Kalirin and NOS-associated protein 1 lOkDa (NAP 110) bind
iNOS monomers, preventing homodimerisation and so decreasing activity (Ratovitski
et al 1999a; Ratovitski et al 1999b). Caveolin-1 binds iNOS in a similar way to that
described for both eNOS and nNOS (Felley-Bosco et al 2000), inactivating the
enzyme. EBP50 is a PDZ domain-containing scaffolding protein that binds iNOS and
interacts with other PDZ-containing proteins such as ion channels. This can localise
iNOS to protein complexes associated with the actin cytoskeleton (Zhang et al 2003).
Rac 1 and Rac 2 are members of the Rac family of Rho-like GTPases and interact
with iNOS (Kone et al 2003; Kuncewicz et al 2001) influencing its intracellular
localisation and activity.
iNOS Proteasomal degradation
Musial and Eissa (2001) showed the two phase regulation of iNOS by the 26s
proteasome degradation pathway. The activation of iNOS by IkBo, degradation and
subsequent NFkB translocation and activation occurs initially, followed by the
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degradation of the iNOS protein itself. The degradation of iNOS is mediated by
binding to Caveolin-1 in human colon carcinoma cells (Felley-Bosco et al 2000).
Other iNOS Regulatory Molecules
The presence of other molecules within the cell also influences the activity of iNOS.
Arginase is an enzyme that competes with iNOS for the substrate arg. The presence
of arginase can deplete cellular arg stores and so regulate the activity of iNOS
(Bogdan 2001). The availability of the substrate arg will control the rate of synthesis
ofNO, and some cells can generate arg from citrulline, so using citrulline to produce
NO (Hattori et al 1994; Nussler et al 1994). In endothelial cells eNOS localises with
the arg transporter CAT-1 and arg-generating enzymes in caveolae (Flam et al 2001).
Glutathione (GSH) is the major thiol in cells and plays an important role as an
antioxidant or detoxicant agent against reactive oxygen species (ROS) and reactive
nitrogen species (RNS). This is likely to be the mechanism by which iNOS producing
cells defend themselves against NO. The NO bound to GSFI can, however, be passed
to other molecules suggesting GSH may be acting as a store that maintains the
biological activity ofNO (Kroncke et al 2001; Meister and Anderson 1983). The
saturation ofGSH stores allows other ROS and subsequent NO released to have
effects on other cellular proteins (Coleman 2001; Wink et al 1996a). Haem
Oxygenase 1 (HO-1) acts as an anti-inflammatory enzyme as it decreases iNOS and
COX-2 production in both migrating leukocytes and in macrophages (Coleman 2001).
HO-1 expression is also induced by oxidised phospholipids, produced following ROS
reaction with phospholipids (Kronke 2003). Superoxide dismutase (SOD) is an
enzyme that scavenges oxygen free radicals, preventing lipid peroxidation, decreasing
iNOS activity and decreasing IL-1(3 and TNFa release (Zhang and Rosenberg 2002).
Alteration of the pH has been shown to influence NOS activity through variations of
calcium sensitivity. A shift from pH 7.2 to 6.8 led to a decrease in NOS activity
(Conte 2003).
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1.3.6 - Effects of NO
NO is a molecule with a short half-life and low molecular weight and with high
diffusibility and lipid solubility, which confers upon it the properties to act as a
signalling molecule. The half-life ofNO is increased at lower concentrations from
seconds to minutes/hours (Wink et al 1996b). The impact ofNO on cell function or
death are complex and often appear contradictory. It can be toxic/antitoxic,
apoptotic/antiapoptotic, antioxidant/compromise cellular redox state via oxidation of
thiols like GSH, inhibit/activate signalling pathways, inhibit/activate gene
transcription (Kroncke et al 2000).
NO can modulate cells by various mechanisms including:-
1) Binding to haem
2) Reaction with free thiols
3) Reaction with superoxide anion
4) Nitrosylation of target proteins
5) ADP-ribosylation of proteins (Studer et al 1999).
The interaction with transition metals and thiol groups located at either allosteric or
active sites are two methods ofNO control that can affect many molecules within the
cell (Table 1.1). This allows NO to influence the activity of enzymes involved in
many cellular functions (Coleman 2001).
Reaction with free thiols leads to the production of molecules with similar biological
activity to NO but a longer half-life, the s-nitrosothiols. Both nitrosylation and ADP-
ribosylation of proteins by NO can modulate their function or behaviour. Reaction of
NO with ROS, such as the superoxide radical (O2"), increases the range of biological
activity ofNO through the production of molecules such as peroxynitrite (ONOO").
NO has been suggested to be a regulator of LPS activated signalling pathways,
whereas IL-1(3 activated signal transduction is more sensitive to peroxynitrite (Mathy-
Hartert et al 2003).
Cysteines are important in DNA binding on several transcription factors, including c-
fos, c-jun, AP-1 and NFkB (Hentze et al 1989; Schreck et al 1991). This allows NO
to cause nitrosylation and function modification, suggested to act as redox-
sulphhydryl switches that directly regulate gene expression (Hentze et al 1989).
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Both activation ofNFkB and inhibition ofNFkB by NO has been described (Coleman
2001). The production ofNO derivatives can explain this difference, with
peroxynitrite promoting NFkB activation through sustaining p65 nuclear
translocation, whereas s-nitrocysteine inhibits NFkB activity (Clancy et al 2004).
NO can also influence other inflammatory mediators in both a positive and negative
way, increasing TNFa release by leukocytes through interaction with an NO
responsive element in the TNFa gene promoter (Lander et al 1993) Coleman 2001).
NO can also decrease the production of PGE2, IL-6 and IL-8 (Coleman 2001;
Henrotin et al 1998).
The list of functions and effects ofNO continues to grow as more is learned about this
molecule in different systems. Potential involvement ofNO in the OA disease
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Table 1.1 - Molecules affected by NO interaction (adapted from Stamler 1994)
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Effects of NO in Cartilage (Table 1.2)
Increased iNOS and NO are detected in OA cartilage and synovium (Grabowski et al
1997). The detection of lipid peroxidation products (Kavanaugh 1998), nitrite
(Spreng et al 2001) and nitrated type II collagen peptide (Henrotin et al 1990) in
chondrocytes implicate NO in the disease process. The increase of nitrotyrosine and
nitrated proteins in cartilage of arthritis patients demonstrates direct involvement of
NO (Fukuda et al 2000; Loeser et al 2002). The increased range of biological activity
after reaction ofNO with ROS is implicated in cartilage degradation (Henrotin et al
2003).
IL-ip mediates a decrease in collagen type II directly by an NO independent action on
collagen II mRNA levels. An NO dependent mechanism also exists where the
inhibition of the enzyme prolyl hydroxylase by NO leads to underhydroxylation of
collagen monomers, causing their degradation (Cao et al 1997). NO has also been
implicated in the inhibition of PG synthesis by IL-ip, which will be discussed in more
detail later in this Chapter and in Chapter 5 (Taskiran et al 1994).
IL-lp causes increased MMP production in chondrocytes (Sasaki et al 1998; Tamura
et al 1996). NO has been implicated in MMP synthesis, as iNOS inhibition decreases
IL-1-induced gelatinase, collagenase, stromelysin (Murrell et al 1995; Stadler et al
1991) and MMP9 (Sasaki et al 1998) gene expression.
iNOS knockout mice, however, show increased susceptibility to adjuvant-induced
arthritis and septic arthritis, which indicates NO may have anti-inflammatory effects
that impede OA development (Gilkeson et al 1997; Mclnnes et al 1998; Veihelmann
et al 2001). NOS inhibitors have been shown to increase MMP activity associated
with IL-ip stimulation (Stefanovic-Racic et al 1997). Bird et al (2000) describe a
catabolic role for NO in decreasing PG synthesis, but a protective role in decreasing
PG degradation through regulation of aggrecanase activity. The inhibition of PGE2 by
NO has been shown using NOS inhibitors (Henrotin et al 1998; Mathy-Hartert et al
2002). This has been suggested to be the mechanism by which NO could inhibit
MMP activity (Stadler et al 1991). Despite its action on PGE2 no effect is seen ofNO
on COXII expression, although this has been shown to be affected by peroxynitrite
(Mathy-Hartert et al 2003).
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NO reacts directly with iron-sulphur enzymes as well as via reaction with the
superoxide radical causing peroxynitrite production. This can lead to the inhibition or
inactivation of enzymes such as Aconitase (rate limiting step of the citric acid cycle),
Complexes I+II in the mitochondrial electron transport chain, and Ribonuclease
reductase involved in the synthesis of deoxyribonucleosides required for cell
replication (Ouellet et al 2002). This allows NO to cause decreased aerobic energy
metabolism (Stadler et al 1991), decreased DNA replication (Lepoivre et al 1990) and
can lead to cytotoxicity (Hibbs et al 1987).
ADP-ribosylation of actin by NO prevents its polymerisation (Clancy et al 1995).
The actin cytoskeleton is an important structure required for a number of cellular
functions including intracellular signalling, chondrocyte migration and attachment to
the ECM, the disruption of which may prevent chondrocyte migration into damaged
areas so impairing cartilage repair (Frenkel et al 1996). Auto-ADP ribosylation of
GAPDH, an enzyme involved in glycolysis and ATP generation, may also be
mediated by NO, causing enzyme inhibition and so affecting energy production
(Dimmeler et al 1992; Duman et al 1991).
The induction of lipid peroxidation by the hydroxyl radical and peroxynitrite may
contribute to tissue damage (Lipton et al 1993), affecting cells by influencing
membrane bound integrin-matrix interactions, activating MMPs, and generating other
ROS and further metabolites in the pericellular environment (Tiku et al 2000).
NO is involved in preventing negative feedback control of IL-ip. Inhibition ofNO
leads to increases in IL-lp induced production of the IL-ip inhibitor IL-lra (Pelletier
et al 1996). Vuolteenaho et al (2003) also demonstrated that IL-lra production by OA
cartilage pieces was increased by IL-ip and further increased by the iNOS inhibitor
1400W, suggesting NO actually inhibits IL-ip negative feedback.
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NO and Apoptosis
Fas is expressed on the surface of cultured chondrocytes from normal and OA
cartilage, with binding of Fas ligand initiating apoptosis. The intact ECM is likely to
protect chondrocytes from Fas ligand, while in damaged cartilage they will be
exposed to it, which will increase apoptosis (Kuhn et al 2004).
Evidence for cell death as a consequence of endogenous NO has not been reported.
NO released by sodium nitroprusside (SNP), however, induced apoptosis in cultured
human chondrocytes (Blanco et al 1995). In rabbit chondrocytes SNP induced p38
dependent cell death via caspase 3 (Kim et al 2002). SNP increased caspase 3 activity
in human OA chondrocytes, and caspase 3 inhibition blocked apoptosis by NO in one
study (Notoya et al 2000). Disruption of the zinc-finger motif in DNA repair enzymes
by NO increases apoptosis (Kroncke and Carlberg, 2000; Kroncke et al, 2002). DNA
itself can also be oxidatively damaged by peroxynitrite, which could influence cell
survival and potentially contribute to joint pathology (Juedes and Wogan 1996). In a
canine model ofOA the iNOS inhibitor L-NIL reduced TUNEL positive cells, but it is
unclear if this was a direct effect ofNO inhibition or due to protective effects against
cartilage degradation (Pelletier et al 2000). In human chondrocytes the effects ofNO
donors on cell death are age dependent. The increased oxidised:reduced glutathione
ratio in older chondrocytes may cause increased susceptibility to oxidant stress and
explain why older donors are more susceptible to cell death due to NO (Carlo and
Loeser 2003). Disruption of the actin cytoskeleton inhibits NO induced apoptosis
through modulation of signalling. An example of this is the increased differentiation
and decreased NO induced apoptosis seen following IGF-1 mediated cytoskeletal
disruption (Lo and Kim 2004).
Carlo and Loeser (2002) reported that NO is not by itself an inducer of chondrocyte
apoptosis, requiring other ROS. NO has been shown to have some protective effects
and NO induced by adenoviral transfer of the iNOS gene to rabbit chondrocytes did
not cause cell death (Studer et al 1999). This protective effect ofNO may be
mediated through the s-nitosylation of cysteine residues in the catalytic centre of
caspases (Kolb 2000).
Van't Hof et al (2000) showed the colocalisation of apoptosis and iNOS production in
cartilage, the iNOS inhibitor L-NMMA inhibited, and the NO donor SNAP induced
this apoptosis. The iNOS knockout mouse highlighted the role ofNO in apoptosis as
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decreased nitrite, increased bone mineral density and little apoptosis was seen
compared to the wild type in a model of inflammation mediated osteoporosis (Armour
et al 2001).
OA progression OA inhibition
J, Collagen and PG synthesis f MMP activity
1 MMP synthesis | pge2
f cellular energy production I Inflammatory cytokine production
Signalling complexes disrupted due to
I actin polymerisation and lipid
peroxidation
| NADPH oxidase activity
DNA damage ^ cell death I iNOS activity
I IL-1 receptor antagonist
I IGF-1 signalling
Role in chondrocyte apoptosis
Table 1.2 — Opposing effects ofNO on OA progression
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1.3.7 - iNOS Inhibition
Positive effect of iNOS inhibition
L-NMA treatment of rat adjuvant induced arthritis (AIA) administered
prophylactically showed decreased disease as measured by paw swelling, plasma
fibrinogen levels and urinary nitrite/nitrate (Stefanovic-Racic et al 1995). Delaying
administration or the use of other inhibitors such as AG and L-NAME, were not
effective. Connor et al (1995) used rat AIA to show that L-NIL and AG led to the
inhibition of disease progression. Two studies by Pelletier et al (1999 and 2000)
using the dog anterior cruciate ligament (ACL) transection model ofOA measured the
effects of L-NIL treatment. A dose dependent decrease in osteophyte size,
macroscopic and histologic lesions, MMP activity and apoptosis associated with
decreased caspase-3 was seen. Addition of an oxygen radical inhibitor decreased
progression of rat AIA (Sakai et al 1999). Cuzzocrea et al (2002) showed cartilage
degradation in collagen induced arthritis is delayed in iNOS knockout mice,
suggesting that NO from iNOS is involved in joint pathology.
Clancy (1999) found that in bovine monolayer chondrocytes the production ofNO led
to decreased proteoglycan synthesis upon stimulation with fibronectin fragments.
These studies suggest that NO produced by iNOS is degradative within these models
leading to the progression ofOA with inhibition protecting against OA progression.
This suggests an antiinflammatory role for iNOS inhibitors in the treatment ofOA.
Negative effect of iNOS inhibition
Several other studies support a protective role for iNOS production. McCartney-
Francis et al (2001) used a rat streptococcal cell wall (SCW) induced arthritis to look
at the effects of L-NMMA, L-NIL and AG. L-NMMA, a total NOS inhibitor,
significantly reduced NO, synovial inflammation and tissue damage, supporting the
previous findings. L-NIL and AG, however, led to the opposite effect suggesting that
either iNOS derived NO has a protective role, or that the constitutive NOS isoforms
may be involved in joint pathology. A murine AIA study (Veihelmann et al 2002)
showed that, in the acute phase, treatment with L-NIL led to increases in swelling,
leukocyte adhesion, leukocyte infiltration and expression of adhesion molecules. A
previous study by the same group using iNOS KO mice showed exacerbation ofjoint
inflammation with increased swelling and leukocyte infiltration.
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Stefanovic-Racic et al (1997) showed that in rabbit cartilage shavings IL-ip led to
decreased PG synthesis and increased degradation. NOS inhibition with L-NMA and
thiocitrulline reversed the effects on PG synthesis, but increased degradation by
collagenase, stromelysin and gelatinase (MMP) activation. The same group found
similar results in bovine cartilage slices (Stefanocvic-Racic et al 1996) and primary
human chondrocytes (Hauselmann et al 1998). This suggests that NO can have both
protective and degradatory effects.
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1.4 - Loading of articular cartilage
Mechanical loading is important in the regulation of articular cartilage structural
integrity. This is shown in normal joints where load bearing areas are thicker, have
higher PG content and are mechanically stronger, with the cells larger and containing
more cellular organelles than non-loaded areas (Urban 1994). Reduced loading
through immobilisation of one limb is deleterious to cartilage integrity, leading to
tissue atrophy with reduced GAG content, elevated water content, reduced cartilage
stiffness, reduced GAG synthesis and reduced aggregation of PGs (Behrens et al
1989). These effects are reversible following low levels of exercise, but the weakened
cartilage is more susceptible to damage by severe exercise (Palmoski and Brandt
1981). Similarly, overloading caused by strenuous running exercise regimes reduce
GAG content and produce local tissue damage at the contact sites of the cartilage
(Palmoski and Brandt 1981) while moderate regimes enhance GAG content and
cartilage thickness locally (Kiviranta et al 1988).
The loading of cartilage leads to a number of physicochemical changes including
mechanical deformation, altered hydrostatic pressure, loss ofwater, streaming
potentials, altered pH and osmolality that may all influence the metabolic activity of
chondrocytes (Urban 1994). The tissue deforms under load as does the cell, leading
to a rise in the hydrostatic pressure in the matrix within milliseconds. If the load is
removed immediately, cartilage returns to its original conformation and the pressure
falls. Load disturbs the osmotic equilibrium with prolonged loading causing the
expression of fluid, increasing the concentration of PGs and cations in the matrix.
Protein synthesis is very sensitive to intracellular ionic composition and rates fall with
changes in extracellular fluid content. It is not surprising, therefore, that the extent of
changes in the matrix vary with the loading pattern. The degree of deformation also
depends on the integrity of the collagen meshwork. OA cartilage deforms more than
normal cartilage under the same load and degenerate joints have a lower PG content
and lose fluid much quicker than normal joints. Superficial cartilage is more
compliant than deeper cartilage so the same load will have different effects on the
cells from different zones and sites in the same joint (Urban 1994).
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Other factors may be important. Oxygen levels may be altered by exercise and,
although the cell metabolises mainly through anaerobic glycolysis, changes in oxygen
tension have big effects on matrix synthesis and cell growth. Load induced solute
movement can influence the rate at which growth factors and cytokines reach the cells
and can alter cell metabolism. Static loading of cartilage decreases PG synthesis in a
dose-dependent fashion (Gray et al 1989). The loss ofwater can lead to decreased pH
and increased osmolality that may be responsible for the decreased PG synthesis.
Pressures can reach 4-5MPa during walking and as high as 20MPa during some
activities. Pressures of 5-50MPa may influence cell morphology, reduce exocytosis,
dissociate cytoskeletal elements, reduce protein synthesis and inhibit membrane
transport (Urban 1994). Pressures above 15-20MPa can lead to disorganisation of the
golgi apparatus and microtubules; this cytoskeletal disaggregation may explain the
decreased PG synthesis at high pressures (Hall et al 1991).
1.4.1 - Chondrocyte mechanotransduction (Figure 1.7)
Many cell types are exposed to mechanical stimuli within the body, however, the level
and type of force experienced alters. Mechanical forces can influence cell signal
transduction, gene expression, growth, differentiation and survival (Chen and Ingber
1999). Within cartilage it is possible that chondrocytes could be exposed to a variety
of mechanical stimuli, including stretch, shear or compressive forces. Chondrocytes
are also capable of generating a contractile force that can model the ECM, and this is
mediated by the actin cytoskeleton (Zaleskas et al 2004). Chondrocytes require the
ability to sense the mechanical signals within their environment and to transduce these
signals into an appropriate response. This requires the presence of cell
transmembrane receptors such as stretch activated ion channels, CD44 (hyaluronan
receptor), anchorin II (collagen type II receptor) and integrin receptors (Loeser 2000).
Integrins have been implicated in a variety of chondrocyte cell functions including
adhesion, proliferation, chondrogenesis and gene expression (Hering 1999) and the
evidence suggesting integrins as mechanoreceptors is growing (Aplin et al 1998;
Giancotti and Ruoslahti 1999; Wright et al 1997; Wright et al 1996). Integrins are
heterodimeric transmembrane glycoproteins made up of an a and a (3 subunit (Hynes
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1992). These contain a large extracellular domain that binds its ligand, a single
transmembrane domain and a short cytoplasmic tail that interacts with intracellular
signalling molecules and the actin cytoskeleton, enabling signal transduction (Shyy
and Chien 1997). Divalent cation binding is essential for integrin receptor function.
Both inside-out signalling, where a conformational change occurs between the active
and inactive states, and outside-in signalling, where intracellular events are triggered,
have been described (Hynes 1992). There are at least 16 a and 8 P subunits that
combine to form more than 20 specific integrin receptors. The a5pi integrin is
required for membrane hyperpolarisation associated with 0.33Hz mechanical
stimulation, and this suggests it has a role as a mechanoreceptor in chondrocytes
(Wright et al 1997).
ECM binding causes clustering of integrins, with recruitment of adaptor proteins such
as paxillin, talin and a-actinin linking the P integrin with the actin cytoskeleton (Howe
and Juliano 1998; Hughes and Pfaff 1998). Recruitment of intracellular signalling
molecules to the site leads to formation of a focal adhesion complex (FAC) (Aplin et
al 1998; Shyy and Chien 1997). The tyrosine kinase focal adhesion kinase (FAK) is
amongst the first molecules recruited to the FAC (Schwartz 2001). FAK
autophosphorylation creates a binding site for the kinases Src and Fyn (Schaller et al
1994; Schlaepfer et al 1994). Both Src and FAK can phosphorylate other components
of the FAC, including paxillin and tensin (Schlaepfer et al 1997; Vuori et al 1996).
Tyrosine phosphorylation ofFAK and paxillin, as well as P-catenin, is seen within 1
minute of 0.33Hz mechanical stimulation, a response that is lost by blocking the
integrins (Lee HS et al 2000). Disruption of the actin cytoskeleton inhibits membrane
hyperpolarisation, suggesting its importance (Wright et al 1996). P-catenin is
associated with integrin signalling via the serine/threonine protein kinase, integrin-
linked kinase (ILK) (Novak et al 1998). 0.33Hz mechanical stimulation also leads to
the activation of the serine threonine kinase, PKC (Lee HS et al 2002), inhibition of
which prevents membrane hyperpolarisation (Wright et al 1996). PKCa translocates
to the cell membrane and associates with receptor for activated C-kinase (RACK-1), a
regulatory protein, and pi integrin following 30 seconds mechanical stimulation (Lee
HS et al 2002). PKC is thought to have a role in the control of signalling through
another serine/threonine kinase pathway, the MAPKs (Aplin et al 1998).
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There is some evidence suggesting that MAPKs are activated by mechanical stimuli
and these may be important in cellular responses to mechanical stimulation, including
transcription factor activation, gene regulation, cell survival and cell differentiation
(Aplin et al 1998; Giancotti and Ruoslahti 1999). Compression of cartilage explants
has been shown to phosphorylate ERK 1 and 2, p38 MAPK and stress activated
protein kinase (SAPK)/ERK (SEK-1) kinase of the JNK pathway in a time dependent
manner (Fanning et al 2003). Studies in cell types other than chondrocytes have also
shown MAPK activation due to mechanical stimulation, with ERK, p38 and JNK all
being activated by mechanical strain in rat cardiac myocytes (MacKenna et al 1998).
Integrins may interact with ion channels, growth factor receptors and other
transmembrane receptors, forming an integrated signalling complex (Ruwhof and van
der Laarse 2000). pi integrins colocalise with Na+-K+ ATPase, epithelial sodium
channels and voltage activated calcium channels in mechanoreceptor complexes in
mouse limb bud chondrocytes (Shakibaei and Mobasheri 2003). This may allow
cellular responses and signalling cascades to be regulated more effectively. Stretch
activated ion channels (SAC) and the glutamate receptor NMDA are involved in the
membrane hyperpolarisation and tyrosine phosphorylation associated with 0.33Hz
mechanical stimulation (Salter et al 2004; Wright et al 1996). Influx of calcium
through SAC may allow direct activation of calcium dependent pathways and is seen
following mechanical stimulation (Roberts et al 2001). ATP release and increased
intracellular calcium levels are seen within 500 milliseconds of mechanical
stimulation (Graff and Lee 2003). The calcium wave activates phospholipase C
(PLC) that produces inositol triphosphate (IP3) and this second messenger can travel
via gap junctions to adjacent cells, stimulating further calcium wave production.
(D'Andrea et al 2000). ATP has been identified as a molecule involved in the
membrane hyperpolarisation of normal monolayer chondrocytes following 0.33Hz
MS for 20 minutes. ATP is upstream of IL-4 in the signal transduction leading to
activation of apamin sensitive small conductance calcium activated potassium
channels (Millward-Sadler et al 2004).
The membrane hyperpolarisation may contribute to the negative regulation of
apoptosis (Gilbert et al 1996; Wang et al 1999). The activation of proteases by large
conductance calcium activated potassium channels in the phagocytic vacuole of
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leukocytes occurs through a combination ofmembrane depolarisation and increased
calcium concentration (Ahluwalia et al 2004). Mechanical stimulation at a frequency
of 0.33Hz causes membrane depolarisation in OA chondrocytes (Millward-Sadler et
al 2000a), and may be involved in activating intracellular molecules in a similar
fashion to the activation of proteases seen in the leukocyte vacuole.
The production of soluble mediators such as cytokines and growth factors in response
to mechanical forces has been described in mechanosensitive cells including
osteoblasts (Salter et al 1997). In vitro mechanical stimulation of chondrocytes shows
similar autocrine/paracrine signalling (Millward-Sadler et al 1999). As chondrocytes
are the only cells present in cartilage they must function as both sensor and effector
cells. However other cell types in the joint may also be affected (Millward-Sadler et
al 2003). The antiinflammatory cytokine IL-4, and neuropeptide substance P, are
secreted early in the mechanotransduction cascade, with production seen within 20
minutes suggesting release from preformed stores. Substance P has been shown to be
upstream of IL-4 in the signal cascade, acting through the NK-1 receptor to induce IL-
4 release. IL-4 and substance P appear to be necessary, but not sufficient, for gene
expression changes induced by MS, suggesting cross-talk may occur with other
integrin dependent signalling pathways activated by MS (Millward-Sadler et al 2003).
IL-4 is suggested to block the activation of latent proMMPs rather than their
production (van Lent et al 2002) and can protect synovial cells from NO-mediated
apoptosis (Relic et al 2001). IL-4 was shown to suppress the IL-1 [3 mediated increase
in MMP3 mRNA, protein and enzyme activity in human articular chondrocytes
(Nemoto et al 1997). IL-4 has been suggested to act by suppressing IL-lgene
expression (Wong et al 1993) and increasing the synthesis of IL-lra via STAT6
(Ohmori et al 1996). However, Palmer et al (2002) suggests that IL-4 did not activate
IL-lra in chondrocytes, and that IL-1 induced IL-lra took 24 hours to reach detectable
levels. IL-4 may also increase the inactive IL-1 receptor, IL-1RII, another potential








Figure 1.7 — Normal chondrocyte mechanotransduction pathway. Mechanical signals are
sensed through attachment to the ECM via the integrins. The function of integrins can be
modulated by associated proteins such as CD47. Stretch activated ion channels also influence
the activation of intracellular molecules. The FAC associated with the integrins intracellular
domain contains molecules that initiate intracellular signalling. The autocrine/paracrine release
of substance P and IL-4 cause activation of PLC and PKC releasing calcium and activating
sodium activated potassium channels that causes membrane hyperpolarisation. The release of
ATP and glutamate have also been implicated in membrane hyperpolarisation, although there
exact position in this pathway is not known.
1.4.2 - OA chondrocyte mechanotransduction (Figure 1.8)
OA cartilage derived chondrocytes show different responses to 0.33Hz stimulation in
monolayer compared to cells from normal joints. Membrane depolarisation is seen in
place of the hyperpolarisation in normal cells, with an absence of the rise of aggrecan
mRNA (Millward-Sadler et al 2000a; Millward-Sadler et al 2000b). The
depolarisation response involves tetrodotoxin sensitive sodium channels rather than
activation of SK channels, which are also present on OA chondrocytes. The loss of
the aggrecan response would be expected to have significant effects on cartilage
structure and function. The effects of the changes in the electrophysiological response
are less clear as it is not involved in the upregulation of aggrecan in normal cells
(Millward-Sadler et al 2000a). Nevertheless it suggests fundamental differences in
mechanotransduction. The altered ECM seen in OA, as discussed earlier, will change
the response to the mechanical stimuli sensed by the cells, and adaptation to the
altered environment may require a different threshold of stimulus before cellular
activation events are stimulated. Altered expression of integrins in OA (Ostergaard et
al 1998) will also influence the mechanotransduction process, although the
depolarisation response associated with OA monolayer chondrocytes at 0.33Hz
appears to be via the same integrin as the hyperpolarisation response seen in normal
chondrocytes, a5pi (Millward-Sadler et al 2000a). Cytoskeletal disruption did not
affect depolarisation which suggests it is unnecessary for the response. An NMDA
antagonist had no effect on depolarisation ofOA chondrocytes, so alteration of
NMDA receptor signalling in OA may be critical in the abnormal response to MS
(Salter et al 2004).
FAK, paxillin and p-catenin show prolonged tyrosine phosphorylation after
mechanical stimulation in OA cells (Lee HS et al 2000), and this may be due to
changes in the phosphatase activity known to regulate these molecules (Giancotti and
Ruoslahti 1999). Mechanical stimulation at 0.33Hz in OA also induces PI3kinase
(Millward-Sadler et al 2000a) that is regulated via integrins, through integrin-linked
kinases that are within the FAC (Dedhar 2000). Changes in the activation of the
kinases PKC and PI3K may adversely influence proteoglycan metabolism (Arner and
Pratta 1991; Kolanus and Seed 1997).
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Autocrine IL-1 p production is seen in addition to IL-4 and substance P after MS in
OA chondrocytes, which is likely to have catabolic effects as IL-1 p can induce MMP
release and can influence cartilage ECM regulation (Millward-Sadler et al 2000a). A
variable response of hyper- and de-polarisation is seen upon addition of IL-4 to
chondrocytes. IL-4 can signal via its type II receptor (Il-4Ralpha/IL-13R), causing
tyrosine phosphorylation of JAK1 and TYK2 and signalling via STAT6. IL-4
signalling can also occur through the Type I receptor (IL-4Ralpha/common gamma
chain) activating JAK1 and JAK 3 and can stimulate STAT5 activity. It may be
through activation of these different receptors that IL-4 is involved in both the
hyperpolarisation seen in normal chondrocytes and the depolarisation in OA
chondrocytes (Salter et al 2002). SOCS-1 binds and inhibits the kinase activity of
JAKs, inhibiting IL-4 mediated JAK1 and STAT6 activation (Losman et al 1999).
SOCS-3 mediates IL-1P inhibition of STAT5 activity (Boisclair et al 2000). These
factors could be produced in OA cells so altering the response due to IL-4 stimulation.
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Figure 1.8 - OA chondrocyte mechanotransduction pathway. Mechanical signals are
sensed through attachment to the ECM via the integrins. The function of integrins can be
modulated by associated proteins such as CD47. Stretch activated ion channels also influence
the activation of intracellular molecules. The FAC associated with the integrins intracellular
domain contains molecules that initiate intracellular signalling. The autocrine/paracrine release
of substance P, IL-4 and IL-1 cause activation of PLC and PKC, releasing calcium and activating
sodium channels that cause membrane depolarisation. The release ofATP and glutamate are not
involved in membrane depolarisation, although their receptors are present.
1.4.3 - Other studies of chondrocyte mechanotransduction
A number of different types of apparatus have been designed to apply strains of
different frequencies, magnitudes and types to cells in monolayer culture, in three
dimensional (3-d) culture and in explants (Reviewed in Brown 2000). The system
used to apply strain is important as alterations in the applied strain will occur between
systems. It is important to highlight some of the other mechanisms that have been
used to study mechanotransduction in chondrocytes, with the relative merits of these
systems compared to that of our own.
Firstly, our system uses chondrocytes seeded in monolayer culture with mechanical
strain transmitted to the cells through the stretch of the culture surface. It has been
reported that chondrocytes dedifferentiate in monolayer culture (Mahmood et al
2004), however our cells have been shown to express markers for differentiation at
the time of experimentation (Edinburgh University OA research group unpublished
observations). The fact that the cells are in monolayer, however, means that they do
not have a fully formed matrix as would be seen in vivo. This will result in alterations
in the level and types of strain experienced by the cell as well as increased access to
the cells for signalling molecules such as cytokines and growth factors. Provided
these limitations are understood, however, this method remains a very useful one in
the study of chondrocyte mechanotransduction. This is due to the relative ease with
which mRNA, protein and enzyme activity studies can be performed and the speed at
which cellular reactions can be stopped and analysed at the end of each experimental
protocol.
The application ofmechanical strain in our system appears to be sensed by the cells
through the a5pi integrin, however it is unlikely that this is the only receptor through
which strain is being sensed. The use of an antibody specific for certain cell surface
molecules with an attached metal fragment has been used (Wang and Ingber 1995).
Here the application of a magnetic field can stimulate the cells via the specific
receptors the antibody is bound to giving data about the differences between
mechanotransduction through certain cell surface molecules. Care must be taken,
however, as the application of a magnetic field may itself have effects on cellular
processes.
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Several other groups have applied cyclic tensile strain through stretching or flexing
the culture membrane. Perhaps the most relevant of these is Agarwal et al (2004).
Here, the application of strain to monolayer chondrocytes was shown to influence
activity of the transcription factor NFkB dependent upon the magnitude of the applied
strain.
D'Andrea et al (2000) used the stimulation of single chondrocytes using a
micropipette to show alterations in calcium concentration within the cell. This was
followed by showing that mechanical strain causes the activation of phospholipase C,
which in turn stimulates Inositol 1,4,5-triphosphate (IP3) release that is responsible
for alterations in calcium concentrations. It was suggested that the IP3 may actually
leave the stimulated cell, travel to an adjacent cell and stimulate calcium signalling.
Methods for the application of strain in monolayer other than through the stretching of
culture membranes include fluid flow and hydrostatic pressure. Hung et al (2000)
used a laminar flow chamber to exert strain on cultured monolayer chondrocytes.
Activation ofERK1/2 was seen following 5-15 minutes of fluid flow with
pharmacological inhibitors used to show that this response was not dependent upon
calcium mobilisation. This technique allows the accurate application of shear stress to
the cells, however the release of signalling molecules that may be involved in
mechanotransduction into the medium may not exert such an effect on the cells due to
the flow of the fluid. The use of a cone viscometer has also been employed to exert
fluid induced shear stress on monolayer chondrocytes (Smith et al 1995). This study
identified increased PGE2 and TIMP levels following the shear stress associated with
fluid flow. The direction of the fluid flow is the main draw back here, with cells
aligning to the flow, which may affect the way in which they sense the strain. A
novel mechanism to investigate the effect of fluid flow on chondrocytes was
employed by Graff and Lee (2003). Here the use of a plate reader that injects medium
into wells containing cells leads to increased ATP release and calcium mobilisation,
which were monitored immediately using the same plate reader. The problem with
this approach is that the strain is very hard to measure and keep uniform.
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Smith et al (1996 and 2000) investigated the effects of the application of hydrostatic
pressure on chondrocytes, identifying the role this plays on matrix synthesis. Here the
culture plates were placed in medium filled bags and immersed in a water tank, the
compression ofwhich was used to apply the pressure. The role of strain on cartilage
matrix homeostasis will be discussed in more detail later. Browning et al (2004) also
investigated the application of hydrostatic pressure on monolayer chondrocytes,
showing effects on calcium concentrations.
Mechanical stimulation using cells in 3-d matrix more closely resembles the in vivo
environment. In this situation the cells retain the chondrocytic phenotype in long term
culture (Yoon et al 2002). They are more likely to experience strains that are similar
to those seen in vivo due to similar attachments to the ECM and production of a
pericellular matrix. This can be achieved by culture in agarose or alginate beads.
Chowdhury et al (2004) used agarose constructs to culture chondrocytes in a 3-d
matrix. The constructs were subjected to compressive stress with the study
identifying the a5(31 integrin as an essential molecule in compression-induced
changes in cellular metabolism. Roberts et al (2001) used the same system to show
calcium concentration alterations due to mechanical compression. The difficulty with
this system is seen during the measurement of transient changes such as that seen
during cell signalling. The phosphorylation of proteins is very often the mechanism
through which they are activated and the isolation of these proteins immediately at the
end of the experimental protocol is complicated by the presence of the matrix itself.
There are also problems associated with the uniform application of strain to the cells
within the construct. Wu et al (2001) cultured chondrocytes in a novel 3-d matrix
composed of collagen, with mechanical stimulation applied by stretching this matrix.
The study showed that mechanical stimulation induced a factor known to control
chondrocyte proliferation and differentiation, Indian hedgehog.
Finally, the use of intact cartilage allows cells to be studied within their natural
matrix. Within this system they should sense strains in the way they do in vivo.
Compression of cartilage explants has been used in several studies. Fanning et al
(2003) used cartilage explants to show the sequence of phosphorylation ofMAPKs
due to mechanical compression. Lucchinetti et al (2004) also used cartilage explants
and compression to show that levels of a5 integrin increased due to strain while [31
46
integrin remained constant. The difficulty with this system is in understanding the
exact strains that are being applied to the cells, and which of these are causing any
effect seen. There are also problems in monitoring the transient changes during cell
signalling which are even more difficult due to the cartilage matrix than seen using
agarose and alginate culture.
Other mechanisms include the use of animal models of arthritis. These allow the
effects of certain mechanical loads to be evaluated in vivo, allowing identification of
global effects on the joint. However, the identification of the exact mechanisms
through which changes occur is very difficult.
Due to the difficulties associated with monitoring the transient effects of mechanical
stimulation on cellular signalling molecules, it is more common for effects of strain to
be determined by detection ofmore stable molecules such as matrix molecules, or the
production of molecules such as NO. The effects of strain on these molecules will be
discussed in more detail in the next section.
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1.5 - Mechanical and cytokine stimulation studies looking at NO
The problem with the study of mechanotransduction is that cartilage is a
heterogeneous tissue. The cells will therefore experience different strains and have
different responses to mechanical stimuli depending upon their position within the
cartilage (Langelier et al 2000). The magnitude of strain experienced within the joint
and the stresses and strains that are experienced by chondrocytes in vivo are not
known. The only study to measure the levels of strain experienced used a sensor
implanted into an artificial hip joint to calculate physiological levels (Hodge et al
1986). The findings reveal high local pressures of up to 18MPa that are not uniform
across the joint.
There have been only a limited number of studies that have investigated the
interactions between mechanical stimulation and cytokine stimulation in chondrocytes
where iNOS and nitrite were used as measures of response (summarised in Table 1.3).
Initial experiments involving strain looked at its effects on proliferation and
proteoglycan synthesis, these experiments will be discussed in more detail in Section
1.6.
A study by Lee DA et al (1998) showed strain (15% compressive strain at 0.3, 1 and
3Hz for 48 hours) having an effect on LPS induced nitrite production in bovine
articular chondrocytes seeded in agarose. This group have since used the same strain
regimen (15% strain, 1Hz for 48 hours) to show that IL-ip stimulates nitrite and PGE2
that are inhibited by strain (Chowdhury et al 2001)
Lapine articular chondrocytes subjected to IL-ip were shown to produce iNOS
mRNA, protein and nitrite. This was inhibited by the application of cyclic tensile
strain at 20% stretch and 0.05Hz (Gassner et al 1999) and showed basal nitrite levels
were not affected by strain (Gassner et al 2000). Xu et al (2000) used the same strain
system but 6% stretch at 0.05Hz to show a similar reversal of IL-ip induced iNOS
mRNA and nitrite as well as COXII mRNA and PGE2. Interestingly this group
studied the effects of adding IL-lp prior to the application of strain and found that
after 1 hour the effects of strain were halved, and after 2 hours strain had no effect on
iNOS, COXII, nitrite and PGE2. Rabbit temperomandibular junction chondrocytes
have been used by this group to investigate the effects of different magnitudes of
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strain, with the use of a flexercell strain unit to apply cyclic strain at 10Hz, 20%
elongation and showing the reversal of IL-1 p induced iNOS and COXII mRNA as
well as nitrite and PGE2 in these cells (Agarwal et al 2001). Long et al (2001) showed
that rabbit articular chondrocytes respond similarly to cyclic tensile strain, reducing
the TNFa-induced iNOS and COXII mRNA levels.
Porcine chondrocytes appear not to follow the same trend as the other species
discussed so far. Fermor et al (2001 and 2002) applied static and cyclic compression
over a range of magnitudes to porcine articular cartilage explants and found that strain
upregulated nitrite and PGE2 production. This suggests that species differences exist
in the regulation of iNOS production and the response of chondrocytes to mechanical
stimulation. This should be considered before drawing conclusions from the results
obtained from different species.









lng/ml IL-1P Strain JiNOS, COXII and MMP1 mRNA as well
as nitrite and PGE2. fTlMP-2
Prevented IL-ip inhibition of PG synthesis





IL-1 p lng/ml CTS reverses IL-1 induced iNOS and COX II
mRNA, nitrite and PGE2. CTS also increases TIMP
and reverses IL-1P reduced coll 11 mRNA.
CTS and IL-1 p in combination increase aggrecan
mRNA. CTS and IL-1 have to be simultaneous - pre
CTS has no effect on IL-1P induced nitrite and iNOS
mRNA - pre IL-1P decreases effect ofCTS.
Gassner 2000 Lapine articular
chondrocytes
CTS for 24hr IL-1 (3 CTS doesn't affect basal NO
CTS decreases IL-1 p induced NO
Gassner 1999 Lapine shoulder and
knee monolayer
chondrocytes




iNOS mRNA, protein and nitrite detected due to IL-
1(3 and inhibited by CTS
PG synthesis also restored
Chowdhury 2001 Bovine chondrocytes in
agarose





Dose increase in nitrite and PGE2 due to IL-1.
Strain inhibits nitrite and PGE2, reversed by L-NIO
suggesting NO involved in PGE2 synthesis.
Proliferation inhibite by IL-1 and reversed by L-NIO
so NO involved. PG synthesis not affected by NO.
Lee DA 1998 Bovine chondrocytes in
agarose





LPS->tnhrite. Strain, L-NAME and DEX ->i nitrite
L-NAME partially blocked nitrite due to strain and
LPS, and reversed strain related increase in
proliferation. PG synthesis is unaffected by NO




Strain increased NO and PGE2. PGE2 was
dependent upon NO.
Fermor 2001 Porcine cartilage
explants
Static and cyclic
(0.5Hz) stain at 0.1,
0.5 and IMPa
1400W Some of the strain regimen increase nitrite and iNOS
protein, but cNOS is not detected. 1400W reduces
NO
Long 2001 Rabbit articular
chondrocytes







IL-1P Strain inhibits COXII and PGE2 production due to
IL-1 p
Table 1.3 - Mechanically and cytokine stimulated chondrocyte experiments
measuring iNOS and NO levels. CTS=Cyclic tensile strain.
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1.6 - PG synthesis following mechanical stimulation and involvement of NO
There have been a number of studies looking at the effects of different mechanical
loads on chondrocytes and cartilage, with proteoglycan synthesis being one of the
parameters monitored. Cartilage explant, three-dimensional cultures and monolayer
cultures of chondrocytes have all shown that, following cyclic mechanical
stimulation, there is an increase in proteoglycan production, while static compression
leads to decreased proteoglycan production (Lee DA et al 2000; Sauerland et al 2003;
Valhmu et al 1998; Waldman et al 2003). Loading frequency and maximal stress are
also important factors in the outcome, with shear, stretch and compression all able to
induce anabolic responses (Wong et al 1999).
The possible involvement ofNO in the altered proteoglycan synthesis due to
mechanical stimulation has been looked at in several studies listed in Table 1.4.
Lee DA and Bader (1997) looked at proteoglycan levels following 48 hours of 15%
compressive strain of bovine articular chondrocytes seeded in agarose constructs.
Proteoglycan levels were increased by 50% at 1Hz, while 0.3Hz and static strain
decreased levels by 5-15%. The same group then looked at the effects ofNO on PG
synthesis (Lee DA et al 1998). Strain increased PG synthesis and decreased nitrite
levels associated with LPS stimulation, with NOS inhibitors showing that strain
increased PG synthesis is only slightly influenced by NO. Chowdhury et al (2001)
then looked at IL-ip in the same system, showing it decreased proteoglycan synthesis
in both an NO dependent and independent manner.
Primary rabbit articular chondrocytes seeded in monolayer were subjected to cyclic
tensile strain (0.05Hz 20% elongation for up to 96 hours) and IL-ip stimulation
(Gassner et al 1999). IL-ip caused decreased proteoglycan synthesis and increased
iNOS mRNA, protein and nitrite. Strain slightly reduced PG synthesis when applied
alone, however it restores PG synthesis levels following IL-ip stimulation as well as
reducing iNOS mRNA, protein and nitrite levels. Xu et al (2000) showed that IL-ip
increases iNOS mRNA and nitrite and the application of strain reverses these. IL-lp
alone decreased proteoglycan synthesis significantly, with strain reversing this effect.
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Gassner et al (2000) showed the involvement ofNO, with L-NMA partially restoring
the inhibition of PG synthesis associated with IL-lp stimulation.
Several other studies have shown similar effects of strain on TNFa mediated PG
suppression (Long et al 2001), L-NMA inhibited NO production and increased PG
synthesis while SNAP increased NO and decreased PG (Liu et al 2001) and NO
mediated the reduced PG synthesis associated with IL-lp in equine articular cartilage,
shown using the inhibitor L-NIO, and donor DETA-NONOate (Bird et al 2000).
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lng/ml IL-1 (3 CTS^jiNOS mRNA and nitrite
CTS ^Prevented IL-1 inhibition of PG
synthesis





IL-ip lng/ml CTS reverses IL-1 induced iNOS mRNA
and nitrite.





CTS for 24hr IL-1 p
L-NMA
CTS-*Reversed |NO and J.PG due to IL-1
L-NMA^|NO and partially restored PG
due to IL-1
Hassner 1999 Lapine articular
monolayer
chondrocytes




IL-1 ■* |iNOS mRNA, protein and nitrite
and decreased PG synthesis
CTS-* Inhibits iNOS mRNA, protein and











Strain-* J, nitrite due to IL-1
PG synthesis is increased by strain and this
increase is inhibited by IL-1 and further
inhibited by L-NIO, so NO involved in
increased PG due to strain.
.ee DA 1998 Bovine
chondrocytes in
agarose






Strain-*! nitrite due to LPS
L-NAME partially blocked nitrite due to
strain plus LPS. PG synthesis is only
slightly influenced by NO
„ee DA 1997 Bovine
chondrocytes in
agarose
0.1, 1, 3Hz 15%
compressive strain
48hrs
fPG synthesis at 1Hz by 50%
J.PG synthesis at 0.3Hz and static by 5-15%





LPS (lug/ml) LPS^ fiNOS mRNA and nitrite and
iaggrecan mRNA
Strain^ jiNOS and nitrite and partially
reversed jaggrecan mRNA caused by LPS
.ong 2001a Articular
chondrocytes
CTS TNFa TNFa induced iNOS mRNA.
CTS inhibits this.
Ju 2001 Human lumbar
disc cubes
Hydrostatic pressure
in syringe (3atm and
30atm)
L-NMA 3atm-> fPG synthesis
30atnr* J.PG synthesis
L-NMA ■* increased PG due to 3atm and
relieved decreased PG due to 30atm






NO fully mediated the decrease PG
synthesis due to IL-1
Table 1.4 - Mechanically and cytokine stimulated chondrocyte experiments
measuring proteoglycan synthesis - involvement ofNO. CTS=Cyclic tensile strain.
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1.7 - Aims and Objectives
The aim of this study was to investigate interactions between mechanical signalling,
nitric oxide synthesis and PG synthesis in human chondrocytes. In order to achieve
these aims a number of objectives were identified:
(I) Investigate NOS isoform expression in chondrocyte cell lines and in
primary human chondrocytes
(II) Investigate the effects ofmechanical stimulation on NOS expression
(III) Investigate the effects ofmechanical stimulation and NO on PG synthesis
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Chapter 2 - Materials and Methods
2.1 Human Articular Chondrocyte (HAC) culture
2.1.1 Isolation of HAC
Human articular cartilage was collected at surgery with informed consent from
patients undergoing joint replacement. The cartilage surface was macroscopically
graded according to the Collins and McElligott scoring system (Collins and
McElligott 1960) (Table 2.1) and sections removed to be snap frozen and stored at -
70°C for microscopic grading (Mankin et al 1971) (Table 2.2). Sterile forceps and
scalpel were used to remove the cartilage from the bone surface, pooling cartilage of
similar grading from the same joint surface within a single sample. Bone tissue was
then soaked overnight in Formalin before being bagged and sent for incineration.
Cartilage was placed in a tissue culture dish (NUNC) containing an antimicrobial
solution composed of 10mM glutamine, 50 I.U/ml penicillin, 50pg/ml streptomycin
2 •and 12.5pg/ml amphotericin B (all Gibco, Paisley, UK), chopped into ~lmm pieces
and left at room temperature for 60-90 minutes. Antimicrobial solution was removed
and fragments were then washed with sterile phosphate buffered saline (PBS) twice
before incubation with 0.25% trypsin (Gibco) for 30 minutes at 37°C. Trypsin was
then removed and the fragments again washed twice with PBS before addition of
3mg/ml collagenase (Sigma Poole, UK) in Iscoves Modified Dulbecco's Medium
(MEM) (Sigma, Poole, UK) supplemented with 10% foetal calf serum (FCS) (First
Link UK Ltd), 10 I.U/ml penicillin, lOpg/ml streptomycin (Gibco) and 2mM L-
glutamine (Gibco) (complete medium) and left overnight in an incubator at 37°C in an
atmosphere of 95%C>2, 5%C02. The following day the tissue culture dish was
removed from the incubator and the sample was gently agitated using a sterile pastette
before being passed through a sterile metal filter into a sterile centrifuge tube. The
sample was then spun at 300g (lOOOrpm) in a MSE Mistral 2000R centrifuge (Sanyo-
Gallenkamp) for 10 minutes. Supernatant was removed, the pellet resuspended in
PBS and centrifuged under the same conditions. This wash step was repeated once
more before the cells were resuspended in complete medium supplemented with
6.25pg/ml amphotericin B (Gibco) (seeding medium) and passed through a 70-micron
filter (Becton Dickinson, Oxford, UK) into a new sterile centrifuge tube, removing
any large cell clumps or pieces of debris.
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Table 2.1 - Collins-McElligott scoring system (Collins and McElligott 1960)
Collins Grade Criteria
0 No cartilage degeneration
1 Limited patches of fibrillation or softening in central
area of articular cartilage
No area ofwhole cartilage thickness loss
No recognisable marginal osteophytosis
No detectable synovial inflammation
II Large area of fibrillation and fissuring without denuding
bone
Early marginal chondro-osteophytosis
III At least one area (30% or less) ofwhole thickness
cartilage loss and extensive fibrillation, fissuring and
bone exposure
More generalised synovial disease and obvious
marginal osteophytosis
IV Extensive cartilage loss and bone exposure
Eburnation and bone grooving, destruction of
intraarticular ligaments and fibrosis or atrophy of
synovial fringes
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Table 2.2 - Mankin histological/histochemical grading system for osteoarthritic






Pannus and surface irregularities
Clefts to middle zone
Clefts to deep zone



































2.1.2 Plating of Cells for Experiments
The cell number in the suspension was assessed using a Neubauer haemocytometer
(Figure 2.1). With a coverslip in place, 10pl cell suspension was mixed with lOpl
0.4% Trypan blue (Sigma). 10pl of this was added to one chamber by touching the
tip to the edge of the coverslip and allowing capillary action to fill the
haemocytometer chamber. Cell number was then calculated by counting all the cells
in the 1mm corner squares (Figure 2.1) with each 1mm square representing a total
volume of 10"4cm3. Therefore, as 1cm3 is equal to 1ml, the number of cells per ml is
equal to the average count per 1mm square x 104.
Cells were seeded in 58mm Petri dishes (Nunc) containing 5ml total volume at
5xl04/ml in seeding medium. After seeding cells were incubated for 48-72 hours at
37°C to allow cells to adhere to the base of the dish. Cells were grown in monolayer
for 7-10 days with complete medium added every 48-72 hours. When the dishes
reached 80-90% confluence the medium was removed and replaced with complete
medium without FCS added (serum free medium) for ~16 hours before commencing







Figure 2.1 - Diagrammatic representation ofNeubauer haemocytometer
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2.1.3 iNOS Inhibitor experiments
iNOS inhibitor experiments were carried out using RPMI 1640 medium with no
added arginine (Sigma). Primary OA HAC were grown to confluence as previously
described and then serum starved for ~16 hours using the arginine free RPMI 1640
supplemented with 10 I.U/ml penicillin, lOpg/ml streptomycin (Gibco), 2mM L-
glutamine (Gibco) and 100pM L-arginine (Sigma).
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2.2 Culture of other cells
2.2.1 Chondrocyte Cell Line Culture
Transformed human chondrocyte cell lines C20A4 and C28I2 (Donated by Dr M
Goldring) were grown at 37°C in an atmosphere of 95%02, 5%C02. Cells were
cultured in complete medium and passaged every 6 days. Trypsin/EDTA solution
(Gibco) was used to detach cells from the base of the tissue culture flask and cells
were then washed in PBS and spun at 300g (lOOOrpm) for 10 minutes. Cells were
resuspended in complete medium before being counted and seeded in the same way as
described for primary HAC. Transformed cells reached confluence in a shorter time
than primary HAC (3-4 days) and were then incubated in serum free medium for ~16
hours before experiments were carried out using a single culture dish without a
replicate for each condition tested.
2.2.2 Culture of cells used as western blot positive controls
DLD-1
The human colorectal adenocarcinoma cell line DLD-1 was cultured as detailed above
for the chondrocyte cell lines. These cells are known to produce iNOS in response to
pro-inflammatory cytokine stimulation (Linn et al 1997; Salzman et al 1996). Upon
reaching confluence these cells were stimulated with the cytokine cocktail containing
IL-ip, TNFa, IL-6 and IFNy (as detailed in Chemicals Reagents Section 2.4) for 16
hours before lysis and protein extraction as detailed in Section 2.8 and used as a
positive control for iNOS western blotting (Tinker et al 2003).
EAhy926
The human umbilical vein endothelial cell line EAhy926 (Donated by Dr S Brown)
(Edgell et al 1983) was cultured as detailed above for the chondrocyte cell lines.
Upon reaching confluence these cells were lysed and protein extracted as detailed in
Section 2.8 and used as a positive control for eNOS (Thum et al 2003).
59
2.3 Mechanical Stimulation
The mechanical stimulation apparatus used is a modification of that previously
described (Wright et al 1992; Wright et al 1996) (Figure 2.2). Flexible 58mm tissue
culture dishes (Nunc) were placed on rubber 'O' rings in polypropylene stimulation
chambers. The lid was screwed down to hold the dish in position with the 'O' ring
ensuring an airtight seal between the chambers above and below the dish (Figure
2.3).
Inlet ports on the stimulation chambers allow the entry ofNitrogen gas into the space
below the dish, increasing the pressure in the lower chamber and causing the dish to
balloon upwards, thus applying strain to both the base of the dish and to adherent
HAC. Outlet ports then allow the release of the Nitrogen gas causing the pressures to
return to normal and the dish returns to its resting state (Figure 2.4). Dr Malcolm
Wright and Mr Paul Parker extensively calibrated the system by the use of strain
gauges attached to the base of the culture dish to measure the strain induced by
various pressures (Figure 2.5).
The frequency with which the dishes were exposed to strain is dictated by an
electronic timer, with 0.33Hz (2sec on, 1 sec off) used in all experiments in this study.
A gas pressure of 0.25atmospheres (190mmITg) was used which results in -31,000
pstain on the bottom of the dish. Experiments were carried out at 37°C in an
























Figure 2.3 - Diagrammatic representation ofmechanical stimulation chambers.
Nitrogen gas enters the lower chamber causing increased pressure and resulting in the







Figure 2.4 - Diagrammatic representation of mechanical stimulation apparatus
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Pressure (atmospheres)
Figure 2.5 - Graph of strain calibration for mechanical stimulation system. A gas
pressure of 0.25atmospheres (190mmHg) was used in these studies, resulting in
~31000pstrain on the base of the dish.
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2.4 Chemical Reagents
To investigate the role ofNOS in cartilage and the effects of mechanotransduction on
NO production a variety of reagents were added to cell cultures. A cytokine cocktail
was used to induce iNOS production with mechanical stimulation or iNOS inhibitor
added simultaneously to determine their effects. The chemicals and concentrations
































IL-ip 0.5ng/ml R&D systems
TNFa 5ng/ml R&D systems
o
O «
IL-6 lng/ml R&D systems























Table 2.3 - Chemical Reagents used in these studies
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2.5 Cell Viability Assays
2.5.1 Acridine Orange staining
Acridine orange (Sigma) is a fluorescent nucleic acid stain (Carmichael et al 1980)
that can be used in cells to detect apoptosis. HAC were stimulated with cyclical
mechanical stimulation (MS) (in 58mm petri dishes) and the chemicals described in
Table 2.3 (in a 24 well plate) in serum free medium at 37°C, 95%02, 5%C02 for 4
and 12 hours. Following the incubation period the medium was removed and the
wells washed gently using sterile PBS. 300pl acridine orange (100pg/ml in PBS) was
added to each well and examined immediately under a fluorescence microscope for
the presence of apoptotic nuclei.
2.5.2 MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazonium bromide] assay
The MTT assay is a colorimetric assay where mitochondrial succinate dehydrogenase
catalyses conversion ofMTT to a blue formazan product. The cells must be viable for
this reaction to occur.
HAC in 96 well plates were incubated with the chemicals described in Table 2.3 in
triplicate using serum free medium at 37°C, 95%02, 5%C02 for 4 and 12 hours.
Triton-X-100 (0.2%) was used as a positive control. The medium was removed after
incubation and cells washed gently with PBS. MTT working solution was made up
by adding 1.6ml ofMTT stock (lOmg/ml in PBS) (Sigma) to 5.4ml of serum free
medium and lOOpl added to each well and incubated for 3 hours in the dark at 37°C,
95%C>2, 5%CC>2. The MTT solution was then removed and cells washed in PBS
before addition of lOOpl dimethyl sulfoxide (DMSO) and gentle agitation for a few
seconds to dissolve the formazan salt. The plate was then read at a wavelength of
630nm using a spectrophotometer within 30 minutes, with absorbance proportional to
cell number.
HAC in 58mm petri dishes were incubated with the cytokine mix or IL-ip and
subjected to MS for 4 and 12 hours before being treated in the same way as the 96




HAC RNA extraction occurred immediately after the 4 and 12 hour experimental
incubation times using a single culture dish for each condition tested. Dishes were
placed on ice, the culture medium removed (1ml was kept to perform the Griess
Assay) and the cells gently washed with sterile PBS. 350pl RNA extraction buffer
RLT (Qiagen, Crawley, UK) plus P-mercaptoethanol (lOpl/ml) (Sigma) was added
directly to the cells. Plates were swirled gently for 5-10 minutes to ensure all cells
were lysed, then scraped using a sterile cell scraper (Greiner, Shroudwater business
park, Gloucestershire) and transferred to a DNase/RNase-free microfuge tube. The
samples were mixed thoroughly using a pipette before being transferred to a
QIAshredder spin column (Qiagen) and spun at 13000g for 2 minutes. 350pl 70%
ethanol (Hayman, Witham, UK) was added to the homogenised lysate and mixed by
pipetting. The sample was then transferred to an RNeasy mini column (Qiagen) and
spun at 13000g for 15 seconds, discarding the flow-through. 350pl buffer RW1
(Qiagen) was added and spun for 15 seconds at 13000g with the flow-through being
discarded. 80pl DNase I (Qiagen) was pipetted directly onto the silica-gel membrane
and left at room temperature for 15 minutes before RW1 was again added and the
sample spun at 13000g, with the flow-through being discarded. 500pl buffer RPE
(Qiagen) was added to the spin column and spun for 15 seconds before adding further
500pl RPE and spinning for 2 minutes at 13000g. The flow through was discarded
and the column placed in a new 1,5ml DNase/RNase-free microfuge tube. 30pl
DEPC treated RNase-free water was added to the column before spinning for 1
minute at 13000g. The flow-through was pipetted back into the spin column and the
spin repeated with the flow through stored at -70°C.
2.6.2 RNA Quantification
An Ultrospec 2000 UV/visible spectrophotometer (Pharmacia Biotech) was used to
quantify the RNA. RNase-free water alone was used to zero the instrument and the
absorbance of lpl RNA in a total of 100pl was measured at both 260 and 280nm to
obtain the DNA/RNA ratio.
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2.7 Polymerase Chain Reaction (PCR) Methods
2.7.1 Reverse Transcription (RT) reactions
0.5ml Sterile RNAse/DNase-free tubes were used to perform RT reactions. Each RT
reaction contained 1 pg RNA, 200ng Random Hexamers (Promega, Southampton,
UK) in a total volume of 11 pi using RNase free water. The contents of the tube were
mixed before being denatured by heating for 10 minutes at 70°C on an Omn-E™
thermal cycler (Hybaid, Teddington, UK). Following this 0.5mM 2'-
Deoxynucleoside 5'-Triphosphates (dNTPs) (Promega), lOmM Dithiothreitol (DTT),
lxRT reaction buffer and 200U Superscript II RT (all Invitrogen) was added to each
tube to give a final volume of 20pl.
The tubes were placed on the Omn-E™ thermal cycler for 50 minutes at 42°C and
70°C for 10 minutes. The synthesised cDNA was stored at -70°C until required.
2.7.2 Primer Design
The sequences used for PCR primers and probes (Table 2.4) were designed in-house
(for this study or previously designed for other studies) using mRNA sequences from
the Genbank database held at the National Centre for Biotechnology Information web
site. Wherever possible primers were designed which were intron spanning to
minimise the chances of genomic DNA contamination. All primers were synthesised
by Applied Biosystems (ABI) (Warrington, UK) and designed using Primer
Express™ vl.O (Perkin Elmer) with a FAM label attached to the probes. 18s is the
exception as it was purchased as a pre-made set (ABI), with the probe being VIC
labelled.
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Specificity Description Sequence (5""♦3")
Aggrecan Forward GCC TGC GCT CCA ATG ACT
Reverse AAT GGA ACA CGA TGC CTT TCA
Probe GCC ATG CAT CAC CTC GCA GCG GTA T
iNOS Forward GCA GGT CGA GGA CTA TTT CTT TCA
Reverse CTT CGC CTC GTA AGG AAA TAC AG
Probe CTC AAG AGC CAG AAG CGC TAT CAC GAA G
eNOS Forward CCC GCT CGA GGC ACA
Reverse TGT TTG GCC GAG TCC TCA
Probe CCC CAA GAC CTA CGT GCA GGA CAT C
nNOS Forward GGC CGA AGC TCC AGA ACT C
Reverse GTG TGG AGA CGC ACG AAG ATA G
Probe TCC AGA GCC CTA AAT CCA GTC GGT CA
Mouse Aggrecan Forward ACT CCC ACA GTT GGC AGG TT
Reverse CAG CCC ACT AAG GTC TCC TGT T
Probe CCT TCG GGG CTC TCA CCT CCA GAG
Table 2.4 - Primer and Probe sequences used in these studies
Primer/Probe set Probe added Primer added RNase-free water
(5pM stock) (lOpM stock) (PD
18s 0.25pl (lOpM stock) 0.625pl (20pM stock) 7.125
Aggrecan 0.5pl 0.125)4.1 6.75pil
iNOS 0.5pl 0.125)41 6.75)41
eNOS 0.5pl 0.75pl 5.5(41
nNOS 0.5pl 2.25pl 2.5(41
Mouse Aggrecan 0.5|il 0.125(41 6.75(41
Table 2.5 - Primer and Probe concentrations used in these studies
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2.7.3 PCR Protocol
PCR reactions were performed using 96 well plates made up of 0.2ml RNase/DNase
free tubes with a final reaction volume of 25pl. A typical reaction contained 12.5pl
2x Mastermix (containing dNTPs, Hot Goldstar DNA polymerase, MgCU, Uracil-N-
glycosylase) (Eurogentec, Romsey, UK), 0.125pl forward primer (lOpM), 0.125pl
reverse primer (lOpM), 0.5pl probe (5pM), 5pl cDNA and 6.75pl RNase-free water.
Details of the primer/probe concentrations used in each reaction are in Table 2.5.
2.7.4 PCR Programme
The samples were run on an ABI PRISM™ 7700 Sequence Detector (Perkin Elmer).
Thermal cycler conditions were in three stages: Stage 1 was 50°C for 2 minutes, Stage
2 was 95°C for 10 minutes and Stage 3 included 40 cycles of 95°C for 15 seconds and
60°C for 1 minute. The fluorescent release from the probe was recorded in real time
by an attached computer using the Sequence Detection Systems vl.6.3 alias software
(Perkin Elmer). Threshold cycle (Cy) values from experimental samples were
converted to relative mRNA levels using a standard curve of dilutions of plasmid






-6 -5 -4 -3 -2 -1 0
Log10 Dilution
Figure 2.6 - Taqman RT-PCR standard curve of iNOS plasmid cDNA dilutions
against Threshold cycle (Cj) value to allow calculation of relative mRNA levels in
experimental samples.
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2.8 Protein Purification -Western Blotting
2.8.1 Protein Extraction
HAC protein extraction occurred immediately after the 4 or 12hour experimental
incubation times with a single culture dish used for each condition tested. Dishes
were placed on ice, the culture medium removed (1ml was kept to perform the Griess
assay) and the cells were gently washed with sterile PBS. 300pl protein extraction
buffer containing 50mM HEPES (pH 7.4) (Sigma), ImM EDTA (Sigma), 0.1 mM
DTT (Sigma), 20mM CHAPS (Calbiochem, Nottingham, UK) and complete mini
protease inhibitor cocktail (Roche, Lewes, UK) was added directly to the cells. Plates
were kept on ice and swirled occasionally for 15-20 minutes to ensure all cells were
lysed, then scraped using a sterile cell scraper (Greiner, Gloucestershire, UK) and
transferred to a microfuge tube. The samples were mixed thoroughly using a pipette,
subjected to centrifugation (13000g for 15 minutes) and the supernatant was
transferred to a fresh microfuge tube and the protein concentration was quantified.
2.8.2 Protein Assay
The protein concentration was quantified using a bicinchoninic acid (BCA) protein
assay reagent kit (Pierce, Perbio Science, Cramlington, UK). The assay is based on
2"b l"b •the biuret reaction, where protein reduces Cu to Cu in an alkaline medium. The
Cul+ binds BCA producing a purple colour that can be read at 540nm (Smith 150, 76
(1985)). Dilutions of a 2mg/ml bovine serum albumin (Sigma) solution were used to
construct a standard curve and 20pl of this and each of the samples was added to a 96
well plate in duplicate. Reagents A and B from the BCA kit were mixed (50:1) and
200pl added to each well. The plate was covered and incubated at 37°C for 30
minutes before reading at 540nm, with absorbance being relative to protein
concentration.
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2.8.3 Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE)
The Bio-Rad (Hemel Hempstead, UK) Protein II xi cell system was used to carry out
SDS-PAGE with resolving and stacking gels made up as shown in Table 2.6 and
Table 2.7 respectively.
20pg total protein was mixed with a half volume of 2xloading buffer made up of 5ml
0.375M Tris (pH6.8), 4.5ml dH20, 8ml 10%SDS, 2ml glycerol, 0.4ml (3-
mercaptoethanol and 150pl of a saturated bromophenol blue solution and put in a
boiling water bath for 5 minutes. Samples were then cooled on ice and loaded into
the gel in a gel tank filled with 4 litres of electrode buffer containing 25mM Tris,
190mM glycine and 0.1%SDS (all Sigma) in dH20. Gels were run at lOOvolts for 35
minutes and then 200volts for 3 hours using a Bio-Rad Powerpac 3000. E. coli
derived NOS isoforms, DLD-1 (iNOS) and EAhy926 (eNOS) cell lysates were used
as positive controls (Table 2.8) and Full Range Rainbow™ molecular weight marker






































Table 2.6 - Resolving gel (10%) Table 2.7 - Stacking gel (3.6%)
Source Control Cone used
E. coli lysate iNOS 1Opl 1:100 stock dilution
E. coli lysate eNOS lOpl 1:50 stock dilution
E.coli lysate nNOS 20pl 1:20 stock dilution
DLD-1 (cytokine
stimulated)
iNOS 50pg total protein
EAhy926 eNOS 50pg total protein
Table 2.8 - Western blot positive controls
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2.8.4 Transfer
Hybond ECL Nitrocellulose membrane (Amersham) was cut to size and soaked for
15minutes in transfer buffer containing 25mM Tris, 190mM glycine and 0.005%SDS
(all Sigma) in dTEO. Blotting paper and sponges were also soaked in transfer buffer
and each cassette set up as shown in Figure 2.7.
Transfer was carried out overnight at 15V and 4°C and then at 25V, 4°C for 1 hour the
following morning. A Bio-Rad Transblot cell with plate electrodes and a Bio-Rad
model 200/2.0 power supply were used.






The nitrocellulose membrane was blocked for 1 hour at room temperature using a
antibody dilution buffer containing 200ml TBS, lOg Dried milk and 0.2ml Tween-20
with gentle agitation applied using a bench top roller. Primary antibody diluted in
antibody dilution buffer was added to the membrane and incubated at room
temperature for 1 hour using the dilutions shown in Table 2.9. This was then washed
in Tris buffered Saline containing 20mM Tris (sigma) and 137mM NaCl (sigma) at
pH7.6 plus 0.1%Tween-20 (TBS-T) for 10 seconds, 30 seconds, 5 minutes and 10
minutes before the addition of HRP-linked secondary antibody at the dilutions shown
in Table 2.9 for 1 hour at room temperature. The 4 washes in TBS-T were repeated
before ECL+ (Amersham) was added for 3 minutes and then the membrane dripped
dry for 10 seconds. The membrane was loaded into a film cassette and taken up to the
dark room where x-ray film (Kodak) was set on top of the membrane, exposing it to
the presence of any fluorescing bands. The film was then developed using a
Hyperprocessor (Amersham).
2.8.6 Stripping membrane
In order to re-probe the same membrane for different proteins of interest the
membranes were stripped of the attached antibodies. This was carried out using a
stripping buffer containing lOOmM P-mercaptoethanol, 2%SDS, 62.5mM Tris-HCl
(pH6.7) and incubated for 30 minutes at 50°C with occasional agitation. The
membrane was then washed using large volumes of TBS-T at room temperature
before proceeding with blocking and probing the membrane as described above.
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Primary Primary Dilution Secondary Secondary Secondary
Antibody Antibody used Antibody Antibody Antibody
Specificity info used Info dilution
iNOS (Santa H-174 1:1000 HRP-linked NA 934 1:2000
Cruz) (sc-8310) donkey anti (Amersham)
rabbit IgG
eNOS (Sigma) aa596-609 1:10,000 HRP-linked NA 934 1:2000
(N 2643) donkey anti (Amersham)
rabbit IgG
nNOS (Sigma) NOS-B1 1:3000 HRP-linked NA 931 1:2000
(N 2280) sheep anti (Amersham)
mouse IgG
GAPDH 6C5 1:12,500 HRP-linked NA 931 1:2000
(Abeam, (ab8245) sheep anti (Amersham)
Cambridge, UK) mouse IgG
Table 2.9 - Antibody details and dilutions used in these studies
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2.9 Nitrite Determination
In order to measure the level ofNO produced during the experiment the level of its
stable degradation product nitrite (NO2") is measured using the Griess Reagent
(Sigma). This is a modification of a diazotization reaction originally described by
Griess in 1879. This is a 2 step reaction where nitrite reacts with sulphanilamide
initially and the product of this reacts with N-l-napthylethylenediamine
dihydrochloride under acidic (phosphoric acid) conditions to produce an Azo
compound (Figure 2.8). lOOpl of post-experimental conditioned medium is added to
lOOpl of Griess reagent and the generation of azo-product can be measured at a
wavelength of 550nm, correlating to nitrite levels. Dilutions of a Sodium nitrite
lOOpM solution were used to create a standard curve.
N-l-napthylethylenediamine
dihydrochloride
Figure 2.8 - Griess assay 2 step diazotization reaction to measure nitrite levels
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2.10 - Statistics
The mean, standard deviation and standard error of the mean (SEM) were determined
in each experiment. Variances were assessed by comparing the F-ratio of the standard
deviations for each pair of values. Where the variance was not significantly different
results were assessed using an unpaired t test. When the F-ratio of the two variances
reached significance the Mann-Whitney U test was used to assess the data which was
not parametrically distributed. In a number of instances where responses in individual
samples followed a closely similar pattern results were compared using a paired t test.
Results were considered statistically significant when the p value was less than 0.05.
Performing multiple T-tests can cause problems as the more tests that are performed
the higher the chance of there being an inaccurate test. It is for this reason that an
adjustment or correction factor may be beneficial where a number of T-tests have
been performed. In order to avoid this overuse of the T-test it may be more
appropriate to use a different statistical method where differences between two or
more groups can be assessed using a single test, such as ANOVA.
78
Chapter 3 - Transformed chondrocyte
Nitric Oxide Synthase (NOS) isoform expression
Aims
Investigate NOS isoform expression in chondrocyte cell lines
Investigate the effects of cytokine stimulation and mechanical
stimulation on NOS isoform expression in chondrocyte cell lines.
3.1 - Introduction
The production of nitric oxide (NO) is known to have many effects on the regulation
of cartilage matrix integrity, as discussed in Section 1.3.6. The cells responsible for
cartilage regulation are the chondrocytes, and the presence and activity of enzymes
that produce NO within these cells are therefore of interest. In this study two
transformed chondrocyte cell lines, C20A4 and C28I2, have been analysed for the
presence of all three enzymes known to produce NO, endothelial (e), neuronal (n) and
inducible (i) nitric oxide synthase (NOS). The effect of cyclic mechanical stimulation
at 0.33Hz and 30,000pstrain (MS) and proinflammatory cytokine cocktail stimulation
(CYT) on NOS expression and activity has also been studied. NOS mRNA levels
were detected using Taqman real time PCR and protein levels investigated by
Western blotting. The activity of the NOS enzymes was determined using a Griess
assay where the stable end product ofNO, nitrite, is measured.
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3.2 - Results of Transformed Chondrocyte Cell line NOS isoform production
3.2.1 - Cell Line NOS Isoform mRNA Detection
Taqman real-time PCR was used to detect the relative levels of the three NOS
isoforms in both C20A4 and C28I2 cells. This technique involves the synthesis of
cDNA from mRNA in the experimental samples, followed by the amplification of
cDNA for forty identical cycles with the release of fluorescence recorded in real time
as the cycles proceed (Section 2.7). The level ofmRNA in the original sample is
calculated using the number of cycles required for cDNA amplification to reach the
log phase, known as the Threshold cycle (Ct) value. A dilution series of plasmid
cDNA coding for the NOS isoforms is used to generate a standard curve by plotting
their Ct values against the dilution factor. Relative mRNA levels from the
experimental samples are then calculated from the standard curve.
eNOS mRNA was detectable following 36 cycles in unstimulated samples from both
cell lines. eNOS mRNA was detected at cycle 35 and 36 in C20A4 and cycle 36 and
38 in C28I2 following the application of 4 and 12 hour MS respectively. Relative
eNOS levels calculated from these Ct values and adjusted for the 18s content (Figure
3.1) show slightly elevated levels after 4 hours MS in C20A4 and decreased levels
after 12 hours MS in C28I2 when compared to unstimulated controls. Relative eNOS
mRNA levels following CYT (Figure 3.1) show decreased levels at 4 hours and
increased levels at 12 hours in C20A4, while increased levels were seen at both 4 and
12 hours in C28I2. eNOS mRNA was detected at cycle 36 and 35 in C20A4 and
cycle 35 and 37 in C28I2 following the simultaneous application ofMS and CYT at 4
and 12 hours respectively. Relative eNOS mRNA levels following CYT plus MS
(Figure 3.1) showed a slight increase at 4 hours and a decrease at 12 hours compared
to CYT alone in both cell lines.
nNOS mRNA was detectable at cycle 37 in C20A4, and cycle 33 in C28I2
unstimulated cells. nNOS mRNA levels are detected from cycle 38 to 40 following
the application ofMS, CYT and CYT plus MS at both 4 and 12 hours in C20A4.
nNOS mRNA levels are detected at cycle 34 following MS, CYT and CYT plus MS
at 4 hours in C28I2. At 12 hours nNOS mRNA levels are detected at cycle 34
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following MS and at cycle 37 following both CYT and CYT plus MS in C28I2.
Relative nNOS levels calculated from these Cj values (Figure 3.2) are higher in the
C28I2 than C20A4 cells. CYT and MS appear to reduce relative nNOS levels from
unstimulated controls at 4 and 12 hours in both cell lines, while MS has little effect on
the nNOS mRNA levels seen following CYT.
iNOS mRNA was detected in unstimulated cells from cycle 39 in C20A4 and cycle 33
in C28I2. C20A4 iNOS mRNA was detected at cycles 36 and 32 following 4 and 12
hours CYT respectively. C28I2 iNOS mRNA was detected at cycles 30 and 29
following 4 and 12 hours CYT respectively. Relative iNOS mRNA levels calculated
from these Cj values (Figure 3.3) following MS are slightly increased from
unstimulated controls after 4 hours, and decreased after 12 hours in both cell lines.
CYT elevated relative iNOS mRNA levels at both 4 and 12 hours in both cell lines,
with MS increasing this effect after 4 hours, while decreasing it after 12 hours.
4h
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C20A4 ;28I2
Figure 3.1 - Taqman PCR analysis of eNOS mRNA levels in transformed
chondrocytes C20A4 and C28I2. Relative levels were evaluated at 4 and
12 hours of culture with no stimulation (ML), Mechanical Stimulation
(MS), Cytokine cocktail stimulation (CYT) and Mechanical plus Cytokine
stimulation (CYT+MS). (n=l)
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Figure 3.2 - Taqman PCR analysis of nNOS mRNA levels in transformed
chondrocytes C20A4 and C28I2. Relative levels were evaluated at 4 and
12 hours of culture with no stimulation (ML), Mechanical Stimulation
(MS), Cytokine cocktail stimulation (CYT) and Mechanical plus Cytokine
stimulation (CYT+MS). (n=l)
Figure 3.3 - Taqman PCR analysis of iNOS mRNA levels in transformed
chondrocytes C20A4 and C28I2. Relative levels were evaluated at 4 and 12
hours of culture with no stimulation (ML), Mechanical Stimulation (MS),




ML MS CYT MS+CYT ML MS CYT MS+CYT
|4hr |4hr | 4hr |4hr T4hr
eNOS Ct=37 T12hr Ct=37
|12hr jl2hr |12hr f 12hr jl2hr
| 4hr |4hr |4hr | 4hr |4hr f4hr
nNOS Ct=37 Ct=32
| 12hr |12r f 12hr | 12hr 112hr J,12hr
iNOS
f4hr | 4hr f4hr |4hr t 4hr |4hr
Ct=37 Ct=33
|12hr T 12hr |12hr il2hr t 12hr |12hr
Table 3.1 - Summary ofNOS mRNA levels in transformed chondrocytes C20A4 and
C28I2. Levels were evaluated at 4 and 12 hours of culture with no stimulation (ML),
Mechanical Stimulation (MS), Cytokine cocktail stimulation (CYT) and Mechanical
plus Cytokine stimulation (CYT+MS). (n=l)
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3.2.2 - Cell Line NOS Isoform Protein Detection
Having detected small amounts ofmRNA for the three NOS isoforms in the two
chondrocyte cell lines, Western blotting was used to determine whether any protein
was detectable. Western blotting was performed using specific antibodies for all 3
NOS isoforms, with GAPDH detected as a measure of protein loading. Appropriate
controls for each of the NOS isoforms, and the use of cytokine stimulated primary
chondrocyte cell lysate show that the blot is working well and if these proteins were
present they would have been detected. However, no protein was detected in either
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Figure 3.4 - Western Blot for NOS isoforms in C20A4 transformed chondrocytes. Protein
levels were evaluated at 4 and 12 hours with no stimulation (ML), Mechanical Stimulation
(MS), Cytokine cocktail stimulation (CYT) and Mechanical plus Cytokine stimulation
(CYT+MS). Lane 1 = iNOS E. coli lysate 2 = CYT stimulated DLD-1 3 - nNOS E. coli
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Figure 3.5 - Western Blot for NOS isoforms in C28I2 transformed chondrocytes. Protein
levels were evaluated at 4 and 12 hours with no stimulation (ML), Mechanical Stimulation
(MS), Cytokine cocktail stimulation (CYT) and Mechanical plus Cytokine stimulation
(CYT+MS). Lane 1 = iNOS E. coli lysate 2 = CYT stimulated DLD-1 3 = nNOS E. coli
lysate 4 = eNOS E. coli lysate 5 = Eahy926 eNOS 6 = CYT stimulated primary HAC.
(n-3)
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3.2.3 - Cell Line Nitrite Production
The Griess assay was performed to identify whether there was any NOS activity
detectable in the chondrocyte cell lines. Medium was collected at 4 and 12 hours
from resting, CYT stimulated, MS, and CYT plus MS, and analysed for nitrite
production. A standard curve constructed from dilutions of sodium nitrite in medium
allowed calculation of the concentration of nitrite in each sample, and acted as a
control to show the assay was working. Very small alterations in the absorbance at
540nm were detected, translating into low levels of nitrite at the extremes of the




































Figure 3.6 - Griess assay to determine levels of nitrite produced by both
transformed cell lines at 4 and 12 hours with no stimulation (ML),
Mechanical Stimulation (MS), Cytokine cocktail stimulation (CYT),
Mechanical plus Cytokine stimulation (CYT+MS) and Sodium nitrite




The results obtained show that mRNA is detected for all three NOS isoforms in the
transformed chondrocyte cell lines. Alterations in mRNA expression were seen
following mechanical and cytokine stimulation as well as differences in the levels
detected between the two cell lines (summarised in Table 3.1). It must be stated,
however, that these data come from a single experiment so it is not possible to draw
any conclusions about the variation in these levels without increasing the number of
replicates.
It must also be noted that in many cases these values are near the end of the
amplification procedure and indicate that very little NOS isoform mRNA was present
within the original sample. This means that the calculation of relative mRNA levels
may show several fold increases in values, while the actual changes in mRNA levels
are unlikely be significant.
The western blot and Griess assay experiments were repeated on a number of
occasions, confirming that NOS protein and enzyme activity is not seen in the
transformed chondrocyte cell lines under any of the conditions tested.
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3.3.2 - Interpretation of results
The detection of iNOS mRNA but the lack of iNOS protein and enzyme activity
implicates factors involved in mRNA transcription, translation or protein degradation
of iNOS in the lack of cytokine induced NO production.
Transcriptional regulation of the iNOS gene can occur at the level of synthesis,
stability and degradation (summarised in Figure 1.6). However, the fact that iNOS
mRNA is detected in these cell lines following cytokine stimulation suggests
transcription takes place and it may be translational events that are responsible for the
lack of iNOS protein and enzyme activity.
The presence of four AUUUA repeats present in the 3'-UTR of the iNOS mRNA
(Geller et al 1993) which have been shown to confer destabilization to cytokine and
oncogene mRNAs may be responsible for a lack of iNOS translation (Caput et al
1986). Several proteins can bind this region and alter its stability, these may be
important in controlling the level of iNOS transcription in our studies.
There also remains the possibility that the mRNA transcripts that are detected by the
Taqman RT-PCR technique are not full length and could be alternatively spliced but
contain the region amplified by this technique (Eissa et al 1998). This could account
for the elevated mRNA levels seen and for the lack of protein transcribed.
88
3.3.3 - iNOS expression in primary chondrocytes
Primary chondrocytes are one of the few cell types that produce iNOS in response to
single cytokine stimulation, including IL-1 (3 or TNFa (Grabowski et al 1996; Palmer
et al 1993). IL-6 and IFNy have not been shown to independently induce iNOS, but
act in synergy with IL-ip and TNFa to increase iNOS production in chondrocytes
(Henrotin et al 2000; Huang et al 2004; Kinugawa et al 1997; Tuna et al 2001). The
proinflammatory cytokine cocktail used in these studies is therefore a potent
stimulator of iNOS production in primary human chondrocytes, and thus may be
expected to induce similar levels in the transformed chondrocytes.
3.3.4 - Factors that may have influenced NOS expression
The experiments in this chapter were carried out using the immortalized chondrocyte
cell lines C20A4 and C28I2 (Goldring et al 1994a). These are derived from costal
chondrocytes from a five year old male and a fifteen year old female respectively.
SV40 large T antigen transfection was used to immortalize the chondrocytes,
stabilising their proliferative capacity (Wolff et al 1992). This transfection may
influence iNOS production. Indeed, there are several reports of other cell lines that
are either unaffected (Horton et al 1998: Liu et al 1993: Murakami et al 2002) or show
decreased iNOS production (Aldieri et al 2004) following SV40 transformation.
Immortalised chondrocytes have previously been shown to be highly proliferative but
express little collagen type II, a marker for cell differentiation (Block et al 1991).
Growth in three dimensional agarose constructs was used to induce differentiation
during development of these cell lines. However, when expanded in monolayer the
maintenance of phenotype decreased with time (Goldring et al 1994b). The
importance of maintenance of the differentiated phenotype is highlighted by the fact
that C20A4 cells only produce COXII after IL-1 stimulation when they have been in




These transformed chondrocytes show several of the responses seen in primary cells
and can display a differentiated phenotype under the correct conditions. In a single
experiment NOS isoform mRNA was detected, but no conclusions can be drawn from
this data without repeat studies. These cells do not produce iNOS protein and enzyme
activity following cytokine stimulation, however, suggesting that they have altered
transcription or translation patterns. The response of these cells may be influenced by
many factors including the transformation, differentiation, age and gender of the
donor cartilage. In addition to altered response to cytokine signalling, alterations in
the actin cytoskeleton (Brown and Benya 1988) and integrin expression pattern
(Loeser et al 2000) seen in transformed chondrocytes will influence the way these
cells sense and respond to mechanical stimuli.
Low amounts of available primary cells and difficulties with in vivo models suggest
that, provided the limitations are understood and results obtained are validated with
primary cells or cartilage explants, the system remains a useful research tool. The
results in this chapter, however, indicate the cell lines are of limited use for the study
of the effects ofNO on chondrocytes.
Summary of findings
The transformed chondrocyte cell lines C20A4 and C28I2 show detectable
levels of e, n and iNOS mRNA, however these data come from a single
experiment
C20A4 and C28I2 do not produce NOS isoform protein or nitrite following
4 or 12 hour incubation with proinflammatory cytokines or mechanical strain.
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Chapter 4 - The effects of cyclical mechanical stimulation on NOS
levels in primary human articular chondrocytes
Aims
Investigate NOS isoform expression in primary osteoarthritic human
articular chondrocytes
Investigate the effects of proinflammatory cytokine stimulation,
mechanical stimulation and a novel iNOS inhibitor on NOS isoform
expression in primary osteoarthritic human articular chondrocytes
4.1 - Introduction
In order to investigate the level of nitric oxide synthase (NOS) enzymes in primary
human articular chondrocytes (HAC) Taqman real-time PCR was used to measure
mRNA levels, and western blotting using NOS specific antibodies was used to detect
protein levels. NOS enzyme activity was determined using the Griess assay,
measuring the levels of the stable nitric oxide product, nitrite, in the medium.
Primary HAC were initially stimulated by either the proinflammatory cytokine
cocktail containing IL-ip, TNFa, IFNy and IL-6 (CYT) or IL-ip alone and the effect
of concentration on NOS expression was evaluated. The effect of cyclical mechanical
stimulation at 0.33Hz and 30,000pstrain (MS) on both CYT and IL-ip stimulated
iNOS levels and activity was studied. The method by which MS may be interacting
with CYT and IL-ip induced iNOS was investigated using IL-4 neutralising
antibodies and a pi integrin function blocking antibody. The effect of a novel iNOS
inhibitor, AR-C102222, on iNOS levels and activity was also evaluated.
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4.2 - Results
4.2.1 -NOS mRNA, protein and nitrite production in primary OA HAC
eNOS, nNOS and iNOS mRNA were detected in unstimulated HAC after 32, 37 and
28 cycles of Taqman PCR respectively. iNOS mRNA levels were measured in
primary HAC after 12 hours incubation with CYT. iNOS mRNA levels were detected
from cycle 23 following incubation with both half and full concentration ofCYT,
calculated as a 50.7 fold increase in relative levels at half and a 139.4 fold increase at
full CYT (p=0.1) (Figure 4.1). CYT stimulation reduced the basal levels of eNOS
mRNA by 64% (Figure 4.2) and nNOS mRNA by 93% (Figure 4.3) in the primary
HAC, although these values were not statistically significant.
iNOS protein levels were not detectable at 12 hours in unstimulated primary HAC or
after halfCYT stimulation, but were seen following full CYT stimulation as
determined by western blot (Figure 4.4). Neither e nor nNOS proteins were detected
in primary HAC prior to, or following CYT incubation (Figure 4.6).
Nitrite levels were detected at 0.2pM in unstimulated cells, which is at the limits of
detection for the assay. Nitrite levels were measured at 4.7pM following halfCYT
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Figure 4.1 - Basal (unstimulated) and cytokine cocktail stimulated iNOS mRNA
levels (12hr). (I) = Pooled values±SEM. (II) = Individual experimental
values. ML = Unstimulated control. HalfCYT = Half concentration of


















ML Half CYT Full CYT
Figure 4.2 - Basal (unstimulated) and cytokine cocktail stimulated eNOS mRNA
levels (12hr). (I) = Pooled values±SEM. (II) = Individual experimental
values. ML = Unstimulated control. Half CYT = Half concentration of
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Figure 4.3 - Basal (unstimulated) and cytokine cocktail stimulated nNOS mRNA
levels (12hr). (I) = Pooled values±SEM. (II) = Individual experimental
values. ML = Unstimulated control. Half CYT = Half concentration of
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ML Half CYT Full CYT
Figure 4.4 - iNOS protein and nitrite levels prior to and following cytokine cocktail
stimulation (12hr). (I) = Western blot probing for iNOS. (II) = Griess assay
pooled nitrite levels±SEM. (Ill) = Griess assay individual experimental values.
ML = Unstimulated control. Half CYT = Half concentration of cytokine
cocktail. Full CYT = Cytokine cocktail stimulation. A=7321 B=7329 C=7488.
(n=3)
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4.2.2 - Effects of cyclic mechanical stimulation on CYT induced iNOS
The levels of iNOS mRNA and protein, as well as nitrite accumulation in the medium,
were measured following 4 and 12 hours ofCYT and MS.
MS reduced unstimulated iNOS mRNA levels by 96% and 79% after 4 and 12 hours
respectively, but this decrease was not significant. CYT stimulation significantly
increased iNOS mRNA levels above unstimulated controls by 16 fold and 432 fold
after both 4 and 12 hours respectively (p<0.0001) (Figure 4.5). The simultaneous
application ofCYT and MS also showed significantly elevated levels of iNOS mRNA
above the level detected in the unstimulated control, 7.2 fold at 4 and 60.1 fold at 12
hours (p=0.0002 and p<0.0001 respectively). The iNOS mRNA level following the
simultaneous application of CYT and MS was 55% lower after 4 hours and 86%
lower after 12 hours than following CYT alone (p=0.0014 and p<0.0001 respectively)
(Figure 4.5).
iNOS protein was not detected in unstimulated controls or after MS. CYT stimulation
significantly increased the level of iNOS protein above unstimulated levels at both 4
and 12 hours (pO.OOOl). Simultaneous stimulation with CYT and MS resulted in
significantly higher iNOS mRNA levels than in unstimulated controls at both 4 and
12 hours (pO.OOOl). iNOS protein levels following the simultaneous application of
both CYT and MS were 70% lower after 4 hours and 76% lower after 12 hours, than
following CYT alone (p=0.04 and p=0.0003 respectively) (Figure 4.6).
There was little nitrite production after 4 hours under any of the conditions tested
(Figure 4.7). Nitrite was detected at 0.6 and 0.9pM at 12 hours in unstimulated
controls and following MS alone respectively, which is at the limits of detection for
the assay. Following 12 hour CYT there was a significant increase in nitrite levels,
with concentrations of 6 and 7.5pM nitrite detected for mRNA and protein adjusted
experiments respectively (p<0.0001). Nitrite concentrations following the
simultaneous application of both CYT and MS were significantly higher than in
unstimulated controls, but protein- and mRNA-adjusted levels were 58% and 63%
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12hr
Figure 4.5 - Effect ofmechanical stimulation (MS) on cytokine cocktail induced
iNOS mRNA levels. (I) = Pooled iNOS mRNA levels±SEM. (II) = Individual
experimental values. ML = Unstimulated control. MS = Mechanical stimulation.
CYT = Cytokine cocktail stimulation. CYT+MS = Both cytokine cocktail and
mechanical stimulation. A=3/10/03 B=18/4/04 C=29/3/04 D=22/3/04 E=8/3/04

























































_i 4ft 1 • * o *
ML MS CYT CYT+MS ML MS CYT CYT+MS
4hr 12hr
Figure 4.6 - Effect ofMS on CYT induced iNOS protein levels. (I) = Western blot
for NOS isoforms (28/6/03). (II) = Densitometry ofWestern blot bands pooled
data±SEM. (Ill) = Densitometry individual experimental values. ML = Unstimulated
control. MS = Mechanical stimulation. CYT = Cytokine cocktail stimulation.
CYT+MS = Both cytokine cocktail and mechanical stimulation. A=17/6/03
B=28/6/03 C=6/12/02 D=DS008/9c E= 10/2/04 F= 14/2/04 G=22/3/04 EU3/10/03
1=11/11/03 J=23/9/03 K=5/9/03 L=3/9/03. * p<0.05 ***p<0.001.
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Figure 4.7 - Effect ofMS on CYT induced nitrite levels. (I) = Griess assay adjusted
according to the quantity of protein in the original sample. Pooled data±SEM. (II) =
Protein adjusted Griess assay individual experimental values. (Ill) = Griess assay
adjusted according to the quantity ofmRNA in the original sample. Pooled
data±SEM. (IV) = mRNA adjusted Griess assay individual experimental values. ML
= Unstimulated control. MS = Mechanical stimulation. CYT = Cytokine cocktail
stimulation. CYT+MS = Both cytokine cocktail and mechanical stimulation.
A=28/6/03 B=DS008/9c C=17/6/03 D=6/12/02 E=22/3/04 F=10/2/04 G=14/2/04
H=3/10/03 1=23/9/03 J=11/11/03 K=3/9/03 L=5/9/03 N=22/6/03 0=27/6/03
P=28/6/03 Q= 17/6/03 R=6/12/02 S=22/3/04 T=8/3/04 U=10/2/04 V=18/4/04
W=3/10/03 X=29/3/04. ***p<0.001.
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4.2.3 - Effects of MS and an IL-4 neutralising antibody on CYT induced iNOS,
4.2.3a - Polyclonal IL-4 Neutralising Antibody
iNOS protein and nitrite levels were measured following CYT stimulation, and the
effects ofMS in the presence of a polyclonal IL-4 neutralising antibody at low
(lpg/ml) and high (lOpg/ml) concentrations were evaluated.
iNOS protein levels were increased following CYT stimulation at both 4 and 12 hours
(Figure 4.8). The simultaneous application of CYT and MS also resulted in increased
iNOS protein levels compared to unstimulated controls, but 79% lower at 4 hours and
74% lower at 12 hours than following CYT alone. The presence of lOpg/ml of the
polyclonal IL-4 neutralising antibody in combination with CYT stimulation was
associated with 66% lower iNOS protein levels after 12 hours, than following CYT
stimulation alone. There was a 76% lower iNOS protein level in cells stimulated with
CYT plus MS in the presence of lOpg/ml polyclonal IL-4 neutralising antibody than
following CYT plus MS. The presence of the antibody at a concentration of lpg/ml
does not influence the level of iNOS protein detected following CYT or CYT plus
MS.
After 4 hours CYT stimulation nitrite levels are at 0.1 pM in the culture medium,
which is at the limits of detection for the assay. Nitrite levels were increased to
5.7pM following 12 hours CYT stimulation (Figure 4.9). The simultaneous
application ofCYT and MS increased nitrite levels to 2.7pM at 12 hours, 52% lower
than following CYT alone. The presence of the polyclonal IL-4 neutralising antibody
at lOpg/ml resulted in reduced CYT-induced nitrite levels, from 5.7pM to 1.4pM, and
decreased concentrations following the simultaneous application ofCYT and MS
(from 2.7pM to 0.3pM). The lower concentration of the polyclonal IL-4 neutralising
antibody did not influence nitrite levels.
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Figure 4.8 - Densitometry data from western blots using polyclonal IL-4 neutralising
antibody. (I) = iNOS western blot. (II) = Pooled densitometry values±SEM. (Ill)
= Individual densitometry experimental values. ML = Unstimulated control.
CYT = Cytokine cocktail stimulation. IL-4 Ab = Polyclonal IL-4 antibody at





Figure 4.9 - Griess assay nitrite data using polyclonal IL-4 neutralising antibody.
(I) = Pooled Griess assay data adjusted for protein levels in the original
sample±SEM. (II) = Individual Griess assay experimental data.
ML = Unstimulated control. CYT = Cytokine cocktail stimulation. IL-4 Ab =
Polyclonal IL-4 neutralising antibody at lpg/ml (Low) and lOpg/ml (High). MS =
Mechanical stimulation. A=5/9/03 B=3/9/03. (n=2)
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4.2.3b - Monoclonal IL-4 neutralising Antibody
iNOS mRNA, protein and nitrite levels were measured following CYT stimulation,
and the effects ofMS and a monoclonal IL-4 neutralising antibody at low (lpg/ml)
and high (lOpg/ml) concentrations were evaluated.
iNOS mRNA levels were elevated following CYT stimulation for both 4 and 12 hours
(Figure 4.10). The simultaneous application ofCYT and MS also elevated iNOS
mRNA levels. However these were 43% lower after 4 hours and 83% lower after 12
hours, than following CYT stimulation alone (p=0.2 and p=0.04 respectively). The
addition of lpg/ml of a monoclonal IL-4 neutralising antibody did not alter iNOS
mRNA levels following stimulation with CYT or CYT plus MS for 4 or 12 hours.
iNOS protein levels were increased by CYT stimulation at both 4 and 12 hours
(Figure 4.11). Increased iNOS protein was also seen following the simultaneous
stimulation with CYT and MS. However these were 88% lower after 4 hours and
83% lower after 12 hours, than following CYT alone (p<0.05). The addition of a
monoclonal IL-4 neutralising antibody at lpg/ml or lOpg/ml did not influence iNOS
protein levels at 4 or 12 hours in combination with CYT or CYT plus MS.
Nitrite levels were detected at 0.2pM at 4 hours in the medium of cells subsequently
extracted for protein (Figure 4.12) and mRNA (Figure 4.13) under all conditions,
which is at the limits of detection for the assay. CYT stimulation increased nitrite
levels at 12 hours to 4.2 and 7.3pM for mRNA- and protein-adjusted experiments
respectively. CYT plus MS elevated nitrite levels to 3.5 and 1.5pM, 79% lower for
protein-adjusted and 17% lower for mRNA-adjusted nitrite than following CYT
alone, however these did not reach statistical significance. The presence of the
monoclonal IL-4 neutralising antibody, at both 1 and lOpg/ml, had no effect on the
level of nitrite detected after cytokine stimulation alone, or following the














































Figure 4.10 - iNOS mRNA levels following incubation with a monoclonal IL-4
neutralising antibody.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. CYT = Cytokine cocktail stimulation. IL-4 Ab =
Monoclonal IL-4 neutralising antibody at lpg/ml. MS = Mechanical
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Figure 4.11 - iNOS protein levels following incubation with a monoclonal IL-4
neutralising antibody. (I) = Western blot for iNOS (3/10/03). (II) = Pooled
densitometry data from iNOS western blots±SEM. (Ill) = Individual iNOS
densitometry values. ML = Unstimulated control. CYT = Cytokine cocktail
stimulation. IL-4 Ab = Monoclonal IL-4 antibody at 1 pg/ml (Low) and 1 Opg/ml
(High). MS = Mechanical stimulation. + = CYT stimulated DLD-1 cells.
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Figure 4.12 - Griess assay protein adjusted nitrite levels following incubation with a
monoclonal IL-4 neutralising antibody. (I) = Pooled protein adjusted nitrite
values±SEM. (II) = Individual protein adjusted nitrite experimental values. ML =
Unstimulated control. CYT = Cytokine cocktail stimulation. IL-4 Ab = Monoclonal
IL-4 antibody at 1 pg/ml (Low) and 1 Opg/ml (High). MS = Mechanical stimulation.





































































































Figure 4.13 - Griess assay mRNA adjusted nitrite levels following incubation with a
monoclonal IL-4 neutralising antibody. (I) = Pooled mRNA adjusted nitrite
values±SEM. (II) = Individual mRNA adjusted nitrite experimental values. ML =
Unstimulated control. CYT = Cytokine cocktail stimulation. IL-4 Ab = Monoclonal
IL-4 antibody at 1 pg/ml (Low) and 1 Opg/ml (High). MS = Mechanical stimulation.
A= 18/4/04 B=3/l0/03 C=29/3/04. (n=3)
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4.2.4 - Effects of MS and a pi integrin function blocking antibody on
CYT induced iNOS
CYT-induced iNOS mRNA, protein and nitrite levels were measured following MS
and incubation with a pi integrin function blocking antibody (lpg/ml).
iNOS mRNA levels were increased following CYT stimulation at both 4 and 12 hours
(Figure 4.14). The simultaneous application ofCYT and MS also elevated iNOS
mRNA, however this was 57% lower after 4 hours and 85% lower after 12 hours, than
following CYT alone (p<0.003). Incubation with a pi integrin function blocking
antibody at lpg/ml did not alter the iNOS mRNA levels following CYT or
simultaneous CYT and MS.
iNOS protein levels are elevated by CYT at both 4 and 12 hours (Figure 4.15). The
simultaneous application ofCYT and MS also increases iNOS protein above
unstimulated controls, however a 66% lower level was seen at 12 hours than
following CYT alone (p=0.08). Incubation with a pi integrin function blocking
antibody does not alter the iNOS protein level following CYT or simultaneous CYT
plus MS.
Nitrite levels were detected below 0.2pM following all stimuli at 4 hours and are at
0.6pM in unstimulated controls at 12 hours, which is at the limits of detection for the
assay. CYT stimulation induced the elevation of nitrite levels to 5.8 and 9.7pM for
mRNA- and protein-adjusted experiments. The nitrite concentration detected
following the simultaneous application ofMS and CYT was 3.7pM, 37% lower for
mRNA-adjusted and 62% lower for protein-adjusted experiments than following CYT
alone (p<0.12). Incubation with a pi integrin function blocking antibody did not alter
the nitrite levels in either the mRNA- (Figure 4.17) or protein-adjusted (Figure 4.16)
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Figure 4.14 - iNOS mRNA levels following incubation with a pi integrin
blocking antibody. (I) = Pooled data±SEM. (II) = Individual experimental
values. ML = Unstimulated control. CYT = Cytokine cocktail stimulation.
Betal Ab = pi integrin function blocking antibody at lpg/ml. MS =
Mechanical stimulation. A=22/3/04 B=8/3/04 C=10/2/04 D=18/4/04.




















































































































































Figure 4.15 - iNOS protein levels following incubation with a (31 integrin function
blocking antibody. (I) = Western blot for iNOS (14/2/04). (II) = Pooled
densitometry data from iNOS western blots±SEM. (Ill) = Individual iNOS
densitometry values. ML = Unstimulated control. CYT = Cytokine cocktail
stimulation. Betal Ab = Betal integrin function blocking antibody at lpg/ml.
MS = Mechanical stimulation. A=10/2/04 B=14/2/04 C=22/3/04. (n=3)
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Figure 4.16 - Griess assay protein adjusted nitrite levels following incubation with a
pi integrin function blocking antibody. (I) = Pooled protein adjusted nitrite
values±SEM. (II) = Individual protein adjusted nitrite experimental values. ML =
Unstimulated control. CYT = Cytokine cocktail stimulation. Betal Ab = pi
integrin function blocking antibody at lpg/ml. MS = Mechanical stimulation.
A=22/3/04 B=10/2/04 C=14/2/04. (n=3). *p<0.05.
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Figure 4.17 - Griess assay mRNA adjusted nitrite levels following incubation with a
pi integrin function blocking antibody. (I) = Pooled mRNA adjusted nitrite
values±SEM. (II) = Individual mRNA adjusted nitrite experimental values. ML
= Unstimulated control. CYT = Cytokine cocktail stimulation. Betal Ab = pi
integrin function blocking antibody at 1 pg/ml. MS = Mechanical stimulation.
A-22/3/04 B=8/3/04 C=10/2/04 D=18/4/04. (n=4). **p<0.01.
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4.2.5 - Effects of MS, IL-4 neutralising antibody and pi integrin function
blocking antibody on CYT induced iNOS - pooled data
iNOS mRNA levels were elevated following CYT stimulation for 4 and 12 hours
(Figure 4.18). The simultaneous application ofCYT and MS also elevated iNOS
mRNA levels. However these were 55% lower at 4 hours and 86% lower at 12 hours,
than following CYT alone (p<0.001). Incubation with both a monoclonal IL-4
neutralising antibody and a pi integrin function blocking antibody (both lpg/ml) had
no significant effect on iNOS mRNA levels following CYT plus MS. The IL-4
antibody had no effect on iNOS mRNA levels following CYT, while the pi antibody
increased the levels of iNOS following CYT with this increase almost reaching
significance (p=0.051).
iNOS protein levels were elevated by CYT at both 4 and 12 hours from the
undetectable levels in the unstimulated control (Figure 4.19). The simultaneous
application of CYT and MS also elevated iNOS protein levels, although this was 70%
lower at 4 hours and 76% lower at 12 hours than following CYT alone (p=0.04 and
p=0.0003 respectively). Incubation with either a monoclonal IL-4 neutralising
antibody or a pi integrin function blocking antibody (both lpg/ml) showed no
significant alteration of the iNOS protein level following CYT or simultaneous CYT
and MS.
Nitrite levels were detected below 0.5pM at 4 hours following all stimuli and at 12
hours in the unstimulated control, which is at the limits of detection for the assay.
Following 12 hours CYT nitrite levels were elevated to 6 and 7.5pM in mRNA
(Figure 4.20) and protein (Figure 4.21) adjusted experiments respectively. The
simultaneous application ofMS and CYT also increased nitrite at 12 hours, however
this was 58% lower for mRNA-adjusted and 63% lower for protein-adjusted than
following CYT alone (p<0.001). Incubation with either a monoclonal IL-4
neutralising antibody or a pi integrin function blocking antibody (both lpg/ml)
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Figure 4.18 - Pooled iNOS mRNA levels following incubation with an IL-4
neutralising antibody or a pi integrin function blocking antibody.
(I) =Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. CYT = Cytokine cocktail stimulation.
Betal Ab = pi integrin function blocking antibody at lpg/ml.
IL-4 Ab = Monoclonal IL-4 neutralising antibody at lpg/ml.
MS = Mechanical stimulation. *p<0.05 ***p<0.001.
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Figure 4.19 - Pooled iNOS protein levels following incubation with an IL-4
neutralising antibody or a pi integrin function blocking antibody.
(I) =Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. CYT = Cytokine cocktail stimulation.
Betal Ab = pi integrin function blocking antibody at lpg/ml.
IL-4 Ab = Monoclonal IL-4 neutralising antibody at lpg/ml.
MS = Mechanical stimulation. *p<0.05 ***p<0.001.
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Figure 4.20 - Pooled mRNA adjusted nitrite levels following incubation with an
IL-4 neutralising antibody or a pi integrin function blocking antibody.
(I) =Pooled mRNA adjusted data±SEM. (II) = Individual experimental
values. ML = Unstimulated control. CYT = Cytokine cocktail stimulation.
Betal Ab = pi integrin function blocking antibody at lpg/ml.
IL-4 Ab = Monoclonal IL-4 neutralising antibody at 1 pg/ml.
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Figure 4.21 - Pooled protein adjusted nitrite levels following incubation with an
IL-4 neutralising antibody or a pi integrin function blocking antibody.
(I) =Pooled protein adjusted data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. CYT = Cytokine cocktail stimulation.
Betal Ab = pi integrin function blocking antibody at lpg/ml.
IL-4 Ab = Monoclonal IL-4 neutralising antibody at 1 pg/ml.
MS = Mechanical stimulation. *p<0.05 ***p<0.001.
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4.2.6 - Effects of IL-ip at a range of concentrations on iNOS mRNA, protein and
nitrite levels
iNOS mRNA levels were elevated from unstimulated controls at IL-1J3 concentrations
ranging from lOpg/ml to 2500pg/ml (p=0.1) (Figure 4.22). lOpg/ml IL-1 elevated
iNOS mRNA levels by 397 and 96.5 fold above unstimulated controls at 4 and 12
hours respectively. lOOpg/ml elevated iNOS mRNA levels above lOpg/ml by 2.4 fold
at 4 and 12.6 fold at 12 hours. 500pg/ml did not increase iNOS mRNA levels above
lOOpg/ml at 4 hours, however a 1.3 fold increase was seen at 12 hours. 2500pg/ml
did not elevate iNOS mRNA levels above 500pg/ml at 4 or 12 hours.
iNOS protein was detected following 4 hours IL-ip, and at higher levels following 12
hours IL-ip stimulation at concentrations ranging from 25pg/ml to lOOOOpg/ml
(Figure 4.23). Primary HAC stimulated with 25pg/ml IL-1 P showed elevated iNOS
protein compared to the unstimulated control at both 4 and 12 hours. 100 and
lOOOOpg/ml IL-1 P showed similar levels of iNOS protein, 2.1 fold higher at 4 hours
and 1.5 fold higher at 12 hours than following 25pg/ml stimulation. 500pg/ml IL-ip
at 4 hours showed an iNOS protein level similar to that seen for 25pg/ml, while at 12
hours they were 1.5 fold higher than 25pg/ml. 2500pg/ml IL-1 p at 4 hours had a 2.4
fold higher iNOS protein level than 25pg/ml, while at 12 hours they were similar to
that seen following 25pg/ml stimulation. This experiment was not repeated, so
statistical analysis can not be performed.
Nitrite levels were below 0.7pM at 4 hours for all IL-ip concentrations investigated,
and in the unstimulated control at 12 hours, which is at the limits of detection for the
assay. At 12 hours the nitrite levels were elevated to 2.3pM following lOpg/ml and
6.7pM following 2500pg/ml IL-1 P stimulation (Figures 4.23 and 4.24). Nitrite
levels were elevated 4.6 fold following lOpg/ml IL-ip compared to the unstimulated
control but this increase was not significant. The nitrite levels detected following
100, 500 and 2500pg/ml showed significant increases compared to the unstimulated
control (p<0.01). lOOpg/ml IL-1 p showed a 2.2 fold elevation above that following
lOpg/ml IL-1 p. 500pg/ml IL-1 p showed a further 1.4 fold elevation in nitrite levels.
2500pg/ml IL-1 p did not alter nitrite levels compared to those seen following
500pg/ml in the mRNA adjusted experiment (Figure 4.24). The protein adjusted
experiment, carried out on a single occasion, suggested that 2500pg/ml elevates nitrite
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Figure 4.22 - iNOS mRNA levels after IL-ip stimulation at a range of concentrations.
IL-lp values in pg/ml. (I) = Pooled data±SEM. (II) = Individual experimental values.
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Figure 4.23 - iNOS protein and nitrite after IL-1 (3 stimulation at a range of
concentrations. IL-1P values in pg/ml.
(I) = Western blot. (II) = Densitometry Values. (Ill) = Protein adjusted nitrite values.
TC= Unstimulated control. Experiment number = 21/11/03. (n=l)
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Figure 4.24 - mRNA adjusted nitrite levels after IL-ip stimulation at a range of
concentrations. IL-ip values in pg/ml.
(I) = Pooled mRNA adjusted nitrite values±SEM. (II) = Individual mRNA adjusted
nitrite experimental values. TC = Unstimulated control. A=21/5/04 B=16/5/04
C=18/5/04. (n=3). **p<0.01 ***p<0.001.
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4.2.7 - Effects MS, IL-4 neutralising antibody and pi integrin function blocking
antibody on IL-ip induced iNOS mRNA, protein and nitrite Levels
IL-ip stimulation (500pg/ml) elevated iNOS mRNA levels above unstimulated
controls at both 4 and 12 hours (Figure 4.25). The simultaneous application of IL-1 P
and MS also elevated iNOS mRNA levels. However these were 47% lower at 4 hours
and 91% lower at 12 hours than following CYT alone (p=0.28 and p=0.1). The
incubation with either a monoclonal IL-4 neutralising antibody or a pi integrin
function blocking antibody (both at lpg/ml) had no effect on the iNOS mRNA levels
following IL-ip alone, or in combination with MS. The exception was IL-
1+MS+piAb at 4 and 12 hours, where a 50% decrease below IL-l+MS levels was
seen, but this was not statistically significant.
Western blotting revealed elevated iNOS protein levels above unstimulated controls
following IL-ip stimulation at both 4 and 12 hours (Figure 4.26 and 4.27). The
simultaneous application of IL-1 P plus MS also elevated the iNOS protein level.
However this was 72% lower at 4 hours and 23% lower at 12 hours than following IL-
ip alone. The densitometry data, however, suggested the difference between cells
stimulated with IL-1 P alone or in combination with MS was not significant.
Incubation with either the monoclonal IL-4 neutralising antibody or pi integrin
function blocking antibody (both at 1 pg/ml) had no effect on iNOS protein levels
after IL-ip stimulation alone, or in combination with MS.
Nitrite accumulation in the medium was below 0.6pM at 4 hours following all stimuli
and in the unstimulated control at 12 hours, which is at the limits of detection for the
assay. Following 12 hours of IL-1 P stimulation the nitrite concentrations were raised
to 6.4 and 12.4pM for mRNA- and protein-adjusted experiments respectively
(Figures 4.28 and 4.29). The simultaneous application of IL-1 P and MS also
increased nitrite levels. However these were 41% lower in mRNA adjusted and 23%
lower in protein adjusted nitrite values than following IL-1 P alone (p=0.13 and
p<0.01 respectively). Incubation with a monoclonal IL-4 neutralising antibody or pi
integrin function blocking antibody (both at 1 pg/ml) had no effect on nitrite levels
following IL-ip stimulation alone, or in combination with MS. The exception to this
was where nitrite levels were reduced 44% following IL-1+MS+piAb (mRNA-
























































Figure 4.25 - iNOS mRNA levels following incubation with IL-ip, pi integrin
function blocking antibody, monoclonal IL-4 neutralising antibody and MS.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. IL-1 = IL-ip stimulation (500pg/ml). Betal Ab = pi
integrin blocking antibody (lpg/ml). IL-4 Ab = IL-4 neutralising antibody (lpg/ml).
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Figure 4.26 - Western blot for NOS isoforms following incubation with IL-1 P, MS,
pi integrin function blocking antibody and monoclonal IL-4 neutralising antibody.
(I) = iNOS. (II) = eNOS. (Ill) = nNOS. (IV) = GAPDH. 18/4/04. ML =
Unstimulated control. IL-1 = IL-1 P stimulation (5OOpg/ml). Betal Ab = pi integrin
function blocking antibody (lpg/ml). IL-4 Ab = IL-4 neutralising antibody (lpg/ml).
MS = Mechanical stimulation.
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Figure 4.27 - Densitometry data from western blots following IL-lp, pi integrin
function blocking antibody and monoclonal IL-4 neutralising antibody.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. IL-1 = IL-ip stimulation (500pg/ml). Betal Ab = pi
integrin function blocking antibody (lpg/ml). IL-4 Ab = IL-4 neutralising antibody
(lpg/ml). MS = Mechanical stimulation. A=18/4/04 B=6/4/04 C=9/4/04. (n=3)
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Figure 4.28 - Protein adjusted nitrite data from Griess assay following incubation
with IL-lp, pi integrin blocking antibody and monoclonal IL-4 neutralising antibody.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. IL-1 = IL-ip stimulation (500pg/ml). Betal Ab = pi
integrin blocking antibody (lpg/ml). IL-4 Ab = IL-4 neutralising antibody (lpg/ml).




Figure 4.29 - mRNA adjusted nitrite data from Griess assay following incubation
with IL-ip, pi integrin blocking antibody and monoclonal IL-4 neutralising antibody.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. IL-1 = IL-ip stimulation (500pg/ml). Betal Ab = pi
integrin blocking antibody (lpg/ml). IL-4 Ab = IL-4 neutralising antibody (lpg/ml).
MS = Mechanical stimulation. A=6/4/04 B=9/4/04 C=18/4/04. (n=3)
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4.2.8 - Effects of the iNOS inhibitor AR-C102222 on CYT induced iNOS
The effects of a novel iNOS inhibitor AR-C102222 (10"6, 10"5 and 10~4M) on CYT
induced iNOS mRNA and protein levels and enzyme activity in primary OA HAC
was investigated.
Compared to the unstimulated control, the iNOS mRNA levels were not altered by the
inhibitor at 10"6, 10"5 or 10"4M at 4 or 12 hours (Figure 4.30). CYT increased iNOS
mRNA levels above unstimulated controls at both 4 and 12 hours (p=0.0006). The
inhibitor at 10"6, 10"5 and 10"4M did not influence CYT stimulated iNOS mRNA levels
at 12 hours. However, at 4 hours the 10"4M concentration of inhibitor had a 66%
lower level of iNOS mRNA than following CYT alone, or CYT in combination with
10"5 and 10~6M inhibitor (p=0.005).
The inhibitor alone at 10"6, 10"3 and 10"4M did not alter iNOS protein production from
unstimulated control levels at 4 or 12 hours (Figure 4.31). CYT stimulation
increased iNOS protein levels above unstimulated control levels at both 4 and 12
hours. The inhibitor at 10" , 10"5 and 10"4M had no significant effect on iNOS protein
levels following CYT stimulation at 4 or 12 hours.
Nitrite accumulation in the medium was below 0.3pM at 4 hours following all the
stimuli, and at 12 hours in the unstimulated control. This is at the limits of detection
for the assay. Following 12 hour CYT stimulation nitrite levels were significantly
increased above unstimulated controls to 3.7 and 6.2pM in mRNA- and protein-
adjusted experiments respectively (p=0.03) (Figures 4.32 and 4.33). The inhibitor
alone at 10"6, 10"5 and 10"4M did not alter nitrite levels from unstimulated control
values. The inhibitor in combination with CYT resulted in lower levels of nitrite than
those seen following CYT alone. There was a 96% and a 98% decrease at 10"4M and
10"5M and a 4.8 and 5.2 fold decrease at 10"6M in mRNA- and protein-adjusted
experiments respectively (p<0.03 for 10"4andl0"5M andp<0.057 for 10"6M). No
significant difference was seen between the unstimulated control and the CYT nitrite
levels when 10"4 and 10°M inhibitor is present (p>0.072). 10"6M inhibitor in
combination with CYT, however, resulted in a 2.3 fold and 5.1 fold elevation in nitrite
levels from unstimulated controls in mRNA- and protein-adjusted experiments
respectively (p=0.045 and p=0.057). These were 79% and 81% lower than those



















n=7 n=6 n=7 n=6
n=7 n=7 n=6
iiii n=7 n=6 n=7 n=5






















-4 -5 -6 CYT C -4C-5C-6
12hr
Figure 4.30 - iNOS mRNA levels following incubation with CYT and the iNOS
inhibitor AR-C102222.
(I) = Pooled data±SEM. (II) = Individual experimental values.
TC = Unstimulated control. CYT and C = cytokine cocktail stimulation. -4 = 10"4M
Inhibitor. -5 = 10"5M Inhibitor. -6 = 10"6M Inhibitor.
A=DS004/8c B=DS008/9c C=6/12/02 D=6/5/03 E=17/6/03 F=18/4/04 G=1 1/5/04
H=21/5/04. **p<0.01 ***p<0.001.
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Figure 4.31 - iNOS protein level densitometry from western blots following
incubation with CYT and iNOS inhibitor AR-C102222. (I) = Western blot (004).
(II) = Pooled densitometry data±SEM. (Ill) = Individual densitometry experimental
values. TC = Unstimulated control. CYT and C = cytokine cocktail stimulation. -4
= 10"4M Inhibitor. -5 = 10"5M Inhibitor. -6 = 10"6M Inhibitor. A-6/5/03 B=6/12/02
C=DS004/8c D=DS008/9c.













n=7 n=6 n=7 n=6
n=5 n=3 n=5 n=4 n=5 n=4 n=5 n=4
A



































Figure 4.32 - mRNA adjusted nitrite levels from Griess assays following incubation
with CYT and the iNOS inhibitor AR-C102222. (I) = Pooled mRNA adjusted
data±SEM. (Ill) = Individual mRNA adjusted experimental values. TC
Unstimulated control. CYT and C = cytokine cocktail stimulation. -4
Inhibitor. -5 = 10"5M Inhibitor. -6 = 10"6M Inhibitor. A=6/5/03 B=DS004/8c
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Figure 4.33 - Protein adjusted nitrite levels from Griess assays following incubation
with CYT and the iNOS inhibitor AR-C102222. (I) = Pooled protein adjusted
data±SEM. (Ill) = Individual protein adjusted experimental values. TC =
Unstimulated control. CYT and C = cytokine cocktail stimulation. -4 = 10"4M
Inhibitor. -5 = 10"5M Inhibitor. -6 = 10"6M Inhibitor. A=6/5/03 B=DS004/8c
C=DS008/9c D=6/12/02. *p<0.05 ***p<0.001.
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4.3 - Discussion of results from mechanical and cytokine stimulation of
primary OA HAC
Taqman real-time PCR analysis of primary OA HAC revealed that mRNA for e, n and
iNOS was present at 12 hours in unstimulated cells. The increased cycle number
required for detection of e and nNOS compared to iNOS suggests that there are lower
levels of these mRNAs present in unstimulated cells. However, these levels can not
be compared directly as the primer/probe efficiency will be different for each.
Following incubation with CYT, iNOS mRNA levels were elevated several fold from
unstimulated controls at 4 and 12 hours, whereas e and nNOS mRNA levels were
decreased at 12 hours following CYT. The application ofMS reduced the level of
iNOS mRNA detected, but this was not statistically significant. However, the
simultaneous application ofCYT and MS significantly decreased the iNOS mRNA
levels compared to those seen following CYT alone at both 4 and 12 hours,
suggesting that MS influences CYT induced iNOS mRNA levels.
Protein analysis revealed that in unstimulated OA HAC, and following MS, e, n and
iNOS were not detected at 4 or 12 hours. Following CYT, however, iNOS protein
was detected at 4 hours and at an increased level at 12 hours. The simultaneous
application ofCYT and MS statistically decreased the level of iNOS protein detected
compared to that seen following CYT alone at both 4 and 12 hours.
The inability to detect nitrite in the medium using the Griess assay at 4 hours, despite
the presence of iNOS protein suggests that either the assay is not sensitive enough to
detect small amounts of nitrite produced, or the protein detected at this time-point is
not in an active state. The absence of nitrite formation could be due to the lack of the
substrate, arginine, the level of which can be influenced by the activity of the enzyme
arginase (Bogdan 2001). The lack of cofactors, such as tetrahydrobiopterin (BH4),
which are required for enzyme activity may also influence the level of nitrite
produced (Tang et al 1995). Dimerisation is required for iNOS enzyme activity (Eissa
et al 1998) and it may be that at 4 hours the enzyme has not yet taken a dimeric
conformation so lacks enzyme activity. The protein detected in these experiments is
denatured before being run on gels. It is therefore not possible to determine the
conformation of the enzyme within the cell. It may also be that the small amount of
NO produced at the 4 hour timepoint is being soaked up inside the cells by molecules
such as glutathione (Kronke et al 2000), so preventing its release into the medium for
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detection by the Griess assay. At 12 hours nitrite levels were elevated following
CYT, and a statistically significant decrease in this level was detected following the
simultaneous application ofCYT and MS. These results suggest interaction between
cytokine signalling and MS.
In order to elucidate the mechanism by which MS interferes with CYT induced iNOS
levels two molecules involved in pathways induced by MS in HAC were blocked.
The first of these, IL-4, is involved in the membrane hyperpolarisation associated with
MS in normal HAC (Millward-Sadler et al 2000a; Millward-Sadler et al 2003).
Initially IL-4 was blocked with a polyclonal IL-4 neutralising antibody. The lower
concentration of this antibody (lpg/ml) did not influence iNOS protein levels
following CYT plus MS. The higher concentration (lOpg/ml) of the polyclonal
antibody reduced the levels of iNOS protein and nitrite detected following CYT plus
MS. However this concentration of antibody also decreased CYT stimulated iNOS
protein and nitrite levels. This suggests that the antibody at the higher concentration
is having an effect on cytokine signalling other than through blocking the action of
IL-4. This may be due to the polyclonal nature of the antibody, allowing binding to
different epitopes, some of which may be similar to other molecules on the surface of
OA HAC, such as cytokine receptors, and thus causing interference with signalling.
In order to try and eliminate this possibility a monoclonal IL-4 neutralising antibody
was used. Incubation with this monoclonal antibody did not significantly alter the
level of iNOS mRNA, protein or nitrite at 4 or 12 hours following either CYT alone
or CYT plus MS.
a5pl integrin has been implicated in the hyperpolarisation response that occurs in
normal chondrocytes and depolarisation seen in OA chondrocytes following 0.33Hz
MS (Millward-Sadler et al 2000a; Wright et al 1997). A pi integrin function blocking
antibody did not influence CYT or CYT plus MS stimulated iNOS mRNA, protein or
nitrite levels at 4 or 12 hours. MS therefore appears to inhibit CYT mediated iNOS
production by a pi integrin and an IL-4 independent mechanism.
Although stimulation of primary OA HAC with a proinflammatory cytokine mix may
mimic in vivo conditions to some extent, it also makes it difficult to elucidate the
mechanism of action ofMS, as each of the cytokines may induce different
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intracellular signalling pathways that could be influenced by MS. The use of a single
cytokine should therefore allow a better evaluation of the effect ofMS. The
stimulation of iNOS production due to IL-ip alone in primary OA HAC was
evaluated and found to induce iNOS mRNA, protein and nitrite in a dose dependent
fashion. MS decreased the iNOS mRNA and nitrite levels induced by IL-ip, although
the protein response did not appear to be altered by MS when looking at the
densitometry data. Densitometry can be misleading as the level of protein present and
the intensity of the band detected do not follow a linear relationship. Analysis of the
films produced from the western blots themselves suggests that there is a decrease in
iNOS protein following MS. Incubation with both a monoclonal IL-4 neutralising
antibody and a pi integrin function blocking antibody had no effect on iNOS mRNA,
protein or nitrite levels at 4 and 12 hours following IL-ip alone or IL-ip plus MS.
This suggests that MS influences IL-ip in a pi integrin and IL-4 independent fashion.
This study suggests that mechanical strain does not decrease CYT stimulated iNOS
levels through a pi integrin or IL-4 mediated pathway. It is necessary therefore to
consider the other possible mechanisms for the action of strain in this system. It is
possible that the strain is being sensed through a mechanoreceptor other than the pi
integrin. Other integrin molecules have been identified on the surface of
chondrocytes including aipi, a3pl, a5pl, alOpi, avP3 and avP5 (Knudson and
Loeser 2002; Loeser et al 1995) and could be responsible for mechanotransduction.
There are also other non-integrin molecules on the chondrocyte surface that could
sense the mechanical strain. CD44 is one such molecule. It is a receptor for
hyaluronan, which binds and aggregates aggrecan molecules. Serine phosphorylation
of the intracellular domain of CD44 has been demonstrated, in addition to association
with actin binding proteins such as ankyrin, suggesting that CD44 could be involved
in signal transduction (Knudson and Loeser 2002). Indeed, the addition of hyaluronan
to cartilage explants inhibits IL-ip mediated release ofMMPs, a response which is
reversed through the blocking ofCD44 with specific antibodies (Julovi et al 2004).
The fact that mechanical stimulation in our study not only decreased IL-1 p mediated
iNOS, but also the cytokine mix induced iNOS in primary OA HAC suggests a more
general mechanism of action as several cytokine signalling pathways are blocked
rather than just one. However, the only parameter measured is iNOS, so it may be
that an iNOS specific mechanism is responsible for the action ofMS on cytokine -
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induced iNOS, while the other effects of the cytokines are unaffected. MS may
influence cytokine signalling through the activation of stress activated ion channels
that can modify the activity of signalling molecules inside the cell. Activation of
potassium channels can activate proteases in the phagocytic vacuole of neutrophil
leukocytes through increased calcium concentration and membrane depolarisation
(Ahluwalia et al 2004), both of which occur following MS in our system (Wright et al
1997). By immunostaining Shakibaei and Mobasheri (2003) showed that in mouse
limb bud chondrocytes pi integrins colocalise with a Na K-ATPase, epithelial sodium
channels and a voltage activated calcium channel. This would allow control of
calcium and sodium influx and so influence the activation of intracellular molecules.
Opening of these ion channels may also alter the pH within the cell. A chondrocyte
cell line study showed that alkalinisation following loading resulted in increased
inositol triphosphate (IP3) levels and the release of calcium (Ca2+) from intracellular
stores, so potentially influencing cell signalling (Browning and Wilkins 2002).
Studies by our group have shown the importance of phospholipase C (PLC) following
2+mechanical stimulation where IP3 mediated Ca release is required for membrane
hyperpolarisation in normal chondrocytes and membrane depolarisation in OA
chondrocytes (Millward-Sadler et al 2000a; Wright et al 1997).
The function of integrins can be modulated by the presence of integrin associated
proteins such as CD47. CD47 has been shown to associate with allb|33 and a4pl and
modulates the function of beta pi, beta P2 and beta P3 integrins through G protein
activation (Brown and Frazier 2001; Fujimoto et al 2003; Li et al 2002).
The downregulation of cytokine receptors is another mechanism through which
mechanical stimulation could decrease iNOS production. However, cyclic tensile
strain applied before the application of IL-ip has only a small effect on iNOS mRNA
and nitrite levels, suggesting that IL-ip receptor downregulation is unlikely to be the
mechanism through which strain acts to decrease iNOS levels (Xu et al 2000).
Stimulation with IL-1 p one hour prior to the application of cyclic tensile strain halves
the response and there is no decrease in iNOS mRNA or nitrite due to strain applied 2
hours after IL-1P (Xu et al 2000). This suggests that cytokine signalling has already
initiated iNOS gene transcription and the application of mechanical strain has no
effect on this. It may also be that the prior application of cytokine signalling
interrupts molecules involved in mechanical signalling, preventing the effects of
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mechanical strain. The production of IL-4 may stimulate the release of IL-lra,
although it has been reported that IL-4 does not stimulate IL-lra production in human
articular chondrocytes, and that IL-ip induced IL-lra takes 24 hours to be expressed
(Palmer et al 2002). This suggests that IL-lra production is unlikely to influence the
production of iNOS during our 12 hour experimental regime.
Another important observation from these results is that within individual experiments
samples can respond differently to each of the stimuli. This may be influenced by
many factors. Differences in proteoglycan synthesis have been shown to be
dependent upon the region of the articular cartilage from which the chondrocytes were
derived (Wiseman et al 2003). The pattern of integrin expression in chondrocytes is
also dependent on the degree of cartilage damage, suggesting that cells extracted from
different grades ofOA cartilage will sense strains differently (Iannone et al 2001).
Cartilage from different joints have different properties that influence the chondrocyte
response to mechanical strain (Xu et al 2004). Increasing age of the donor cartilage
influences the response of the chondrocytes to IL-lp stimulation, with less generation
of iNOS with increasing age (Min et al 2001). Oestrogen may antagonise the
production of iNOS in chondrocytes. Oestrogen production is decreased in
menopausal females suggesting that gender related differences will influence the
response of chondrocytes to cytokine stimulation (Cuzzocrea et al 2003). The
treatment a patient with OA may have been receiving is also important. NSAIDs
influence the production of inflammatory mediators from chondrocytes, and so can
influence their response to proinflammatory cytokine stimulation (Sanchez et al
2002).
The differentiation state of these cells during experimentation should also be
considered. Primary chondrocytes are known to dedifferentiate in monolayer culture,
resulting in expression of different ECM molecules and integrins which can influence
the way in which strains are sensed (Mahmood et al 2004). This altered pattern of
ECM synthesis can be partially reversed by 3-d culture in alginate (Yoon et al 2002).
However, dedifferentiation was not an issue in my experiments as culture in
monolayer was limited to less than 10 days. At this time point HAC continue to
express chondrocyte phenotypic markers such as collagen type II and aggrecan and
continue to maintain their integrin expression profile (Edinburgh University OA
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research group unpublished observations). The relative lack of ECM produced by
cells in monolayer cells is also important as it will allow better diffusion of the
cytokines added. It may however also allow better diffusion of signalling molecules
secreted by the cells, so causing a more general effect than might be seen in cartilage
itself where the ECM restricts the diffusion of signalling molecules.
Potential interactions between mechanotransduction and cytokine signalling
pathways (Figure 4.3.2)
In order to understand how MS may be interfering with CYT signalling it is first
necessary to understand what is known about the signalling mechanism of each of
these stimuli individually.
The mechanism by which chondrocytes sense mechanical signals has been discussed
in detail in Chapter 1 (Figures 1.7 and 1.8). Briefly, integrins on the surface of
chondrocytes bind components of the ECM and transduce mechanical signals to an
intracellular signalling complex, the focal adhesion complex (FAC). This contains the
actin cytoskeleton and tyrosine kinases such as focal adhesion kinase (FAK), paxillin
and (3-catenin that are activated by mechanical stimulation (Lee HS et al 2000). The
activated kinases initiate intracellular signalling cascades involving PLC and protein
kinase C (PKC) that result in altered gene transcription (Millward-Sadler et al 2000b).
The activation of calcium dependent potassium ion channels by mechanical signals is
a response involving the autocrine/paracrine production of soluble mediators, such as
substance P and IL-4, leading to the measured hyper and depolarisation responses
seen in normal and OA HAC respectively following MS (Millward Sadler et al 2000a;
Millward-Sadler et al 2003). Much of the work in cartilage has focussed on the
outcomes ofmechanical stimulation, such as altered proteoglycan synthesis
(discussed in Chapter 5) and relatively little is known about the intracellular signalling
cascades leading to these responses.
Cytokine signalling, also discussed in Chapter 1 (Figure 1.3), occurs through the
binding of the soluble cytokine molecules to their receptors on the cell surface.
Intracellular signalling events occur upon cytokine binding, with each cytokine using
different signalling pathways. IL-ip functions through the activation of the upstream
regulator ofmitogen activated protein kinase (MAPK) activity TAK1, which can
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control the activation state of the transcription factor NFkB (Slack et al 2000). TNFa
signals through the activation of the upstream regulator ofMAPK activity MEK1/2
and NFkB activation (Seguin and Bernier 2003). The phosphorylation of the Janus
activated kinases (JAKs) attached to the IFNy receptor (Watling et al 1993) activates
p91 which moves to the nucleus where it binds the gamma activated sequence (GAS)
on gene promoter regions (Shuai et al 1992). IL-6 activation causes Janus activated
kinase (JAK) and Tyk2 phosphorylation, activating the signal transducer and activator
of transcription (STAT) 3 that binds the promoters of certain genes (Stahl et al 1994).
Each of the cytokines can therefore influence gene transcription patterns. There is,
however, crosstalk between these signalling pathways, as highlighted by gene deletion
studies which reveal that few individual cytokines are absolutely essential for life or
even for individual cellular functions, suggesting that one cytokine can compensate
for the loss of another (Ozaki and Leonard 2002).
Growth factors and cytokines affect integrin expression and matrix affinity, and so
can influence integrin signalling (Giancotti and Ruoslahti 1999; Jobanputra et al
1996). This may occur through direct alteration of the integrins expressed; expression
of the a5 integrin subunit is increased following cyclic compressive stress in bovine
articular explants (Lucchinetti et al 2004), while alpha2 and alpha5 integrin subunits
are increased in human articular chondrocytes cultured in monolayer on flexible
membranes and subjected to cyclic strain for 24 hours (Lahiji et al 2004).
Alternatively, integrin signalling can be influenced through the production of an
altered ECM that allows the cells to sense mechanical signals differently (Loeser
1997). The reverse is also true. Cytokine signalling pathways can be influenced by
integrin activation, as illustrated by the requirement for a5(31 integrin binding to
fibronectin to allow a rabbit chondrocyte proliferative response following fibroblast
growth factor (FGF) stimulation (Enomoto-Iwamoto et al 1997). Interaction between
cytokine and mechanical signalling molecules would appear unlikely if the receptors
were signalling through distinct points at the cell membrane surface. However, there
is evidence suggesting a close association between these cell surface receptors, and
some of the intracellular signalling molecules may be activated by either stimulus.
Several cytokine and growth factor receptors that have an association with FAC have
been identified, including the IL-1RI (Lo et al 1998) and the insulin receptor (Vuori
and Ruoslahti). It has been suggested that interaction with the integrin complex
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causes partial activation of growth factor receptors, which are then fully activated
following ligand binding (Giancotti and Ruoslahti 1999).
Load alters the physical environment of chondrocytes in a complex fashion as
discussed in Chapter 1. The tissue and cells deform, leading to a rise in the
hydrostatic pressure of the matrix, and fluid is expressed in order to restore osmotic
equilibrium. Increases in extracellular osmolarilty, ion concentration, and the fall in
pH that follows, can influence chondrocyte metabolism as can be seen as
proteoglycan synthesis decreases following static load (discussed in Chapter 5)
(Urban et al 1993). Other factors such as the alteration of oxygen levels during
exercise, which is known to affect matrix synthesis and cell growth may also be
important (Marcus 1973). Mechanotransduction through cell surface receptors may
influence chondrocyte function. However, cell deformation and associated distortion
of intracellular organelles may also influence the cells response to a mechanical
stimulus (Knight et al 2002). Indeed, pressures in the range of 5-50MPa may alter
cell morphology, reduce exocytosis, dissociate cytoskeletal elements, reduce protein
synthesis and inhibit membrane transport (Hall et al 1991).
It has been suggested that the application of mechanical stimulation to cartilage
results in release ofECM attached growth factors that influence the activity of the
chondrocytes (Vincent et al 2004). However, in this system the cells are in monolayer
culture and produce only a limited ECM, and so are unlikely to be affected in this
way. It has also been suggested that mechanical stimulation affects chondrocytes by
speeding the rate of diffusion of soluble factors from the surrounding medium in
explant studies (Bonassar et al 1997; Jin et al 2003) and induces solute movement
through cartilage which can alter cellular metabolism (O'Hara et al 1990). This is
also unlikely to be an important factor in these experiments where the cells are in
monolayer and express a limited ECM.
It is also possible that mechanical stimulation could activate a transcription factor by
binding to a mechanoresponsive element. An example of this is seen where Tenascin-
C is upregulated by mechanical stimulation. A mechanoresponsive element in the
Tenascin-C promoter was identified and found to be present in the collagen type XII
promoter also, although the transcription factor that binds to it has yet to be identified
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(Chiquet et al 2003). It is also possible that strain acts by inducing the synthesis of a
nuclear factor which then activates ECM genes, such as the EGR-1 gene
(Schwachtgen et al 1998). Mechanical strain may also act through the induction of
the synthesis or secretion of soluble factors that regulate ECM gene expression via an
autocrine/paracrine mechanism.
It is therefore worth considering, given that mechano-responsive elements exist, that
the outcome following mechanical and cytokine stimulation is the result of a
cumulative effect of both the positive and negative factors on the promoters of genes
that define their rate of synthesis. Indeed, considering the complexity of regulation of
the human iNOS promoter (discussed in chapter 1), and the interactions between
transcription factors it is possible that this may be the case.
An example of a mechano-responsive transcription factor is NFkB, which has been
activated following mechanical stimulation in a manner that is dependent upon the
magnitude of the signal applied. Agarwal et al (2003) initially showed this using low
and high magnitudes of strain on osteoblast like periodontal ligament cells,
subsequently showing the same effect in lapine temperomadibular junction
chondrocytes in monolayer (Agarwal et al 2004). These studies showed the low strain
inhibits IL-1 (3 induced NFkB nuclear translocation, stabilising the IkB/NFkB
complex, while high strain mimics IL-1 (3 and induces NFkB nuclear translocation. As
discussed in Chapter 1, NFkB is a major transcription factor involved in the synthesis
of iNOS following IL-1J3 stimulation of chondrocytes, so its inhibition is a mechanism
by which strain could be causing its effects within our experiments following single
cytokine stimulation. The inhibition of iNOS production when the cytokine cocktail
is added could also be explained by this phenomenon, however, it is also likely that
control of such a response would need to be more general, such as through the
activation of ion channels, rather than through the integrins alone. This is supported
by our finding that the p 1 integrin function blocking antibody does not prevent the
effect of mechanical strain, suggesting an alternative mechanism of action.
IL-1RI colocalisation with vinculin at sites of fibronectin attachment suggest it can be
recruited to the FAC. RhoA is involved in FAC formation and is associated with
ligand bound IL-1 receptor and activated by IL-1 P, confirming the interaction of IL-
RI and FAC (MacGillivray et al 2000). Increased activation of signal transduction
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pathways and enhanced release of inflammatory mediators is seen when the IL-1RI is
localised to FAC in human gingival fibroblasts (Huang et al 2001). Association of IL-
1RI with the G proteins Ras and Rac occurs in the FAC and may represent a method
of enhanced signal transduction (O'Neill 2002).
MAPK
The MAPKs (Figure 4.3.1) are of interest as they are activated both by mechanical
and cytokine signalling (Fanning et al 2003; Mendes et al 2002). These molecules
require threonine and tyrosine phosphorylation in order to activate them, which
ensures they remain inactive within the cell unless the appropriate stimulation is
received.
MAPK activation by mechanical stimuli has been investigated in chondrocytes and in
other cell types. Compression of cartilage explants was shown to phosphorylate
extracellular signal regulated kinases (ERK) 1 and 2, p38 MAPK and stress activated
protein kinase (SAPK)/ERK (SEK-1) of the c-Jun NH2 terminal kinase (JNK)
pathway in a time dependent manner (Fanning et al 2003). Fluid flow in bovine
articular chondrocytes increases ERK1/2 activation at a shear stress of 1.6Pa (Hung et
al 2000). Studies in other cell types show activation ofERK, p38 and JNK due to
mechanical strain in different systems, an example of which is seen during 4% stretch
of rat cardiac myocytes where increased ERK2, JNK1 and p38 MAPK activation
occurs via an integrin dependent mechanism (MacKenna et al 1998).
Studies using 0.33Hz MS within our system have shown that JNK phosphorylation
and activation, which is partially integrin-dependent, occurs following MS in
chondrocyte cell lines, while p38 and ERK 1/2 remain unaffected (OA research group,
Edinburgh University, submitted for publication). The presence of p38, ERK and
JNK has been identified in primary OA HAC, with increased p38 phosphorylation
following MS that is a5(31 integrin-independent (OA research group, Edinburgh
University, unpublished observations). This supports an alternative mechanism of
mechanical signalling in our experiments leading to the decreased CYT induce iNOS
mRNA, protein and nitrite observed. The transient association of intracellular receptor
activated kinase (IRAK) with the FAC in IL-1(3 stimulated human gingival fibroblasts
is involved in IL-ip-induced ERK activation, a response that requires an intact
cytoskeleton. However, in the absence of the FAC, IL-ip still activates p38 and JNK.
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This suggests that the cytoskeleton may be the scaffold for ERK and other signalling
molecules to be brought together to allow ERK phosphorylation at the FAC following
exposure to IL-ip (MacGillivray et al 2000).
The activation ofMAPKs has also been demonstrated following cytokine and growth
factor stimulation. p38 MAPK phosphorylation and activation is required for iNOS
mRNA, protein and NO production in bovine articular chondrocytes following IL-ip
stimulation, whereas ERK 1/2 is not required (Mendes et al 2002). The activation of
p38 and NFkB are both required for IL-lp induced iNOS production, signalling
through distinct pathways. The MAPK signalling cascade has, however, been
implicated in NFkB signalling, through the upstream kinase involved in MAPK
activation, MAPK and ERK kinase (MEKK) 1. MEKK1 is suggested to be part of the
IkB/IKK/NFkB complex, causing phosphorylation and activation of IkB kinase (IKK)
which phosphorylates the inhibitor ofNFkB, IkB, targeting it for degradation. This
exposes the nuclear localisation sequence on NFkB allowing it to travel to the nucleus
and influence gene transcription (Hagemann and Blank 2001). The transcription
factor AP-1 contains the subunit c-Jun that is a direct target for JNK, which is
activated through TNF receptors via a MEKK1-SEK-JNK module using a similar
mechanism to NFkB, with MEKK1 being recruited to the receptor complex
(Elagemann and Blank 2001).
The role ofMAPK in the production of iNOS could be explained by decreased
mRNA stability due to strain (Sironen et al 2002). It has been suggested that ERK
does not regulate iNOS mRNA expression but possibly influences post-transcriptional
events such as mRNA stabilisation (Wang and Brecher 1999). It is possible that this
may be due to decreased post translational processing, allowing AU rich regions to
remain, or could involve the synthesis of regulatory proteins such as HuR (Rodriguez-
Pascual et al 2000).
The phosphorylation ofMEKK1 is essential for its catalytic activity and this requires
direct upstream kinases. It has been suggested that protein kinase C (PKC)
phosphorylates MEKK1, leading to JNK activation (Siow et al 1997). This is of
particular interest as PKC is involved in the mechanotransduction response to 0.33Hz
MS. PKCa, gamma, delta, iota and lambda have been identified in human articular
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chondrocytes (Lee HS et al 2002), with the translocation of PKCa to the FAC through
interaction with receptor for activated c-kinase (RACK-1) and association with the (31
integrin. Loeser et al (2003) showed that a fibronectin fragment and an a5pi integrin
activating antibody stimulate PKC activation, causing proline rich tyrosine kinase 2
(PYK2) activation and MAPK stimulation and resulting in the upregulation of
MMP13 expression. Cheng et al (2001) showed that cyclic strain applied to
endothelial cells resulted in PKCa activation followed by PKCs activation, causing
sustained Raf/ERKl/2 activation and stimulation of Elk 1 promoter activity.
Mesangial cells subjected to cyclic strain showed rapid SAPK/JNK activation that
was dependent on increased intracellular calcium and PKC, which activates Elk-1,
stimulating c-fos production and leading to AP-1 activation and increased fibronectin
mRNA levels (Ingram et al 2000a).
PKC activation is also seen as a result of growth factor and cytokine signalling in
response to TNFa (Hagemann and Blank 2001), vitamin D (Maeda et al 2001) and
histamine (Sohen et al 2001). TGF-p addition to rat chondrocytes causes increased
proliferation and proteoglycan synthesis. This occurs via the stimulation ofG
proteins that activate phospholipase A2, causing PKA activation that activates PKC
(Rosado et al 2002). PKC has also been suggested to have the ability to
phosphorylate IkB, causing the release and nuclear translocation ofNFkB (Steffan et
al 1995). PKC induction due to strain can inhibit NO production due to IL-ip and
IFNy in rat cardiac myocytes (Yamamoto et al 1998).
It has also been suggested that PKC can phosphorylate ion channels, altering their
activity and therefore influencing the intracellular environment of the cell. An
example of this is where cyclic stretch upregulates the production ofNa+, K+-ATPase
in rat smooth muscle cells via a PKC dependent mechanism (Songu-Mize et al 1998).
The activation ofG proteins has been demonstrated following both cytokine and
mechanical stimulation of cells. G proteins are targeted to specific cell surface
microdomains (Oh and Schnitzer 2001). Mechanical compression of cartilage results
in changes in cell volume and calcium concentration oscillations. The use of
pharmacological inhibitors of signalling molecules revealed that this response
required gadolinium sensitive stretch activated ion channels, IP3 and G protein
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activity (Erickson et al 2001). The activation of the small G protein Ras by fluid
induced shear stress of human vascular endothelial cells was shown to be mediated
through G proteins (Gudi et al 2003). Ras and RhoA have been implicated in the
processing ofmechanical signals to downstream signalling molecules such as ERK1/2
and protein kinase C (PKB) (Sugden 2003). G proteins have been implicated in the
modulation ofNO release from osteoblasts, where cyclic tensile strain activates the G
protein which enhances JNK/SAPK activity and decreases NO through a mechanism
that requires an intact cytoskeleton (Hara et al 2001).
P2Y(2) receptors are able to bind integrin subunits and through association with G
proteins and CD47 can activate FAK, ERKs and initiate PLC dependent mobilisation
of intracellular calcium (Erb et al 2001). Millward-Sadler et al (2004) showed the
presence of P2Y2 purinoreceptors on normal and OA chondrocytes and that binding
of ATP was sufficient to stimulate the membrane hyperpolarisation associated with
MS in normal cells.
The question of how specificity is achieved within these pathways has to be
addressed, especially when considering that the loss of one pathway can be
compensated for by another. The N-terminal motifs of the MAPKs alter allowing
different subcellular localisation. MEKK1 can bind a-actinin, locating it to focal
adhesions which suggests it may be involved in mechanotransduction. Proteolytic
processing ofMEKK1 alters its function, possibly by allowing it to interact with
different pools of signalling molecules, and this has been implicated in IL-1 p (Kopp et
al 1999) and TNFa (Fanger et al 1997) mediated NFkB and AP-1 activation.
Binding ofMEKKs to regulatory proteins can alter specificity, seen in TNFa
signalling where Gck links MEKK1 to JNK activation, whilst Tax association allows
preferential NFkB stimulation (Shi and Kehrl 1997; Yin et al 1998; Yuasa et al 1998).
14-3-3 proteins associate with MEKKs and have a scaffold function, bringing
attached factors together as well as acting as chaperones, binding serine
phosphorylated proteins and preventing their dephosphorylation (Fanger et al 1998).
This allows the control ofMEKK function through mediating interactions with other
proteins and controlling subcellular localisation. Other scaffold proteins have also
been identified that bind MAPK module members, bringing them together and so
influencing the pathways activated. MEKK1 itself acts as a scaffold for Raf-MEK-
ERK2, and since it is also associated with the cytoskeleton, it could keep the signal
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module close to FAC so allowing efficient cellular responses to MS (Karandikar et al
2000). The different subcellular localisation ofRaf alters its function from
proliferative to pro-apoptotic (Wang et al 1996) so scaffold proteins can increase the
specificity of signalling pathways activated, but they restrict the signal amplification
that occurs through sequential kinase interactions.
Integrin mediated MAPK pathways converge with cytokine induced pathways
(Sundberg and Rubin 1996), so will both have an effect on the regulation of cell
function. The exact biological functions of these kinases will depend upon a number
of factors including the nature, intensity and duration of upstream signals, the cellular
localisation of the signalling proteins and crosstalk with other signalling pathways.
The complicated interactions between the MAPK signalling pathways, activation of
MEKK cleavage to alter its subcellular location, production of regulatory proteins,
scaffold proteins or the activation ofPKC activity are some of the ways in which
mechanical strain could interfere with cytokine signalling through the MAPKs. It is
also possible that mechanotransduction occurs at a faster rate than cytokine signalling,
so uses up the signalling molecules in the FAC, leaving less available for cytokine
signalling. This hypothesis is supported by the fact that cytokine stimulation for 1
hour prior to mechanical stimulation reduces the inhibitory response of strain on
iNOS mRNA and nitrite production, and 2 hours before completely inhibits the
response compared to when both stimuli are applied simultaneously (Xu et al 2000).
It is necessary to identify and understand the function of the upstream regulators,
downstream mediators and target genes of the MAPKs in chondrocytes in order to






















Figure 4.3.1 - MAPK pathways where receptor stimulation causes phosphorylation
ofMAPKKK, which phosphorylate MAPKK resulting in MAPK phosphorylation and
activation. Phosphorylation of substrates and transcription factors causes specific
responses through altered gene transcription. (Stanton et al 2003).
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Figure 4.3.2 - Possible interactions between mechanical signalling and cytokine signalling in
OA HAC. (1) Calcium increased through stretch activated ion channels and from intracellular
stores can activate signalling molecules and may be responsible for stabilising the NFkB/IkB
complex so inhibiting NFkB signalling. (2) PKC activated by both mechanical and cytokine
signals and can influence MAPK signalling and transcription factor activation. (3) Activation
of other stretch activated ion channels may influence intracellular signalling molecules. (4) The
MAPKKK MEKK1 is involved in release ofNFkB through activation of IKK. Its role in
mechanotransduction may mean it is localised to a different cellular compartment so less activation
ofNFkB is seen following cytokine stimulation. (5) There may be positive and negative regulatory
elements on the iNOS gene promoter, influencing the rate of its expression. (6) Other cell surface
Molecules may sense the mechanical signals and influence cytokine signalling.
iNOS Inhibitor AR-C102222
The novel iNOS inhibitor AR-C102222 did not induce iNOS mRNA, protein or nitrite
synthesis at 4 or 12 hours at any of the concentrations tested. The inhibitor did not
significantly alter the level of iNOS mRNA and protein at 4 and 12 hours at the two
lower concentrations (10"5M and 10"6M). However at the highest concentration used
(10"4M) iNOS mRNA levels decreased at 4 hours following CYT. The 18s mRNA
levels detected remain at a similar level to those seen for the other treatment regimes,
and the cell viability studies show no effect on cell death at this concentration
(Appendix 1 and 2). This suggests that the inhibitor is not causing general
downregulation ofmRNA production, or decreasing the cell number and thus
lowering the levels detected. It would appear more likely that the inhibitor is
interfering with the actual iNOS mRNA synthesis or degradation at this concentration.
AR-C 102222 inhibits the increase in nitrite levels following CYT at both 10"4 and 10"
5M. However a small amount of nitrite is still produced at 10~6M suggesting
incomplete inhibition of enzyme activity at this concentration. These results suggest
that 10"5M may be the optimal concentration to use this inhibitor as it is high enough
to completely inhibit enzyme activity without altering iNOS mRNA levels through an
unknown mechanism.
Method of Inhibitor action
A high degree of structural conservation within the active site of the NOS enzymes
makes it difficult to design isoform specific inhibitors (Crane et al 1998). Many of
the inhibitors described interact with the active site where the substrate L-arginine
binds. There are also several inhibitors of the cofactor tetrahydrobioterin (BH4), as
well as molecules that prevent NOS dimer formation. Inhibitors of electron transfer
in the reductase domain can be effective in vitro, however, there is considerable
potential for interaction with other molecules in vivo.
L-arginine site
NO itself inhibits NOS activity at the L-arginine binding site. N(G)-monomethyl-L-
arginine (L-NMMA) and L-NIO work in a similar fashion to NO, with the gradual
decrease in NO production as the enzyme becomes inactivated due to alkylation of
haem by substituents of the inhibitor (Raman et al 2001).
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N-3-aminoethyl-benzyl-acetamidine hydrochloride (1400W) is a slow, tight binding
and highly selective iNOS inhibitor that requires NADPH, with L-arginine acting as a
competitive inhibitor of 1400W binding (Garvey et al 1997). Crystal structure
binding of 1400W to eNOS revealed that the inhibitor binds haem, suggesting it is
likely to be iNOS selective partially due to higher iNOS turnover, when compared
with e and nNOS, leading to peroxide production and irreversible haem damage (Li et
al 2001). Recent work has, however, revealed the binding of 1400W to both the
active site and to isoform specific residues outside the active site, with conformational
flexibility of the active site allowing structural changes when bound to the inhibitor
(Fedorov et al 2003). Despite good penetration into tissues and cells, and high
specificity, there is toxicity associated with this compound that is likely to prevent its
use as a therapeutic agent in human conditions (Garvey et al 1997).
The GW compounds (3-[[2-(ethanimidoylamino)ethyl]sulphonyl]-L-alanine) are
hetero-substituted analogues and homologues of L-NIL, with similar potency to L-
NIL but significantly increased iNOS isoform selectivity. The activity of these
compounds is maintained in intact cells and tissues, with no evidence of acute toxicity
(Cuzzocrea et al 2002; Young et al 2000).
Tetrahydrobiopterin (BH4) site
Some pterin analogues such as 4-amino-BH4 and BH2 exist, as well as other non-
analogue inhibitors including 7-nitroindazole (7NI) and 3-Br-7-nitroindazole (7NIBr)
(Bommel et al 1998). 7-NI (Alderton et al 2001) and 7NIBr (Bland-Ward and Moore
1995) inhibit all three NOS isoforms in vitro. High level nNOS specificity is seen in
vivo, as monitored by a lack of changes in blood pressure (Handy and Moore 1998).
It is thought that different cell-type specific uptake pathways may play a role in this
selectivity, conferring neuroprotective properties on mouse models of stroke (Nanri et
al 1998) and Parkinsons disease (Zhang et al 2000). Analysis of the crystal structure
of the catalytic haem domain of eNOS bound to 7NIBr by Raman et al (2001) showed
inhibitor binding causes conformational change in the enzyme, causing elimination of
the BH4-haem interaction.
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Inhibitors of NOS dimerisation
The pyrimidine imidazoles are potent and selective inhibitors of iNOS dimerization,
identified from a library of compounds using a cell based assay with a specific
radiolabel for iNOS in its monomeric form (McMillan et al 2000). These were found
to be 1000 fold more potent than mechanism based inhibitors such as 1400W, and
1000 fold more selective for iNOS compared to eNOS in vitro with activity in vivo,
suggesting therapeutic potential. Crystal structure analysis of the enzyme bound to
the inhibitor revealed that the molecule acts by allosterically disrupting the protein-
protein interactions at the dimer interface.
The determination of the selectivity ofNOS inhibitors requires the use of isolated
NOS enzymes. Previous studies have identified isoform selectivity through in vivo
physiological effects which can lead to inappropriate classification of inhibitors. The
iNOS inhibitor AR-C102222 was identified as a molecule that had shown a 50%
inhibition (IC50) of isolated iNOS enzyme activity at 0.037pM, eNOS IC50 of >100
pM and nNOS IC50 of lpM. The activity was also assessed in the human
adenocarcinoma cell line DLD-1 with an IC50 of 0.9pM and an in vivo IC50 in rat of
3pmol/kg (Tinker et al 2003).
In vitro analysis of the inhibitor AR-C 102222 shows strong iNOS selectivity and
good cell permeability (Tinker et al 2003). The inhibitor is a spirocyclic
quinazolinamine. This molecule is not an analogue of arginine, but the requirement
for the use of a medium containing low arginine suggests that it acts through
competition with the enzyme substrate. Our study showed that the inhibitor does not
inhibit iNOS mRNA or protein levels following CYT stimulation of OA MAC.
However, a dose dependent decrease in the level of nitrite detected is seen, with 10"4
and 10"5M completely inhibiting nitrite while 10"6M shows incomplete inhibition.
This suggests the inhibitor functions as an inhibitor of enzyme activity rather than
through alteration ofmRNA or protein levels. This is most likely to be through its
competition with L-arginine for the enzyme substrate binding site. It is possible,
however, that some other interaction with the iNOS protein may cause structural
changes that could alter enzyme activity.
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4.4 - Conclusion
Understanding the mechanisms involved in mechanical signalling in cartilage and
chondrocytes is greatly complicated by the heterogeneity of cartilage and cells, and
the plethora of factors that have the potential to influence signals being sensed by
each chondrocyte in vivo. The present situation is also complicated by the fact that
each group of investigators uses different strain frequencies and loads as well as
different cells and cell culture conditions to study the effects of strain. Despite these
drawbacks there is a general trend which demonstrates that cyclic strain at low loads
and frequencies appears to be beneficial and anti-inflammatory, as seen in our
experiments where MS inhibits CYT induction of iNOS. By contrast, static strains, as
well as higher loads and frequencies, are catabolic for cartilage matrix homeostasis. It
is therefore necessary to understand the forces and loads experienced by these cells in
vivo in order to allow appropriate study of the intracellular signalling mechanisms in
in vitro models. The exact nature of the strain experienced by these cells is
complicated by the fact that, aside from the cyclic tensile strain they also experience
some shear stress due to fluid flow, and this is known to have effects on chondrocytes
including altering matrix synthesis (Das et al 1997). The relative lack of pericellular
matrix produced by these cells in monolayer culture means they do not have the
appropriate matrix that is seen in cartilage itself, so all strains will be greater than the
in vivo situation (Urban 1994).
However, despite the limitations of the experimental system it provides a model
through which the signalling pathways activated by mechanical strain can be studied.
This series of experiments has shown that strain is not working through a pi integrin
or an IL-4 mediated pathway to decrease the levels of iNOS mRNA, protein and
nitrite detected following proinflammatory cytokine stimulation. The potential
interactions through the MAPK and PKC signalling, actions on transcription factor
synthesis and activation as well as the presence of mechano-responsive elements on
gene promoters are all factors that need further study in order to fully understand how
interactions could be leading to changes in gene expression.
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Summary of findings
Primary osteoarthritic human articular chondrocytes produce e, n and
iNOS mRNA, however no e or nNOS protein is detected.
Primary osteoarthritic human articular chondrocytes produce iNOS
mRNA, protein and nitrite following stimulation with a
proinflammatory cytokine cocktail or IL-ip alone.
The application of mechanical stimulation (0.33Hz, 30,000pstrain)
reduces the level of iNOS seen following CYT or IL-ip stimulation.
This decrease occurs through a pi integrin and IL-4 independent
mechanism.
A novel iNOS inhibitor, AR-C102222, inhibits iNOS enzyme activity
without affecting its mRNA or protein expression.
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Chapter 5 - Effects of cyclical mechanical stimulation, CYT and
IL-ip on aggrecan mRNA levels in primary OA HAC
- is there a role for NO?
Aims
Investigate the effects ofmechanical stimulation and nitric oxide on
proteoglycan levels in primary osteoarthritic human articular
chondrocytes
5.1 - Introduction
Aggrecan mRNA levels were detected in primary osteoarthritic (OA) human articular
chondrocytes (HAC). Taqman real-time PCR was used to measure aggrecan mRNA
levels using two separate primer/probe sets that have both been designed to detect
human aggrecan mRNA. These are described as primer/probe sets 1 and 2, with set 1
primarily used and set 2 used to confirm results in several experimental series.
In the previous chapter the level of inducible nitric oxide synthase (iNOS) mRNA,
protein and NOS enzyme activity was determined in primary OA HAC. Here, nitrite
levels were detected by the Griess assay as a measure of nitric oxide (NO) release into
the medium by the NO donor SNAP following proinflammatory cytokine cocktail
stimulation (CYT).
Primary OA HAC were initially stimulated with either CYT or IL-ip alone and the
effect of dose on aggrecan mRNA expression was evaluated. The effect of cyclical
mechanical stimulation at 0.33Hz and 30,000pstrain (MS) on both CYT and IL-ip
stimulated aggrecan mRNA levels was then studied. The method by which MS may
be interacting with CYT and IL-ip stimulated aggrecan mRNA levels was
investigated using IL-4 neutralising antibodies and a pi integrin function blocking
antibody. The effect ofNO on aggrecan mRNA levels was studied using a novel
iNOS inhibitor, AR-C102222, and an NO donor, SNAP.
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5.2 - Results
5.2.1 - Effects of CYT stimulation on aggrecan mRNA levels
5.2.1a - Aggrecan mRNA levels in primary OA HAC
Aggrecan mRNA was detected in unstimulated primary human OA HAC from cycle
25 using primer/probe set 1. Aggrecan mRNA levels were decreased 65% and 80% at
12 hours following incubation with half and full concentration ofCYT respectively
(p=0.1 and p=0.047 respectively) (Figure 5.2.1).
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Figure 5.2.1 - Basal (unstimulated) and cytokine cocktail stimulated aggrecan mRNA
levels (12hr). (I) = Pooled values±SEM. (II) = Individual experimental
values. ML = Unstimulated control. HalfCYT = Half concentration of
cytokine cocktail. Full CYT = Cytokine cocktail stimulation. (n=3). *p<0.05.
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5.2.1b - Effects of CYT and MS on aggrecan mRNA levels
Aggrecan mRNA levels were detected at 4 and 12 hours following CYT and MS
using primer/probe set 1.
MS decreased aggrecan mRNA levels at 4 hours, 37% below those seen in the
unstimulated control (p=0.16) (Figure 5.2.2), MS did not alter the level of aggrecan
mRNA detected from those seen in the unstimulated control at 12 hours.
Lower aggrecan mRNA levels were detected following CYT stimulation than in the
unstimulated control: 41% lower at 4 hours and 37% lower at 12 hours (p=0.09 and
p=0.04 respectively).
Simultaneous stimulation with CYT and MS decreased aggrecan mRNA levels
compared to unstimulated controls by 37% at 4 hours and 50% at 12 hours (p=0.11
and p<0.001 respectively). The level of aggrecan mRNA following CYT plus MS
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Figure 5.2.2 - Aggrecan mRNA levels following CYT and MS. (I) = Pooled iNOS
mRNA levels±SEM. (II) = Individual experimental values. ML = Unstimulated
control. MS = Mechanical stimulation. CYT = Cytokine cocktail stimulation.
CYT+MS = Both cytokine cocktail and mechanical stimulation. *p<0.05
***p<0.001.
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5.2.1c - Effects of CYT, MS and an IL-4 neutralising antibody on aggrecan
mRNA levels
Aggrecan mRNA levels following CYT stimulation in combination with MS and a
monoclonal IL-4 neutralising antibody (lpg/ml) were measured by Taqman real-time
PCR using two separate human aggrecan primer/probe sets (primer/probe sets 1 and
2).
There was little alteration in aggrecan mRNA levels detected at 4 hours following any
of the stimuli using either primer/probe set 1 or 2 (Figures 5.2.3 and 5.2.4). The
exception to this was where a 1.6 fold and 1.7 fold increase in aggrecan mRNA levels
above unstimulated controls were seen following simultaneous CYT, MS and IL-4
neutralising antibody stimulation using primer/probe sets 1 and 2 respectively.
However this increase was not statistically significant.
At 12 hours following both CYT and CYT in combination with the IL-4 neutralising
antibody no change was seen in aggrecan mRNA levels using either primer/probe set.
CYT in combination with MS at 12 hours decreased aggrecan mRNA levels by 44%
and 41% compared to unstimulated controls using primer/probe sets 1 and 2
respectively (p=0.02 and p=0.07 respectively). The simultaneous application ofCYT,
MS and IL-4 neutralising antibody did not alter aggrecan mRNA levels from the
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Figure 5.2.3 - Aggrecan mRNA levels detected with primer/probe set 1 following
incubation with a monoclonal IL-4 neutralising antibody.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. CYT = Cytokine cocktail stimulation. IL-4 Ab =
Monoclonal IL-4 neutralising antibody at lpg/ml. MS = Mechanical
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Figure 5.2.4 - Aggrecan mRNA levels detected with primer/probe set 2 following
incubation with a monoclonal IL-4 neutralising antibody.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. CYT = Cytokine cocktail stimulation. IL-4 Ab =
Monoclonal IL-4 neutralising antibody at lpg/ml. MS = Mechanical
stimulation. (n=3). (paired t test used).
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5.2.Id - Effects of CYT, MS and a pi integrin function blocking antibody
on aggrecan mRNA levels
Aggrecan mRNA levels following CYT stimulation in combination with MS and a pi
integrin function blocking antibody (lpg/ml) were measured by Taqman real-time
PCR using the two separate human aggrecan primer/probe sets.
The addition of the pi integrin function blocking antibody (lpg/ml) alone was carried
out in a single experiment (10/2/2004). Aggrecan mRNA increased by 3.1 and 2.8
fold at 4 hours and 2 and 1.5 fold and at 12 hours using primer/probe sets 1 and 2
respectively (Figures 5.2.5 and 5.2.6).
At 4 hours CYT and CYT plus pi integrin function blocking antibody did not appear
to alter the aggrecan mRNA levels compared to the unstimulated control using either
primer/probe set 1 or 2. The analysis of single experiments, however, revealed that
the 8/3/04 sample shows a 3.8 and a 1.9 fold increase in aggrecan mRNA following
CYT stimulation using primer/probe sets 1 and 2 respectively, a response which was
lost at 12 hours. The application ofCYT+MS appeared to elevate the aggrecan
mRNA levels by 2.7 and 1.5 fold at 4 hours using primer/probe sets 1 and 2
respectively, but this was not statistically significant. Analysis of the individual
experimental values, however, revealed that these values were heavily influenced by
the sample from 22/03/04.
At 12 hours CYT and CYT plus MS the aggrecan mRNA levels were decreased by
60% and 58% respectively when compared to unstimulated controls and detected
using primer/probe set 1 (p=0.07 and p=0.02 respectively). Primer/probe set 2,
however, did not show such a clear decrease in aggrecan mRNA: 23% and 29%
following CYT and CYT plus MS respectively (p=0.18 and p=0.11). The
simultaneous application of pi integrin function blocking antibody did not alter the
level of aggrecan mRNA in combination with CYT or CYT plus MS using either
primer/probe set. The use of both primer/probe sets revealed that CYT in
combination with the pi integrin function blocking antibody induced a higher level of















22/03/2004 08/03/2004 10/02/2004 x 18/04/2004
X) h- X2 CO
< >- <













































Figure 5.2.5 - Aggrecan mRNA levels detected with primer/probe set 1 following
incubation with a (31 integrin blocking antibody. (I) = Pooled data±SEM.
(II) = Individual experimentalvalues. ML = Unstimulated control.
CYT = Cytokine cocktail stimulation. Betal Ab = (31 integrin function
blocking antibody at lpg/ml. MS = Mechanical stimulation. (n=4). *p<0.05















































































































































Figure 5.2.6 - Aggrecan mRNA levels detected with primer/probe set 2 following
incubation with a (31 integrin blocking antibody. (I) = Pooled data±SEM.
(II) = Individual experimental values. ML = Unstimulated control.
CYT = Cytokine cocktail stimulation. Betal Ab = (31 integrin function
blocking antibody at 1 pg/ml. MS = Mechanical stimulation. (n=4). (paired t
test used)
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5.2.le - Effects ofCYT, MS, IL-4 neutralising antibody and pi integrin function
blocking antibody on pooled aggrecan mRNA values
Aggrecan mRNA levels were detected using primer/probe set 1.
The level of aggrecan mRNA was decreased compared to the unstimulated control at
4 hours following MS, CYT alone and CYT in combination with MS by 44%, 29%
and 23% respectively (p=0.19, p=0.09 and p=0.38) (Figure 5.2.7).
At 12 hours aggrecan mRNA levels were 41%, 55% and 58% lower than the
unstimulated control following MS, CYT alone and CYT in combination with MS
respectively (p=0.21, p=0.0001 and pO.OOOl).
The aggrecan mRNA levels following CYT or CYT plus MS were not altered
following 4 or 12 hour incubation with a monoclonal IL-4 neutralising antibody
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Figure 5.2.7 - Pooled aggrecan mRNA levels detected with primer/probe set 1
following incubation with an IL-4 neutralising antibody or a pi integrin
blocking antibody. (I) = Pooled data±SEM. (II) = Individual experimental
values. ML = Unstimulated control. CYT = Cytokine cocktail stimulation.
Betal Ab = pi integrin function blocking antibody at lpg/ml. IL-4 Ab = IL-4
neutralising antibody at lpg/ml. MS = Mechanical stimulation. ***p<0.001.
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5.2.2 - Effects of IL-ip on aggrecan mRNA levels
5.2.2a - Effects of IL-ip at a range of concentrations on aggrecan mRNA levels
Primary OA HAC were incubated with IL-1 (3 at a range of concentrations and the
effect on aggrecan mRNA levels was evaluated using both primer/probe sets 1 and 2.
Aggrecan mRNA levels were not altered from unstimulated control levels by IL-ip
from 10 to 2500pg/ml at 4 hours using either primer probe set (Figures 5.2.8 and
5.2.9). The exception to this was lOOpg/ml IL-1 (3 stimulation of the sample from
18/04/04, which showed a 2.1 and 1.2 fold increase in aggrecan mRNA levels
compared to the unstimulated control using primer/probes 1 and 2 respectively.
At 12 hours aggrecan mRNA levels were lower than unstimulated levels following
IL-1P incubation from lOpg/ml to 2500pg/ml. Primer probe set 1 showed levels
lower than unstimulated controls of 33%, 47%, 58% and 64% for 10, 100, 500 and
2500pg/ml IL-1P respectively, however these were not statistically significant.
Primer/probe set 2 showed levels lower than unstimulated controls of 41%, 41%, 52%
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Figure 5.2.8 - Aggrecan mRNA levels detected with primer/probe set 1 following
IL-ip stimulation. IL-lp values in pg/ml. TC = Unstimulated control.
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Figure 5.2.9 - Aggrecan mRNA levels detected with primer/probe set 2 following
IL-ip stimulation. TC = Unstimulated control. IL-lp values in pg/ml.
(I) = Pooled data±SEM. (II) = Individual experimental values. (n=3)
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5.2.2b - Effects of IL-ip, MS, IL-4 neutralising antibody and pi integrin
function blocking antibody on aggrecan mRNA levels
The effect of IL-1(3 stimulation (500pg/ml) on aggrecan mRNA levels following
incubation with MS, a monoclonal IL-4 neutralising antibody (lpg/ml) or a pi
integrin function blocking antibody (lpg/ml) was evaluated using both primer/probe
sets 1 and 2 in primary OA HAC.
Aggrecan mRNA levels were 55% and 23% lower at 4 hours and 64% and 33% lower
at 12 hours than the unstimulated control following IL-ip stimulation detected with
primer/probe sets 1 and 2 respectively (p=0.38, p=0.09, p=0.04 and p=0.09) (Figures
5.2.10 and 5.2.11).
Primer/Probe set 1
Primer/probe set 1 (Figure 5.2.10) detected aggrecan mRNA at 17% and 44% lower
levels than in unstimulated controls following IL-ip plus MS at 4 and 12 hours
respectively (p=0.78 and p=0.024). The aggrecan mRNA levels following IL-ip plus
MS were 1.9 and 1.6 fold higher than following IL-1 (3 stimulation alone at 4 and 12
hours respectively (p=0.01 and p=0.24). Incubation with IL-1 p, MS and a (31 integrin
function blocking antibody (lpg/ml) showed aggrecan mRNA levels that are similar
to those following IL-1P stimulation alone at 4 and 12 hours. The aggrecan mRNA
levels following IL-1 (3, MS and a pi integrin function blocking antibody (lpg/ml)
were 55% and 62% lower than those seen following IL-1 p plus MS at 4 and 12 hours,
although these values did not reach statistical significance. Incubation with a
monoclonal IL-4 neutralising antibody (lpg/ml) did not alter the aggrecan mRNA
levels when in combination with IL-ip or IL-ip plus MS compared to those following
IL-1P or IL-1P plus MS alone at 4 or 12 hours. Analysis of the individual
experimental values, however, revealed that the monoclonal IL-4 neutralising
antibody was associated with 1.7 fold higher aggrecan mRNA levels in two samples
when in combination with IL-1P and IL-1P plus MS than following IL-ip or IL-ip
plus MS without antibody at 4 hours.
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Primer/Probe set 2
Primer/probe set 2 (Figure 5.2.11) showed little change in aggrecan mRNA levels
following any of the stimuli at 4 hours. Incubation with IL-ip decreased aggrecan
mRNA levels, although this was not statistically significant (p=0.09). Incubation with
IL-ip plus MS did not cause altered aggrecan mRNA levels compared to IL-ip alone.
Incubation with either a monoclonal IL-4 neutralising antibody or a pi integrin
function blocking antibody did not appear to influence aggrecan mRNA levels.
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(I)
Figure 5.2.10 - Aggrecan mRNA levels detected with primer/probe set 1 following
incubation with IL-1 (3, a monoclonal IL-4 neutralising antibody or a (31 integrin
function blocking antibody. *p<0.05 **p<0.01 (paired t test used).
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. IL-1 = IL-lp stimulation (500pg/ml). Betal Ab = (31
integrin function blocking antibody (lpg/ml). IL-4 Ab = IL-4 neutralising antibody


































































Figure 5.2.11 - Aggrecan mRNA levels detected with primer/probe set 2 following
incubation with IL-ip, a monoclonal IL-4 neutralising antibody or a [31 integrin
function blocking antibody.
(I) = Pooled data±SEM. (II) = Individual experimental values.
ML = Unstimulated control. IL-1 = IL-1 (3 stimulation (500pg/ml). Betal Ab = pi
integrin function blocking antibody (lpg/ml). IL-4 Ab = monoclonal IL-4
neutralising antibody (lpg/ml). MS = Mechanical stimulation. (n=3)
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5.2.3 - Effects of Nitric Oxide (NO) on aggrecan mRNA levels
5.2.3a - Effects of the iNOS Inhibitor AR-C102222 on aggrecan mRNA levels
Aggrecan mRNA levels were detected in primary OA HAC with both primer probe
sets 1 (Figure 5.2.12) and 2 (Figure 5.2.13) following incubation with CYT and 10"4,
10"5 and 10"6M of the iNOS inhibitor AR-C102222.
Primer/Probe set 1
Aggrecan mRNA levels detected with primer/probe set 1 following incubation with
inhibitor alone at 10"4, 10~5 and 10"6M were 23%, 55% and 42% lower than
unstimulated control levels at 4 hours respectively (p=0.32, p=0.04 and p=0.05)
(Figure 5.2.12). The level of aggrecan mRNA following incubation with the inhibitor
at 10"4, 10"5 and 10"6M was not different from unstimulated controls at 12 hours.
Aggrecan mRNA levels were 44% and 23% lower than unstimulated controls
following CYT at 4 and 12 hours respectively (p=0.18 and p=0.29). The inhibitor at
10"4, 10"5 and 10"6M did not influence aggrecan mRNA levels in combination with
CYT at 12 hours.
Primer/Probe set 2
The inhibitor at 10"4, 10° and 10"6M did not change aggrecan mRNA levels from
unstimulated controls at 4 or 12 hours using primer/probe set 2 (Figure 5.2.13).
Aggrecan mRNA levels were 29% and 33% lower at 4 and 12 hours respectively
following CYT than in unstimulated controls (p=0.3 and p=0.02). The inhibitor at 10"
4, 10"5 and 10"6M in combination with CYT does not alter aggrecan mRNA levels
following CYT alone.
Pooled values
The levels detected using primer/probe set 1 were pooled with an earlier study to
allow greater confidence when calculating significance (Figure 5.2.14), These
showed that aggrecan mRNA levels at 4 hours were 33%, 37% and 50% lower
following incubation with the inhibitor at 10"4, 10° and 10"6M respectively (p=0.1,
p=0.09 and p=0.012). The inhibitor at 10"4, 10° and 10"6M also showed 33%, 23%
and 55% lower aggrecan mRNA levels at 12 hours compared to unstimulated
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controls, although statistical significance is not reached. The level of aggrecan
mRNA was 44% and 62% lower than unstimulated controls following CYT
stimulation at 4 and 12 hours (p=0.028 and p=0.07). The inhibitor at 10"4, 10"5 and 10'
6M did not alter aggrecan mRNA levels when in combination with CYT compared to
CYT alone at 4 or 12 hours. The possible exception was 10"5M inhibitor in
combination with CYT, which showed a 1.3 fold increase in aggrecan mRNA levels
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Figure 5.2.12 - Aggrecan mRNA levels detected with primer/probe set 1 following
incubation with CYT and the iNOS inhibitor AR-C102222.
(I) = Pooled data±SEM. (II) = Individual experimental values.
TC = Unstimulated control. CYT and C = Cytokine cocktail stimulation. -4 - 10"4M
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Figure 5.2.13 - Aggrecan mRNA levels detected with primer/probe set 2 following
incubation with CYT and the iNOS inhibitor AR-C102222.
(I) = Pooled data±SEM. (II) = Individual experimental values.
TC = Unstimulated control. CYT and C = Cytokine cocktail stimulation. -4 = 10~4M
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Figure 5.2.14 - Pooled aggrecan mRNA levels detected with primer/probe set 1
following incubation with CYT and the iNOS inhibitor AR-C102222.
(I) = Pooled data±SEM. (II) = Individual experimental values.
TC = Unstimulated control. CYT and C = Cytokine cocktail stimulation. —4 = 10~4M
Inhibitor. -5 = 10°M Inhibitor. -6 = 10"6M Inhibitor. *p<0.05 **p<0.01.
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5.2.3b - Effects of the NO donor SNAP on aggrecan mRNA levels
Primary OA HAC were incubated with the NO donor SNAP at 10-lOOOpM and
aggrecan mRNA levels were detected with primer/probe set 1. Nitrite levels in the
medium were detected using the Griess assay as a measure ofNO released.
The Griess assay showed that incubation with SNAP from 10-lOOOpM increased the
levels of nitrite detected in the medium above unstimulated controls (Figure 5.2.16).
Nitrite levels of 3.4±0.6, 15.8±6.3 and 63.6±2.9pM were detected following
incubation with SNAP concentrations from 10, 100 and lOOOpM at 4 hours (p=0.04,
p=0.13 and p=0.002 respectively). Nitrite levels of 2.3±0.3, 14.8±1.2 and
104.7±23.1pM were detected following incubation with SNAP concentrations from
10, 100 and lOOOpM at 12 hours (p=0.02, p=0.007 and p=0.045 respectively).
Aggecan mRNA levels at 4 hours were not altered from unstimulated control levels
following incubation with SNAP at 10, 100 or 1000pM at 4 or 12 hours (Figure
5.2.15). One exception to this followed lOOOpM SNAP incubation for 12 hours
where aggrecan mRNA levels were 2 fold higher than unstimulated control levels
(p=0.03). Individual experimental values revealed that one sample (DS008/9c)
showed a 3.2 fold elevated aggrecan mRNA level compared to the unstimulated
control, which remained elevated at 100 and 1000gM SNAP. The other two samples
(DS004/8c and 28/6/2003) showed increased aggrecan mRNA levels above control
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Figure 5.2.15 - Aggrecan mRNA levels detected with primer/probe set 1 following
incubation with the NO donor SNAP. TC=Unstimulated control. SNAP values in
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Figure 5.2.16 - Nitrite levels detected by the Griess assay following incubation with
the NO donor SNAP. TC=Unstimulated control. SNAP values in pM. (n=3).
*p<0.05 **p<0.01 (paired t test used).
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5.3 - Discussion of aggrecan mRNA levels following CYT, IL-ip, MS,
iNOS inhibitor and an NO donor
There have been a number of studies which have examined the effects of different
mechanical loads on proteoglycan (PG) synthesis in chondrocytes and cartilage. The
importance of mechanical loading in the maintenance of articular cartilage
homeostasis was highlighted in a study by Behrens et al (1989). The complete
immobilisation of canine legs decreased the levels of PG synthesis, and a cast that
allowed limited motion showed a smaller depression in PG synthesis. The application
of cyclic loads can significantly enhance PG synthesis (Sauerland et al 2003), while
increased magnitude of load and the application of static compression decreases the
level of PG synthesis (Wong et al 1999).
The possible involvement ofNO and mechanical strain in the regulation of PG
synthesis has been addressed in several studies (Chapter 1). Aggrecan is the major
PG in cartilage, so it is likely that any changes in total PG synthesis involve
alterations in the production of this molecule. This, however, is not necessarily the
case and some studies have therefore investigated the effect mechanical stimulation
has on aggrecan mRNA levels (Table 5.1). These show that cyclically applied load
generally increases aggrecan mRNA levels. Short term static loads initially increase
aggrecan mRNA whereas longer term static loading decreases aggrecan mRNA
levels.
Taqman real-time PCR analysis of primary OA HAC revealed that mRNA for
aggrecan could be detected using two separate primer/probe sets. The two
primer/probe sets detect the same molecule within these experiments from the same
samples. Although they do generally show similar trends, slight differences are seen
between the two that are likely to be due to differences in efficiency of detection.
Exposure of these cells to mechanical strain alone, CYT, IL-ip and MS in
combination with CYT or IL-lp caused a decrease in the level of aggrecan mRNA
when compared to unstimulated controls.
Addition of the pi integrin function blocking antibody alone was associated with
increases in aggrecan mRNA levels of 3.1 and 2.8 fold using primer/probe sets 1 and
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2. This suggests that the antibody may have some independent effect on aggrecan
mRNA levels. However the result comes from a single experiment. Neither the (31
integrin function blocking antibody or the monoclonal IL-4 neutralising antibody
appeared to influence the decreased aggrecan mRNA levels following CYT
stimulation.
The sample labelled 22/3/04 (Figures 5.2.5 and 5.2.6) and the sample labelled
18/4/04 (Figures 5.2.8 and 5.2.9) showed different responses to the application of
cytokines and mechanical load than the others under the same conditions. Many
factors can influence the cells from a particular sample including the site the cartilage
is taken from, as well as the age and gender of the donor. An example of this is the
difference in PG synthesis seen following cyclic loading of equine chondrocytes from
high and low load bearing areas of the same joint (Wiseman et al 2003).
There are two studies which have looked at aggrecan mRNA levels following tensile
strain which are similar to that used in our system (Lahiji et al 2004; Xu et al 2000).
Lahiji et al (2004) showed that OA human articular chondrocytes in monolayer
subjected to 24 hours cyclic tensile strain had increased aggrecan mRNA levels, a
response not seen in our study. Xu et al (2000) used normal rabbit articular
chondrocytes in monolayer and showed that the load alone slightly decreased PG
synthesis, however no effect on aggrecan mRNA was seen at 4, 24 and 48 hours. This
supports our findings where MS did not cause increased aggrecan mRNA levels,
actually slightly decreasing them, at 4 and 12 hours. Millward-Sadler et al (2000b)
also showed that no alteration in aggrecan mRNA levels were seen due to 0.33Hz MS
in OA HAC, although increased aggrecan mRNA was seen in normal HAC.
Chowdhury et al (2004) showed increased PG synthesis due to mechanical strain in
primary human chondrocytes in agarose constructs, with strain acting through an
integrin dependent mechanism. Several studies have shown that strain influences
aggrecan mRNA levels in bovine chondrocytes (Table 5.1). Lee MS et al (2003a and
2003b) also used OA human articular chondrocytes in monolayer, showing alterations
in aggrecan mRNA levels due to both constant shear stress and intermittent
hydrostatic pressure.
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Several studies, including our own, have shown decreased aggrecan mRNA levels
associated with the action of proinflammatory cytokines, which are known to induce
NO (Table 5.1). There are several mechanisms by which NO could potentially
influence the level of PG synthesis.
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Mechanisms by which NO can influence proteoglycan synthesis
The increased PG synthesis due to mechanical stimulation (Table 5.1 and 5.2) could
be disrupted by NO through its interaction with mechanical signalling pathway
molecules. The prevention of focal adhesion kinase (FAK) recruitment to the focal
adhesion complex (FAC) (Clancy et al 1997) and FAC disruption by NO in bovine
chondrocytes without influencing integrin expression, distribution or attachment to Fn
(Clancy et al 1997) will influence mechanical signalling. The actin cytoskeleton is
important in bringing signalling molecules to the FAC and so allowing interactions
resulting in signal transduction. Inhibition of actin polymerisation through NO
mediated ADP-ribosylation (Clancy et al 1995) prevents the anchorage of these
molecules near to the FAC. The application of cyclic stretch has been shown to
activate extracellular regulated kinase (ERK) 1/2, c-Jun NH2 terminal kinase (JNK)
and p38 mitogen activated protein kinase (MAPK) (Ingram et al 2000b; Ingram et al
2000c; Ingram et al 2000d) in mesangial cells. NO donors such as SNAP inhibit this
activation and prevent the downstream activation of the transcription factors AP-1 and
NFkB. MAPK activation requires an intact actin cytoskeleton, and it may be through
inhibition of cytoskeletal assembly that NO is having its effect. Zhou et al (our lab -
submitted for publication) showed inhibition of the upregulation of PG synthesis
following MS by the MAPK inhibitor SB203580 in transformed chondrocyte cell
lines. SNAP also decreases protein kinase c (PKC) activity, a response that requires
an intact cytoskeleton, the very structure it is shown to disrupt (Gopalakrishna et al
1993; Kim et al 2003; Kim and Chun 2003). Xu et al (2000) suggested that
preincubation with cytokine inhibits the decreased iNOS mRNA and nitrite following
simultaneous strain and cytokine in rabbit chondrocytes. This may be due to the fact
that NO disrupts the mechanical signalling pathways before strain is applied, with the
strain being sensed at a quicker rate than cytokine signalling can occur. This suggests
that the simultaneous application of strain and CYT in our system allows strain to
exert its effects on cytokine signalling before NO can cause disruption.
The regulation of PG synthesis levels may also be explained by the action ofNO on
insulin-like growth factor (IGF-1) signalling. NO from various sources, including
SNAP and IL-ip, decrease PG synthesis associated with the incubation of
chondrocytes with IGF-1 (Studer et al 2000). This was shown to be mediated through
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the reaction ofNO with the sulfhydryl groups on the cysteines of the IGF-1 receptor
kinase, forming s-nitrosothiols that may cause functional modification, preventing
receptor autophosphorylation and so inhibiting downstream signalling (Studer 2004).
Indeed, decreasing the intracellular NO regulator, glutathione, increases the effect of
NO on preventing IGF-1 mediated PG synthesis. So by inhibiting the signalling and
action of growth factors NO may decrease the level of PG synthesis. The use of iNOS
knockout mice have highlighted the importance ofNO in decreased PG synthesis due
to IGF-1, where the knockouts respond by increased PG synthesis in an almost normal
fashion (van den Berg et al 1999).
NO can also have effects on PG levels through promoting its degradation. This can
be mediated through influencing the activity of the proinflammatory transcription
factor NFkB. This has been shown to occur via the redox derivatives ofNO, where
peroxynitrite production promotes NFkB activation through sustaining p65 nuclear
translocation, whereas S-nitrocysteine inhibits NFkB in bovine chondrocytes
stimulated with a proinflammatory cytokine mix (Clancy et al 2004). Agarwal et al
(2001) showed that cyclic tensile strain prevented the inhibition of PG synthesis
caused by IL-ip in rabbit temparomandibular junction chondrocytes in monolayer
culture. A later study (Agarwal et al 2004) applied both low (4-8%) and high (15-
18%) cyclic tensile strain to these cells, showing that differential strain regimen can
either inhibit (low) or mimic (high) the effects of IL-1 (3 by inhibiting (Low) and
activating (high) the transcription factor NFkB. Van't Hof et al (2000) showed iNOS
KO mice had defects in bone resorption due to IL-1P, with abnormalities in IL-1P
induced NFkB p65 subunit nuclear translocation and DNA binding which were
reversed by treatment with SNAP.
Tomita et al (2001) showed rabbit chondrocyte respiration and ATP synthesis were
inhibited by NO, particularly in low oxygen conditions similar to those seen in
cartilage, with the presence ofNO or specific mitochondrial electron transport
inhibitors decreasing PG synthesis. Johnson et al (2000) showed NO and
peroxynitrite donors decrease respiration and ATP generation in chondrocytes, with
mitochondrial oxidative phosphorylation inhibitors decreasing PG synthesis.
Stefanovic-Racic et al (1994) showed rabbit articular chondrocytes plus IL-ip
produce NO and lactate, with decreased ATP levels. L-NMA, an iNOS inhibitor,
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blunts the glycolytic response while SNAP, an NO donor, increased lactate to the
same extent as IL-ip. PG synthesis rates are therefore influenced by the action of
NO, in part through regulation of intracellular ATP concentration and may be
influenced by changes in pericellular pH due to lactate production.
There are therefore several ways in which NO may interfere with PG synthesis in
chondrocytes. Mechanical stimulation decreases the production of iNOS mRNA,
protein and nitrite following CYT and IL-1 (3 stimulation in our study (Chapter 4). It
is possible that mechanical strain may regulate PG synthesis through its control of the
production ofNO. Indeed, the simultaneous application of mechanical strain and
cytokine stimulation has been shown to reverse the decrease in PG synthesis (Table
1.4) and aggrecan mRNA (Table 5.1) caused by proinflammatory cytokines. It would
have been reasonable, therefore, to suggest that through the decrease ofNO
production, mechanical strain should allow some recovery of the aggrecan mRNA
levels towards those seen in unstimulated cells. Our study, however, shows no such
recovery in aggrecan mRNA following the simultaneous application ofCYT plus MS
or IL-1P plus MS.
It is possible that alterations in aggrecan mRNA may actually be missed due to the
length of time that strain is applied, as a study by Millward-Sadler et al (2000b)
showed that alteration occurred within the first hour following the application of
mechanical strain for twenty minutes, and were back to unstimulated levels by 3
hours. It is also possible that the fact that these cells come from OA cartilage means
an altered response to mechanical stimulation that does not involve changes in
aggrecan mRNA levels. Indeed, no changes were seen in aggrecan mRNA levels in
the OA chondrocytes studied by Millward-Sadler et al (2000b). However, the
application of intermittent hydrostatic pressure to monolayer OA human chondrocytes
in a separate study showed a reversal of lipopolysaccharide (LPS) induced decreased
aggrecan mRNA levels after 4 hours (Lee MS et al 2003a) and decreased aggrecan
mRNA due to shear stress was reversed by the NO inhibitor L-NMA (Lee MS et al
2002).
The application of cyclic strain, as mentioned, is generally anabolic and causes
increases in matrix synthesis. However, if the magnitude of strain or the cyclic
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pattern is too great and does not allow recovery of the cell before the next cycle it
begins to function as a negative factor. The application of a static strain for a short
period of time (30 minutes) increases aggrecan mRNA, while longer times (4 hours)
lead to decreases (Ragan et al 1999). It must be considered, therefore, that the
application of strain using our system (0.33Hz - 2 seconds ON, 1 second OFF), which
appears to be anabolic after 20 minutes (Millward-Sadler et al 2000b) may be acting
as a negative factor which is seen at 4 and 12 hours. The slight decrease in aggrecan
mRNA due to strain alone supports this, however, the decrease would be expected to
be greater and accompanied by elevation in NO levels (Lee MS et al 2002). Reversal
of iNOS mRNA, protein and nitrite levels due to our strain regimen (chapter 4) is in
conflict with this and suggests the strain is acting in an anabolic fashion.
It must also be remembered that these results are drawn directly from mRNA studies
without looking at protein levels. It is possible that increased aggrecan mRNA
synthesis occurs, but increased degradation also occurs so showing little alteration of
the aggrecan mRNA levels. Although mRNA studies can be indicative of events
occurring at the protein level, it is the proteins that are secreted and become part of the
ECM so are ultimately the important molecules to monitor. Two of the studies
discussed above looked at the level of aggrecan protein bound to the cell surface and
found increases due to intermittent hydrostatic pressure in monolayer human OA
chondrocytes (Ikenoue et al 2003) and bovine monolayer chondrocytes (Smith et al
1996). However, the decrease in the level of cell associated aggrecan due to cytokine
induced NO and potential restoration by the application of mechanical stimulation
remains to be studied.
Decreases in synthesis of aggrecan can be difficult to monitor. However the
breakdown products associated with aggrecan catabolism can be detected and NO is
believed to inhibit this breakdown, possibly via the modulation of aggrecanase
activity (Bird et al 2000; Cai et al 2002). IL-ip causes increased MMP production in
chondrocytes and NOS inhibitors have been shown to increase MMP activity
associated with IL-ip stimulation (Stefanovic-Racic et al 1997). This suggests that
NO may not only function as a negative regulatory element in the synthesis of PGs,
but may also act to prevent PG breakdown by MMPs.
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The fact that NO may act as an inhibitor of PG degradation suggests that mechanical
stimulation, through the decrease ofNO, may act to reverse the inhibition of PG
synthesis caused by CYT, but may also increase the rate of degradation so resulting in
the lower aggrecan mRNA levels than detected in unstimulated controls.
The use of the CYT or IL-ip stimulation have been shown to induce iNOS synthesis
and NO production, however, there is potential for these molecules to interfere with
PG levels in an NO independent fashion (Taskiran et al 1994). The effect ofNO on
the aggrecan mRNA levels was therefore studied using several strategies including the
inhibition of iNOS activity and the application of an NO donor.
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The use of iNOS inhibitors has allowed the study of the role ofNO in both the
synthesis and degradation of PGs. Hauselmann et al (1994) used the NOS inhibitor L-
NMA, and the NO donor SNAP, to show that NO was partially responsible for IL-ip
mediated decreases in PG synthesis in human articular chondrocytes in alginate
culture. Lee DA et al (1998) used NOS inhibitors (L-NAME and Dexamethasone) to
show that NO partially inhibited PG synthesis in bovine chondrocytes seeded in
agarose. The same group (Chowdhury et al 2001; Chowdhury et al 2003) has since
shown that the iNOS inhibitor L-NIO inhibited increased PG synthesis following
cyclic compressive loading. Liu et al (2001) used L-NMA to show that NO inhibited
increases in PG in response to low hydrostatic pressure and was involved in decreased
PG due to high hydrostatic pressure in human lumbar disc cubes. Gassner et al
(2000), using cyclic tensile strain similar to that used in our system, showed that L-
NMA partially restored the inhibition of PG synthesis associated with IL-ip in
monolayer rabbit chondrocytes. The only study to show the role ofNO in the control
of aggrecan (Lee MS et al 2002) used L-NMA to show shear stress induced NO was
responsible for decreased aggrecan mRNA levels. An in vivo study (Presle et al 1999)
showed that IL-ip injections into rat knee caused increased NO leading to decreased
PG synthesis. The iNOS inhibitors L-NMA and L-NIO decreased NO production and
partially restored PG synthesis.
Stefanovic-Racic et al (1997) showed that in rabbit cartilage shavings IL-lp led to
decreased PG synthesis and increased degradation. NOS inhibition with L-NMA and
thiocitrulline reversed the effects on PG synthesis, but increased degradation by
collagenase, stromelysin and gelatinase (MMP) activation. The same group found
similar results in bovine cartilage slices (Stefanocvic-Racic et al 1996) and primary
human chondrocytes (Hauselmann et al 1998). This suggests that NO can also have
protective effects through prevention of cartilage degradation.
In our study with the iNOS inhibitor (ARC-102222) where data from primer/probe set
1 was pooled (Figure 5.2.14) showed that the inhibitor itself appeared to slightly
reduce aggrecan mRNA levels compared to the unstimulated control at both 4 and 12
hours. The slight decrease due to inhibitor alone suggests that it is interfering with
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mRNA synthesis in some way. This is supported by the fact that the highest
concentration of the inhibitor, 10"4M, also lowered iNOS mRNA levels (chapter 4). It
may therefore be acting by an NO independent, non-specific inhibition of gene
transcription. However, GAPDH levels remain unaffected, suggesting that there may
be a specific mechanism through which the inhibitor could be acting, such as through
the inhibition of action of another enzyme involved in mechanical or cytokine
signalling. It is possible that, despite the lack of detection ofNO without cytokine
stimulation, some basal production occurs that may be blocked by the inhibitor. This
would, however, be expected to cause a slight increase in the levels detected rather
than the decrease seen, suggesting some other mechanism of action is more likely.
Significant reduction in aggrecan mRNA levels follows the addition ofCYT, and the
simultaneous addition ofCYT and inhibitor have no significant effect on these levels.
The inhibitor was shown in Chapter 4 to decrease iNOS nitrite levels, and as
discussed above, NO is involved in the decrease in proteoglycan and aggrecan mRNA
due to LPS and IL-ip stimulation. This would suggest that the inhibitor, through its
inhibition ofNO production, can prevent the action of the cytokine mix in decreasing
aggrecan mRNA levels. These alterations in aggrecan mRNA levels are, however,
not seen which suggests that the cytokine mix is acting independently ofNO to
decrease aggrecan mRNA levels. It is also possible that the decreased NO production
in these experiments could have a dual effect on aggrecan mRNA levels. The
decrease in NO would restore aggrecan mRNA synthesis to unstimulated controls, but
it would also interfere with the inhibitory effect ofNO on cytokine mediated
proteoglycan degradation that may lower aggrecan mRNA levels.
In future experiments levels of aggrecan mRNA following IL-ip stimulation alone in
the presence of the inhibitor should be undertaken. It is possible that in these
circumstances a reversal of the decrease in aggrecan mRNA could be demonstrated.
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NO donor S-Nitroso-N-acetylpenicillamine (SNAP)
Although the iNOS inhibitor did inhibit NO production (Chapter 4) it did not prevent
the effects of the cytokines on PG levels. Thus the effect ofNO could be masked by
an NO independent decrease in aggrecan mRNA. In order to determine the effects of
NO alone an NO donor was used.
Several studies have looked at the effect ofNO donors on PG synthesis.
Hauselmann et al (1994) showed that SNAP mimicked the effects of IL-1 p, causing
decreased PG synthesis in human articular chondrocytes cultured in alginate. Lee MS
et al 2003b) showed that the NO donor sodium nitroprusside (SNP) decreased
aggrecan mRNA by 30-40%. Taskiran et al (1994) showed that SNAP mimicked the
effect of IL-1 P, decreasing PG synthesis in slices of rabbit cartilage. Liu et al (2001)
showed that SNAP increased NO and decreased PG synthesis. Two studies by Studer
et al (Studer et al 2000; Studer et al 2004) looked at the effects ofNO on IGF-1
mediated increases in PG synthesis and showed that the NO donors SNAP, NOC-7
and DETA-NONOate inhibit PG synthesis through prevention of IGF receptor kinase
auto and substrate phosphorylation. The iNOS inhibitor L-NMA restored the
decrease in PG induced by IL-1 p. The NO donor glycerol trinitrate (nitroglycerin)
also implicates NO in PG depletion, causing reduced PG within the articular cartilage
of sheep in vivo (Cake et al 2003).
There are a number ofNO donors that have been produced and are commercially
available. These each have different properties that allow the release ofNO at
different rates. SNAP is an NO donor that spontaneously releases NO upon
solubilisation in aqueous buffers with a half-life of 10 hours (SIGMA data sheet).
This makes it ideal for use in our system, where the effects ofNO at 4 and 12 hours
are being studied. However, the biological half-life is decreased due to a rise in pH or
the presence ofmetal ions, particularly copper and iron, increasing the decomposition
rate (Askew et al 1995). Within our system SNAP will be exposed to metal ions
through the opening of ion channels in response to mechanical strain, however these
are potassium, calcium and sodium, not copper and iron (Millward-Sadler et al
2000a). The production ofNO may also lead to the altered production of energy by
the cell, causing lactate production that will alter the pH (Stefanovic-Racic et al
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1994). Indeed SNAP increased lactate production to the same extent as IL-ip, and so
could potentially induce an increase in its own generation ofNO. Therefore it is
possible that in our system SNAP could generate NO more quickly than might be
initially expected.
SNAP addition led to large increases in the level of nitrite detected in the medium,
suggesting that NO release does occur. This production was seen at 4 hours and not
greatly increased at 12 hours at the lower concentrations, suggesting early release of
NO compared to that seen following CYT stimulation, where significant levels are
detected only at 12 hours. This may be important as any change due to NO may occur
at a much earlier stage than that following CYT, and so may be missed at the time
points measured. Indeed, this may be the case as the level of aggrecan mRNA does
not alter following SNAP addition at 4 or 12 hours, with the exception of a slight
increase at the highest concentration (lOOOpM). The level of nitrite detected at this
concentration of SNAP is far in excess of that seen following CYT, and would be
expected to cause reduction in aggrecan mRNA levels. The reason for this small
elevation in aggrecan mRNA levels at 12 hours is unclear, with no response seen at 4
hours. It may be important to note that only small increases were seen in 2 of the
samples, whereas one sample (28/6/03) showed a greater increase. This sample
showed higher levels ofNO release due to SNAP at the highest concentration, which
might affect aggrecan mRNA. Potential interaction ofNO with other molecules
within the cell can not be ruled out. Chenevier-Gobeaux et al (2004) showed that
SNAP causes increased hyaluronic acid at 12 hours with little response seen at 6
hours in synovial cells from rheumatoid arthritis patients. The higher concentrations
(0.1 and ImM) induced a greater increase than O.OlmM.
It must also be considered, however, that NO may actually have no effect on the level
of aggrecan mRNA within our system.
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5.4 - Conclusion
Decreased CYT and IL-ip stimulated iNOS mRNA, protein and nitrite have been
demonstrated following MS in these studies (Chapter 4). The addition ofCYT and
IL-ip decreased the level of aggrecan mRNA detected. The studies have employed
mechanical stimulation, an iNOS inhibitor and an NO donor to determine the role of
NO on aggrecan mRNA levels. The use of iNOS inhibitors and NO donors by others
(Bird et al 2002; Chowdhury et al 2001; Chowdhury et al 2003; Gassner et al 2000;
Lee DA et al 1998; Liu et al 2001) has demonstrated the involvement ofNO in the
decreased PG synthesis due to proinflammatory molecule stimulation. Only one other
group has however shown the same response in aggrecan mRNA using SNP (Lee MS
et al 2003b) and L-NMA (Lee MS et al 2002) in primary OA human articular
chondrocytes cultured in monolayer (Table 5.1). Given the evidence suggesting a
role for NO in decreasing PG levels it would have been expected that, through the
decrease ofNO production, MS should allow the aggrecan mRNA levels to return to
unstimulated levels. This, however, was not the case and no return towards
unstimulated levels was seen following the simultaneous addition ofCYT and MS or
IL-ip and MS. The possibility for NO independent effects of the cytokines and MS
led to further studies to determine the effects ofNO on aggrecan mRNA levels. The
use of a novel iNOS inhibitor showed efficacy in decreasing the level ofNO produced
(Chapter 4). However little effect was seen on the decreased aggrecan mRNA levels
following CYT stimulation. The NO donor SNAP was used to determine the effects
ofNO on aggrecan mRNA levels alone, but no decrease was seen. The possible
reasons for the lack of response to altered NO levels have been discussed.
Despite all the evidence suggesting a role for NO in PG degradation, the possibility
that NO may not be involved in degradation in our system must be considered.
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NO-Independent Mechanisms for Decreasing Proteoglycan Synthesis
Inflammatory cytokine stimulation may reduce aggrecan mRNA levels through
decreased mRNA transcription, by increased mRNA degradation or by alteration in
mRNA stability.
Separation of deep and superficial chondrocytes has suggested that deep cell
proteoglycan synthesis is influenced by an NO mechanism alone, whilst superficial
cells show IL-lp suppressed proteoglycan synthesis in both an NO-dependent and
independent fashion (Chowdhury et al 2003; Hauselmann et al 1998). A similar
situation is seen in the inhibition of proteoglycan by IL-lp where NOS inhibitors
partially reverse IL-ip induced decreases in proteoglycan synthesis (Taskiran et al
1994) and NO donors partially decrease PG synthesis but not to the levels seen for IL-
1P (Oh et al 1998). These studies suggest an NO-independent action. However no
mechanism for this has been elucidated. Partial reversal may also occur through the
incomplete inhibition ofNO production, allowing NO to have residual effects.
It is possible that the environment within the chondrocytes steers the activity ofNO in
a particular direction. Molecules such as glutathione, which mops up NO, could bind
it and prevent its effects within the cell. If this were indeed the case detectable NO
levels would be reduced as less would accumulate in the medium, as seen at 4 hours
in our experiments. However, detectable levels at 12 hours suggest that any effects
would simply delay NO reduction of PG. The simultaneous production of the
superoxide radical (O2") and NO has been shown to be required for IL-ip to inhibit
PG synthesis, suggesting a role for peroxynitrite (Oh et al 1998). It may be that O2" is
not produced in our system, so NO does not affect proteoglycan synthesis. The
presence of superoxide dismutase (SOD) may be important, as this enzyme scavenges
oxygen free radicals and so may influence the levels of O2" available for reaction with
NO (Zhang and Rosenberg 2002).
It is also important to consider the effects ofmechanical strain on cells independent of
its action on NO. Changes in cytoskeletal organisation, cell shape and nuclear
diameter were seen due to compressive strain of bovine chondrocytes in agarose
constructs (Lee DA et al 2000). High hydrostatic pressure disrupts the cytoskeletal
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network (Parkkinen et al 1995) and Golgi complex (Parkkinen et al 1993). Constant
high hydrostatic pressure decreases aggrecan mRNA and proteoglycan synthesis
(Lammi et al 1994) and effects on cell shape, intracellular transport and protein
modification may account for some of its inhibitory effect on proteoglycan synthesis.
Indeed, excessive mechanical load effects the MMP/TIMP ratio and the expression of
IL-1 (3 and TNFa, and so influences cartilage metabolism (Honda et al 2000).
Summary of findings
Aggrecan mRNA levels are reduced by both CYT and IL-1P
stimulation.
The lower levels ofCYT induced NO seen following mechanical
stimulation or incubation with the iNOS inhibitor did not restore CYT
mediated decreases in aggrecan mRNA levels.
The NO donor SNAP did not alter aggrecan mRNA levels.
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Chapter 6 - Conclusions and general discussion
(I) The transformed chondrocyte cell lines C20A4 and C28I2 show detectable
levels of e, n and iNOS mRNA, but do not produce NOS isoform protein or
nitrite.
(II) Primary osteoarthritic human articular chondrocytes produce e, n and iNOS
mRNA, however no e or nNOS protein is detected.
(III) Primary osteoarthritic human articular chondrocytes produce iNOS mRNA,
protein and nitrite following stimulation with a proinflammatory cytokine
cocktail or IL-ip alone.
(IV) The application ofmechanical stimulation (0.33Hz, 30,000pstrain) reduces the
level of iNOS seen following CYT or IL-ip stimulation. This decrease
occurs through a pi integrin and IL-4 independent mechanism.
(V) A novel iNOS inhibitor, AR-C102222, inhibits iNOS enzyme activity without
affecting its mRNA or protein expression.
(VI) Aggrecan mRNA levels are reduced by both CYT and IL-1 p stimulation.
(VII) The lower levels ofCYT induced NO seen following mechanical stimulation
or incubation with the iNOS inhibitor did not restore CYT mediated decreases
in aggrecan mRNA levels.
(VIII) The NO donor SNAP did not alter aggrecan mRNA levels.
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The chondrocyte can sense and respond to mechanical signals through its attachment
to the extracellular matrix (ECM) causing the altered synthesis and turnover ofECM
molecules. The importance of this interaction is seen as the loss ofECM contact
results in cell death. The extracellular environment and the mechanical stimuli the
cells are exposed to are altered in osteoarthritis (OA), possibly contributing to the
degeneration of articular cartilage. Understanding the response of cells from OA
tissue to mechanical signals may point to novel targets for the development
therapeutic strategies for the treatment ofOA.
The avascular, aneural and alymphatic structure of articular cartilage requires that
molecules enter the tissue by diffusion, a process which is enhanced during the
movement ofwater which accompanies the application of load to the tissue. As
chondrocytes are the only cell type in cartilage and are sparsely distributed they must
communicate through the release of soluble mediators. The detection of molecules
such as growth factors and cytokines by the chondrocytes alters their gene expression
patterns and so influences the regulation of cartilage homeostasis. The concentrations
of proinflammatory molecules are enhanced in OA, causing an imbalance between
matrix synthesis and degradation that disrupts cartilage homeostasis and results in
cartilage breakdown and OA progression. The inhibition of the action of these
proinflammatory molecules has been highlighted as a mechanism through which the
progression ofOA could be prevented.
This study has investigated the interaction between two important regulators of
chondrocyte function; mechanical signalling and cytokine signalling.
The transformed human chondrocyte cell lines C20A4 and C28I2 did not produce
detectable levels of endothelial (e), neuronal (n) or inducible (i) nitric oxide synthase
(NOS) protein. NOS isoform protein and enzyme activity was not detected following
4 or 12 hour stimulation with a proinflammatory cytokine cocktail (CYT) or
mechanical stimulation (0.33Elz, 30,000|istrain) (MS). NOS isoform mRNA was
detected, however this was carried out on a single occasion preventing any analysis of
variation in the levels detected. The lack of detectable NOS protein or enzyme
activity, however, suggests that there are alterations in the signal transduction
pathways or alterations in protein production at some stage from mRNA stabilisation
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to protein synthesis and degradation. The fact that these cells are virally transformed
and de-differentiation in some respects following their long term culture in monolayer
are possible reasons for their lack of response.
Primary osteoarthritic human articular chondrocytes (HAC) did not produce NOS
isoform protein or show enzyme activity when unstimulated despite the
proinflammatory rich in vivo environment from which they were isolated. CYT
stimulation and IL-ip alone significantly increased iNOS mRNA, protein and nitrite
levels. The application of simultaneous CYT and MS resulted in levels of iNOS
mRNA, protein and nitrite that were elevated above unstimulated controls, but were
significantly lower than following CYT alone. While previous studies have shown a
reversal of single cytokine induced NO (both IL-1 P and TNFa), this is the first study
to show mechanical stimulation reverses iNOS levels induced by a proinflammatory
cytokine mix of IL-1 p, TNFa, IL-6 and IFNy. The level of iNOS mRNA, protein and
nitrite is similar when using the cytokine mix or IL-ip alone which suggests the IL-lp
may be the main inducer of iNOS in this system. The stimulation of iNOS in
chondrocytes has been shown using IL-ip and TNFa alone while the other cytokines
in the mix, IFNy and IL-6, do not stimulate iNOS alone but enhance its induction by
IL-lp and TNFa. It may therefore be that maximal iNOS stimulation can be achieved
by CYT or by IL-ip alone. The reversal of CYT induced iNOS levels suggests that
the application of MS may be interfering with the CYT induced signal transduction
pathways that lead to elevated iNOS. This could be mediated through either an iNOS
specific action or a more general interference in cytokine signalling. It would be of
interest to look individually at each of the cytokines and their effects on iNOS
induction as well as the effect of mechanical strain in each case. This would allow
more detailed identification of the effects of each of the cytokines as well as those
influenced by MS.
MS has been shown to induce membrane depolarisation in OA chondrocytes through
a mechanism that involves the autocrine/paracrine production of the cytokine IL-4,
IL-ip and a5pi integrin (Millward-Sadler et al 2000a). The close association that has
been described between the integrin-mediated mechanical signalling molecules and
cytokine receptors provides a possible mechanism for signalling interactions (Lo et al
1998). An IL-4 neutralising antibody and a pi integrin function blocking antibody
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were used to investigate possible mechanisms by which MS was interfering with
CYT-induced iNOS production. These studies demonstrated that MS is acting
through a (31 integrin and IL-4 independent pathway to decrease CYT induced iNOS.
The question which then has to be addressed is 'How are the mechanical signals
interfering with CYT induced iNOS?'. There are other receptors on the surface of the
chondrocyte that may be involved in the sensing of these mechanical signals,
including other integrins (Loeser et al 1995) and CD44 (Knudson and Loeser 2002).
The activation of transmembrane ion channels following mechanical stimulation has
been described (Wright et al 1996). It is possible that these channels could cause a
widespread alteration in the activation of signalling molecules within the cell. It is
also possible that through the control of intracellular pH these channels could alter the
activity of the NOS enzyme (Conte 2003). This could account for the decreased
nitrite detected in our studies, but not the decreased iNOS mRNA and protein levels.
The phosphorylation and activation of signalling molecules, particularly the mitogen
activated protein kinases (MAPK), protein kinase C (PKC) and integrin-linked kinase
(ILK), are involved in both CYT and mechanical signalling pathways. It is possible
that, through alterations in the activation pattern of these molecules, MS could
interfere with CYT induced iNOS. Another molecule that is important in CYT
induced iNOS production is the transcription factor NFkB. This has been shown to be
influenced by mechanical strain (Agarwal et al 2004) and may represent a mechanism
by which MS can interfere with CYT induced iNOS. Indeed, two of the
proinflammatory cytokines that can induce iNOS, IL-1(3 and TNFa, can also stimulate
NFkB activation, and NFkB is an important molecule in the induction of iNOS
mRNA synthesis. It may however be that these pathways do not interact, but rather
that they both produce molecules that bind the iNOS promoter, which has multiple
control elements, and that the combined effects of these result in the lower level of
iNOS production following simultaneous CYT and MS than following CYT alone.
The inhibition of cell surface molecules that sense mechanical signals, or any of the
molecules potentially involved in intracellular signalling would allow identification of
the mechanism through which mechanical strain is acting to decrease CYT-induced
iNOS levels. Stimulation with single cytokines would allow a better determination of
this effect.
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As previously mentioned, chondrocytes are responsible for the maintenance of
cartilage matrix homeostasis. This involves the synthesis and degradation of
molecules important to the structure of cartilage including the proteoglycans (PG).
Proinflammatory cytokines have been implicated in the alteration of proteoglycan
synthesis, with the production ofNO suggested by several groups as a mechanism
through which this may occur. The production ofNO has been implicated in the
progression of osteoarthritis, with detectable levels found in human OA and inhibitors
shown to have beneficial effects in animal models. The effects ofNO, however, have
been shown to be complicated. In addition to being able to decrease the synthesis of
proteoglycans, NO also inhibits the activation ofmatrix degrading enzymes.
Mechanical loads of a physiological magnitude and frequency increase PG synthesis.
However, static loads and excessive magnitudes or frequencies can lead to decreased
proteoglycan synthesis.
Both cytokine and mechanical signals alter matrix homeostasis by influencing
proteoglycan synthesis and degradation. The production of iNOS due to CYT
stimulation and the interference by MS in our system led to the investigation of the
possible role ofNO on the major proteoglycan in cartilage, aggrecan. Aggrecan
mRNA levels were studied using mechanical stimulation, an iNOS inhibitor and an
NO donor. Several studies have shown that cyclical strain reverses both cytokine
induced NO levels and the decreased aggrecan mRNA levels associated with IL-lp
and LPS. However, a link between these has only been shown by one group
previously. They initially used the iNOS inhibitor L-NMA to show reversal of shear
stress-induced decreased aggrecan mRNA levels, and then demonstrated that the NO
donor sodium nitroprusside decreased aggrecan mRNA levels (Lee MS et al 2002,
Lee MS et al 2003b).
Following CYT stimulation aggrecan mRNA levels were decreased in our study. The
evidence that suggests NO inhibits PG synthesis, along with the fact that mechanical
stimulation decreases the NO levels associated with CYT, led to the theory that
mechanical stimulation may reverse the decreased aggrecan mRNA levels following
CYT stimulation. This was not seen, however, suggesting that the CYT may be
acting in an NO-independent fashion to decrease PG synthesis. It may be that the
individual cytokines in the cytokine mix are having several independent effects on
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aggrecan mRNA levels. Mechanical stimulation did show some reversal of the IL-ip
mediated decrease in aggrecan mRNA levels, but this was seen using only one of the
two primer/probe sets and did not reach statistical significance. This suggests that it
may be important to investigate the effects of each of the cytokines individually. The
potential complications of using a the cytokine mix are highlighted in previous studies
which demonstrated that IL-6 (Legendre 278, 2903 2003), IFNy and TNFa (Dodge
41, 274 1998), as well as IL-ip (Xu 2000) all decreased aggrecan mRNA levels, with
NO only implicated in the IL-ip mediated decrease. It is possible, therefore, that the
decreased NO due to mechanical strain does partially reverse the IL-lp mediated
decrease in aggrecan mRNA levels but the other cytokines act to keep the levels
below that seen in unstimulated cells. Investigation of the effects of each of the
cytokines individually and the influence ofMS would allow a better understanding of
the role each plays in regulating aggrecan mRNA levels. It is also important to
consider that mechanical stimulation itself can result in structural changes within the
cell, disrupting the cytoskeleton and golgi and so influence proteoglycan synthesis.
The experiments reported in this thesis only measure the level of aggrecan mRNA,
and not the rate of synthesis or degradation. It has been shown that NO may act as an
inhibitor of PG degradation as well as causing decreased PG synthesis. By decreasing
NO levels, mechanical strain may act to reverse the inhibition of PG synthesis caused
by CYT, but may also increase the rate of degradation resulting in aggrecan mRNA
levels remaining lower than unstimulated controls.
The iNOS inhibitor, AR-C102222, was initially shown to have little effect on iNOS
mRNA or protein levels but showed a dose dependent decrease in iNOS enzyme
activity associated with CYT stimulation. The use of iNOS inhibitors has previously
been reported to reverse the decreased proteoglycan synthesis associated with IL-ip
stimulation (Gassner et al 2000). The decrease in NO levels due to AR-C 102222,
however, did not affect the aggrecan mRNA levels detected. The use of the cytokine
cocktail allows for the activation ofmultiple signalling pathways that may allow
alterations in aggrecan mRNA levels through NO-independent mechanisms. The
study of the effects of the inhibitor on the single cytokine mediated decreased
proteoglycan levels would address this problem.
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The NO donor SNAP was used to identify the effect ofNO alone on aggrecan mRNA
levels. SNAP has previously been shown to mimic the effects of IL-1 (3, decreasing
PG synthesis (Hauselmann et al 1994). There was no alteration in aggrecan mRNA
levels following SNAP incubation at a range of concentrations. The experimental
conditions may however have resulted in an increased rate ofNO release from SNAP
inducing alterations in aggrecan mRNA levels that were restored before they were
measured at 4 and 12 hours. Alteration in the culture conditions or the use of a range
ofNO donors at a series of time-points would allow a better evaluation of the effects
ofNO on aggrecan mRNA levels.
The iNOS inhibitor and SNAP experiments suggest that the cytokines may be acting
in an NO-independent fashion to decrease aggrecan mRNA levels. This has been
previously suggested by other studies that have shown NOS inhibition only partially
reverses IL-1 (3 mediated decreases in PG synthesis. Direct effects on gene promoter
activity through transcription factor induction is likely to be one mechanism through
which these proinflammatory cytokines could influence PG synthesis. The aggrecan
promoter contains two NFkB sites as well as STAT and AP-1 sites (Valhmu 273,
6196 1998). These transcription factors are induced by the proinflammatory
cytokines, providing a mechanism through which they could downregulate aggrecan
gene expression. Four shear stress response elements have also been identified that
provide a mechanism by which MS can influence aggrecan mRNA levels (Valhmu
1998).
It has also been suggested that the superoxide radical is required for NO mediated
decrease in PG synthesis. Reduced levels of superoxide would therefore prevent NO
from having a negative effect. This could result from the action of the enzyme
superoxide dismutase (SOD) that scavenges free oxygen radicals. Detection of SOD
within chondrocytes may therefore explain the lack of effect of SNAP. Mechanical
strain decreases cytokine induced NO levels. However, decreases in SOD levels or
activity due to mechanical strain may increase the level of proteoglycan degradation.
The level of glutathione within the cell may also be important and should be
monitored as it binds NO and inhibits its action within the cell.
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Although the C20A4 and C28I2 cell lines can be induced to produce iNOS mRNA by
proinflammatory cytokines, they do not produce iNOS protein or nitrite under any
conditions tested. These cells have also been shown to produce PG synthesis in
response to mechanical stimulation (Zhou et al submitted for publication). This
suggests that they may be used as a model to investigate the effects of cytokine
stimulation on PG synthesis in the absence of iNOS.
The effects ofNO within cartilage are difficult to understand as both pro¬
inflammatory and anti-inflammatory effects have been reported in different systems.
Indeed, even within the same system NO can act to decrease proteoglycan synthesis
while preventing proteoglycan breakdown through inhibition ofMMP activity. NO is
a highly reactive molecule that can have a variety of effects depending upon the
molecules present within its environment. The ability ofNO to react with cysteine
and iron containing molecules provides a mechanism through which it can influence
many molecules within the cell. Understanding NO and the possible mechanisms by
which it may be functioning in tissues in patients with OA and inflammatory arthritis
is therefore an important area for study.
This study has demonstrated that mechanical stimulation can be used as an anti¬
inflammatory tool that operates through the reversal of cytokine stimulated NO
production. However the complex interactions ofNO require elucidation in order to
determine if the decrease in NO production does indeed have an anti-inflammatory
effect. Further study is therefore required to determine the mechanism(s) through
which MS inhibits iNOS production.
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Chapter 7 - Future work and future directions
The research contained within this thesis provides a number of answers to questions
which have been posed throughout the course of the study. The answers to these
questions have invariably led to the posing of further questions, and it is these and the
potential strategies that could be adopted to address them that this chapter aims to
discuss.
The first thing that requires attention is the number of replicates. Human
chondrocytes show a large amount of variation in their responses and this influences
the level of statistical significance. Thus, increased replicates would increase the
power of the results.
The two main areas of this study that would be of interest to further research are;
- How do cytokine and mechanical stimulation pathways interact during
iNOS production?
What are the effects ofNO on matrix regulation?
Investigation of the interaction between cytokine and mechanical
stimulation
These studies have been carried out in monolayer culture, enabling the extraction of
mRNA, protein and assay of enzyme activity immediately at the end of each
experiment. This has allowed the investigation of the pathways through which
mechanical strain may be influencing the level of iNOS production following
cytokine stimulation. We have shown that blocking of the pi integrin and the release
of IL-4 has no effect on this mechanically induced suppression of cytokine induced
iNOS. Further studies would need to increase the number of replicates of these
experiments as well as investigating other strategies that could be adopted to confirm
these results. This could include the use of gene mutational studies to determine the
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importance of these molecules or the use of other pharmacological inhibitors. The
next step would be to investigate the other mechanisms that may be involved. This
would include the use of pharmacological stretch activated ion channel blockers such
as apamin, other integrin blocking antibodies as well as blockers of other cell surface
molecules such as CD44.
The inhibition of signalling molecules that are common to both pathways using
pharmacological inhibitors would also be of interest. The use of knockouts for certain
signalling molecules could be beneficial in studying this. The activation ofMAPK
that lead to NFkB activation is likely to play a role in the interaction between
mechanical and cytokine signalling pathways. The uses ofmobility shift assays to
track the activation ofNFkB as well as the production of iNOS could be used as a
measure of interaction between mechanical and cytokine signalling.
Gene chip technology where a large number of genes can be simultaneously analysed
may be beneficial within these studies, allowing a more global understanding of the
interactions between cytokine and mechanical stimulation pathways. This may
identify further molecules of interest that should be monitored in more detail.
Monolayer culture is not ideal, however, as the cells are extracted from their 3-d
matrix and allowed to proliferate. Despite the fact that they have been shown to retain
their chondrocyte phenotype in monolayer for the duration of our study the cells will
not be attached to the matrix in the same way as in vivo so will sense strain
differently. There will also be altered exposure to the cytokines due to the lack of
matrix. The use of 3-d culture in alginate has been used in the study of chondrocytes.
This provides a similar conformation to the in vivo situation so is a better model for
the study of chondrocytes. The problem has been that, until recently the extraction of
protein from this was difficult to achieve without exposing the cells to conditions that
would alter their composition from that seen at the end of the experimental protocol.
Flowever, the development of this technique makes it an exciting prospect to be able
to take our studies and assess their relevance and reproducibility within 3-d culture.
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Investigation of the effects of NO on matrix regulation
These studies have shown that cytokine stimulation led to the decrease of aggrecan
mRNA levels at 4 and 12 hours. However, investigation of the effects ofNO on
aggrecan mRNA levels within our system have failed to directly link this decrease to
the increased iNOS production and activity. These have been carried out using an
iNOS inhibitor and NO donor. The increasing of the number of replicates would be
beneficial here, increasing the power of these results and allowing more confidence
when changes are monitored.
The level of aggrecan mRNA was detected at 4 and 12 hours. Some literature
suggests that to detect an effect would require looking at an earlier time point, so this
would be of value to study. The use of some other available inhibitors, including
1400W or GW274150 may be of use. Similarly an NO donor from the increasing list
of those commercially available that releases NO at a slower rate, such as glyco-
SNAPs or NONOates may enhance these studies.
These studies began the process of investigation of the effects ofNO on aggrecan
mRNA levels using knockout mice, however time constraints and difficulties
obtaining the mice allowed for only one experiment to be carried out. This would
obviously need to be repeated in order to gain results of any significance that
conclusions could be drawn from, but would be a worthwhile exercise in
understanding the effects ofNO on aggrecan levels.
Aggrecan mRNA levels were detected at 4 and 12 hours in these studies. This allows
an understanding ofwhat has happened to the mRNA levels at these time points.
However, in order to show how these levels have been affected it would be necessary
to monitor mRNA degradation or synthesis. This could be achieved through the use
of pharmacological inhibitors ofmRNA synthesis and degradatory pathways. It
would also be beneficial to study the changes in aggrecan mRNA levels at different
time-points. This would allow an understanding of how these levels alter over time.
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These studies only show what is happening to the aggrecan mRNA levels. It would
be necessary, therefore, to enhance this research by measuring the levels of aggrecan
protein produced. The detection of aggrecan breakdown epitopes in the medium of
cultured cells using specific antibodies may also be of interest.
Although aggrecan is the major proteoglycan in cartilage there are many other
molecules present. It would therefore be of interest to monitor the effect ofNO on
several of these molecules such as collagen II or the proteoglycans, decorin and
fibromodulin. The potential number quantity of work involved in this means that an
initial study using a gene chip may allow the identification of certain molecules that
are worthy of further study.
The other consideration is the conditions under which these cells are cultured. This is
in light of recent evidence suggesting factors such as oxygen tension may influence
the response of chondrocytes to molecules such as NO. It would therefore be of
interest to determine if alteration of oxygen tension would influence the level of
aggrecan mRNA within our system following proinflammatory cytokine stimulation.
The final consideration again stems from these studies being carried out in monolayer.
The use of a model that more closely mimics the in vivo environment must be
favoured. The repeating of these studies in 3-d culture would therefore be of
considerable interest.
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Appendix 1 - Acridine Orange Staining
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Figure 7.1 - Acridine orange cell viability studies using experimental conditions following
4 hour (I and II) and 12 hour (III and IV) incubation. CYT=Cytokine cocktail stimulation.
MS=Mechanical stimulation. BetalAb=pi integrin function blocking antibody (lpg/ml).
IL-4Ab=IL-4 neutralising antibody (lpg/ml). I=Inhibitor AR-C102222 at 10"4, 10"5 and 10"
6M. n=l
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Appendix 2 - MTT Assays
(I)
12hr
Figure 7.3 - MTT assays looking at cell viability under experimental conditions at (I)
4 hours and (II) 12 hours. CYT=Cytokine cocktail stimulation. n=3. *p<0.05













Figure 7.4 - MTT assays looking at cell viability under experimental conditions at (I)
4 hours and (II) 12 hours. I=Inhibitor AR-C102222 at 10" , 10"5 and 10"6M.
CYT=Cytokine cocktail stimulation. n=3. *p<0.05 (paired t test used).
216
Appendix 3 - Sample details








CYT+MS 22/06/03 DS031c TA II 9
27/06/03 DS037c TA I 10
28/06/03 DS037c FA II 11
24/05/03 DS008/9c 10
17/06/03 14038 TA II 11
06/12/02 166WGH373c
CYT+MS+piAb 22/03/04 14080 FA II 10 66 year old Female
08/03/04 DS206c FA II 11
10/02/04 DS184c FA I 11
14/02/04 14077 TA II 8 70 year old Male
CYT+MS+IL-4Ab
(monoclonal)
18/04/04 DS248c TA II 11
03/10/03 DS104c TA I 9
23/09/03 DS087c FA I 11
11/11/03 DS126c FA I 12
29/03/04 14081 11 72 year old Female
CYT+MS+IL-4Ab
(polyclonal)
03/09/03 DS079c TA III
05/09/03 14056 FA II 54 year old Female
1L-1 concentration 21/11/03 DS130c FA II 10
21/05/04 14089 TA 9 73 year old Male
16/04/04 DS248c TA II 11
18/04/04 14085 FA II 9 53 year old Female
IL-1 complete 18/04/04 14085 FA II 9 53 year old Female
06/04/04 DS242c FA II 7
09/04/04 DS230c FA II 10




17/06/03 14038 TA II 11
18/04/04 DS248c TA II 11
11/05/04 14087 FA 11 56 year old Female
21/05/04 14089 FA 9 73 year old Male
SNAP 28/06/03 DS037c FA II 11
24/05/03 DS004/8c 10
24/05/03 DS008/9c 10
MTT 24/05/04 DS274c TA II
31/08/04 DS335c FA 76 year old Male
03/09/04 14099 TA 72 year old Male
Acridine Orange 05/09/04 14099 FA 9 72 year old Male
28/09/04 14101 TA 11 72 year old Male
Table 7.1 - Sample details for experimental sets. CYT=Cytokine cocktail stimulation.
MS=mechanical stimulation. piAb=(31 integrin function blocking antibody. IL-
4Ab=IL-4 neutralising antibody. Inhibitor=AR-C 102222. SNAP=NO donor. MTT
and Acridine orange = cell viability. FA=fibial abnormal. TA=Tibial abnormal.
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Accelerated proteoglycan synthesis in human chondrocyte cell lines following cyclic
mechanical strain is associated with inhibition of neuronal nitric oxide synthase.
Rheumatology 41, Abstracts supplement I, pi25 abstract number 351 (2002)
A novel highly selective quinazolinamine inhibitor of iNOS inhibits nitrite
production, but not iNOS protein, in cytokine stimulated articular chondrocytes from
patients with osteoarthritis. Osteoarthritis and Cartilage 11, Supplement A, SI 00,
abstract number P280 (2003).
Cyclic mechanical stimulation decreases inducible nitric oxide synthase levels
through a [31 integrin independent pathway in primary osteoarthritic human articular
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